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1 Granulocytes, mediators of inflammation
The human body contains about five liters of blood, accounting for 7% of body weight. Red blood cells constitute
about 45% of this volume and white blood cells around 1%, the rest being the liquid blood plasma. The white blood
cells, or leukocytes, can be sub-divided into: granulocytes, monocytes and lymphocytes. The granulocytes, as their
name suggests, contain many granules in their cytoplasm. They represent the largest group of leukocytes and can
themselves be subdivided in neutrophils, eosinophils and basophils. Neutrophils are the most common type of
granulocytes and are also called polymorph nuclear cells, due on their multi-lobed nucleus. Their main task in the
human body is to phagocytose and destroy invading microorganisms especially bacteria 1. Eosinophils, which form
the second group help to destroy invading parasites and are involved in allergic inflammatory responses 2. Most
leukocytes function in tissues while blood acts to transport cells to where they are required. Normally, granulocytes
have a short life span and undergo spontaneous apoptosis. However, upon interaction with inflammatory cytokines,
their life span can be increased 3.
A local infection or injury in tissue rapidly attracts leukocytes to the effected region as part of the inflammatory
response, helping to fight the infection or heal the wound. This complex inflammatory response is mediated by
multiple inflammatory proteins, which are produced locally by a variety of cells. Once, the granulocytes have arrived
at the inflammatory site, they recognize opsonized microorganism’s. They express surface receptors, allowing them
to attach to a variety of microorganisms. Granulocytes ingest the infecting microorganisms by a process known as
phagocytosis. The ingested bacteria are then killed by reactive oxygen species (ROS) derived from superoxide
produced by an activated, phagosome bound, NADPH-dependent oxidase 4 and proteolytic enzymes released from
intracellular granules 5. Additionally, other proteins produced at the inflammatory site by, for example, by the
granulocytes themselves, are released into the blood and stimulate the bone marrow to produce more granulocytes.
This result in a positive feedback loop recruiting more immune cells to the site of inflammation. Finally, for rapid
resolution of inflammation, granulocyte apoptosis and the subsequent recognition and removal of these apoptotic
cells by macrophages is important 6. The molecular mechanisms underlying regulation of these neutrophil effector
functions (described later in more detail) are complex and still not completely understood.
This efficient and aggressive response makes the granulocyte an efficient killer of, and protector against, invading
pathogens 1. Consequently, a defect in their functionality can lead to dramatic immune failure, such as that observed
in chronic granulomatous disease (CGD), a disorder of the NADPH dependent oxidase 7, Chediak-Higashi syndrome
(caused by a granule defect) 8 or neutrophil adhesion deficiencies 9. Additionally, dysregulation of one of the effector
functions can result in chronic inflammation, which can cause aspecific tissue damage and improper tissue
functioning 10. Inflammatory disorders such as Chronic Obstructive Pulmonary Disease (COPD) or Allergic Asthma
are both characterized by chronic lung inflammation. COPD is correlated with neutrophils infiltrated into the lung
and chronic asthma with infiltrated eosinophils, contributing to the pathogenesis of these inflammatory disorders 11-
14. Correct differentiation towards mature and functional granulocytes, as well as proper and tight regulation of
granulocyte effector functions, are therefore critical to eliminate invading pathogens in our body, without inducing
chronic inflammation.
2  Maturation of human granulocytes
Hematopoietic progenitor cells present in the bone marrow can differentiate into lymphoid and myeloid lineages.
Cells of the lymphoid lineage consist of T- and B-cells and are involved in humoral- and cellular defense. The innate
immune system is composed of cells of the myeloid lineage and includes the monocytes, macrophages and
granulocytes. The maintenance of normal numbers of these terminally differentiated cells is regulated by continuous
self-renewal, control of proliferation and differentiation of CD34+ hematopoietic stem cells. This process is closely
coordinated by expression of, cytokines and colony stimulating factors, their receptors, and transcription factors 15-19.
General myelopoiesis is driven by cytokines, such as GM-CSF and IL-3 20; 21. However, terminal differentiation
towards the neutrophilic and eosinophilic lineage can be directed by G-CSF and IL-5 respectively 15. Based on
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nuclear shape and formation of granules, neutrophil differentiation can be divided into several stages 22: myeloblast,
promyelocyte, myelocyte, banded cells, which contain a banded-shaped nucleus, and segmented cells, which contain
a segmented-shaped nucleus (Fig. 1). During maturation, proteolytic enzymes and membrane-bound proteins are
synthesized and stored in granules. At the stage of the myeloblast or pro-myelocyte, formation of azurophilic
granules occurs, which are characterized by their content of hydrolytic and anti-bacterial proteins such as elastase,
defensins and myeloperoxidase (MPO) 22 (Fig. 1). At the myelocytic stage, specific granules arise which
predominantly express lactoferrin and are characterized as MPO negative. At this stage, synthesis of the fMLP
receptor and CD11b (β2 integrin) is initiated and these stay present in the membranes of the granules formed at this
stage of differentiation 23; 24. Gelatinase positive granules belonging to the specific granules are formed around the
stage of banded cells. Finally, at the segmented stage of the neutrophil the secretory vesicles are formed, of which the
membranes are rich with receptors 19; 25-27. Mature granulocytes express a large number of receptors not only on the
membrane of the granules but also on the cell surface. Under normal conditions, granulocytes, especially neutrophils,
have a short life span and spontaneously undergo apoptosis 28. However, when infection or inflammation is ongoing,
the receptors expressed on the cell surface are stimulated by inflammatory mediators. This results in extension of
their life span, and activation of granulocyte effector functions, which finally leads to elimination of pathogens
(described in more detail in paragraph 1.5).
Figure 1: Maturation of human granulocytes.
Differentiation of hematopoietic stem cells towards neutrophils involves several stages. Myoblast, myelocyte, metamyelocyte,
banded cells and segmented cells. At the stage of the myeloblast the  formation of azurophilic granules occurs containing the
component synthesized at that stage as indicated. At the myelocyte stage specific granules are formed with lactoferrin as a
component. At the metamyeloid/banded stage gelatinase positive granules are formed and finally at the last stage the segmented
granules are formed. At which stage differentiation of eosinophils diverge from the neutrophilic lineage is unclear.
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3   Surface receptors involved in granulocyte activation
Several classes of receptors, expressed on the surface of human granulocytes have been shown to be important for
granulocyte differentiation, priming or activation. Important groups of cell surface receptors expressed by
granulocytes are the cytokine receptors, the tumor necrosis factor (TNF) receptors, the G-protein coupled receptor
(GPCR) family, the integrins and Fc receptors. Upon ligand binding, cytokine receptors undergo homodimerization,
and TNF receptors undergo oligomerization to form trimers 29. The GPCRs include those for formyl-peptides
(fMLP), Platelet Activating Factor (PAF) and Interleukin-8 (IL-8) 30; 31. These receptors transduce signals through
associated G-protein subunits that interact with the intracellular tail of the receptor. Integrins and Fc-receptors also
represent an important group, and these single-transmembrane-domain receptors require cross-linking for activation
32. In this thesis work is mainly focussed on the cytokine receptors and the G-protein coupled receptors.
3.1   Signaling through Cytokine receptors
Cytokines can induce proliferation, differentiation, priming and survival signals in human granulocytes by binding to
their cognate receptors. The cytokine receptor family consists of (i) Growth Hormone Receptor subfamily, which
form homodimers, such as the granulocyte colony stimulating factor receptor (G-CSFR), (ii) the interleukin-3 (IL-3)
receptor subfamily, which form heterodimers with a common chain (βc), e.g. IL-3R, IL-5R and GM-CSFR, (iii) the
IL-6 receptor subfamily, which form complexes with gp130, (iv) the IL-2 receptor subfamily which form complexes
with IL2Rγ, and (v) the class II cytokine receptor family which includes the IL-10 and interferon receptors 29.
Dimerization of cytokine receptors results in a conformational change, leading to receptor activation. These receptors
do not contain an intrinsic kinase domain, but their activation is mediated by binding of cytoplasmic tyrosine kinases
such as Src kinases (Lyn, Hck and Fes) and the Janus Kinase family (JAK) 33-35. Upon cytokine binding to the
receptor, JAKs can directly phosphorylate tyrosine residues in the cytoplasmic tail of the receptor 36; 37. These
phospho-tyrosines can then recruit cytoplasmic signaling molecules containing SH2-domains to the receptor
complex, such as members of the signal transducer and activator of transcription (STAT) family 38. Other signaling
molecules are activated by receptor phosphorylation, which include small GTPases such as p21Ras, and
phosphatidylinositol-3-kinase (PI3K) 39-41. The adaptor protein Shc docks to the phosphorylated receptor and in turn
interacts with mSos, an exchange factor for p21Ras. Activated p21Ras can subsequently activate the Raf-MEK-
MAPK pathway 42; 43. Initiation of the PI3K pathway at receptor level is not completely clear. However, it has been
suggested to be dependent on the activity of Src kinases 44; 45. An alternative mechanism has been demonstrated for
the βc. In this model, serine phosphorylation of the βc, mediated by protein kinase A, forms a docking site for the 14-
3-3 adaptor protein. This association is needed for PI3K recruitment to the receptor and activation of downstream
targets for PI3K 46.
3.2   Signaling through G-protein coupled receptors
Chemoattractants and chemokines are important inflammatory mediators for granulocytes, and they activate G-
protein coupled receptors (GPCRs) expressed on the cell surface 47. Chemokines are small proteins with four
conserved cysteine residues forming two essential disulphide bonds and can be divided into CXC and CC, C and
CX3C chemokines. To date a large number of chemoattractant receptors have been cloned 48; 49. These include the
fMLP and C5a receptor, sixteen CXC chemokine receptors (CXCL1-CXCL16), twenty eight CC chemokine
receptors (CCL1-CCL28), two C chemokine receptor (XCL1,2) and one CX3C chemokine receptor (CX3CL) 50. All
these receptors possess seven transmembrane domains, which are characteristic of G-protein-coupled receptors.
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Seven-membrane spanning or “serpentine” receptors are characterized by the association of heterotrimeric G-
proteins with the cytoplasmic tail of the receptor and therefore also termed G-protein coupled receptors 51. These
heterotrimeric G-proteins consist of an α- and a βγ-subunit. Agonist binding to the receptor results in the exchange of
GTP for GDP on the Gα subunit, resulting in dissociation of Gβγ. Twenty seven different α subunits have been
described, and these can be subdivided into four groups based on sequence homology and interaction with effector
molecules: Gαi, Gαq , Gαs and Gα12 52. Furthermore, there are five different β subunits and 10 different γ subunits.
Chemoattractant receptors, such as the IL-8 receptor or fMLP receptor, are coupled to Gαi proteins, a class of G-
protein that is sensitive to pertussis toxin (PTX) 53. PTX is a bacterial toxin that specifically modifies a subset of Gα
subunits including Gαi, but not the α subunits of the Gs, Gq or G12 classes. Evidence exist that chemoattractant
induced signaling is mediated by the Gβγ subunits. It has been demonstrated that the βγ subunit released from Gαi
proteins can activate phospholipase (PLC) β2 54-57. Indeed, purified Gβγ proteins can directly activate recombinant
PLC-β2 as well as PLC-β3 58-60. In addition, PI3K activation, which is also stimulated by chemoattractants, has also
been described to be activated directly by βγ subunits 61. Based on this, together with the finding that many responses
to chemoattractants are PTX sensitive, a role for the Gαi and βγ has been suggested to mediate chemoattractant
induced responses in human granulocytes.
4   Signaling pathways regulating granulocyte activation
The final activation state of human granulocytes is dependent on the stimulus, the receptor-type and the intracellular
signaling pathways which are activated. Although a plethora of intracellular signaling molecules are activated upon
stimulation of human neutrophils, it is still unclear which signal transduction pathways specifically lead to priming
versus activation of these phagocytes. This section focuses on signaling “modules” activated by a wide variety of
stimuli. These pathways, which include the small GTPases, MAPK, PI3K and Ca2+/calmodulin have been suggested
to play critical roles in regulating neutrophil effector functions.
4.1   Small GTPases
small GTPases play a crucial role in transducing signals from receptors to downstream effector molecules. They can
be divided into the Ras superfamily, which includes Ras, Rap1 and Ral 62; 63 and the Rho family, which includes
RhoA, -B and -C, Rac1 and -2 and Cdc42 64. All GTPases cycle between inactive GDP-bound forms and active GTP-
bound forms. GDP-GTP exchange and hydrolysis of GTP to GDP are catalyzed by guanine nucleotide exchange
factors (GEFs) and GTPase activating proteins (GAPs), respectively 65. Binding of GTP occurs due to the fact that
GTPases have a high affinity for GTP and because GTP is in a ten times molar excess over GDP in the cytosol.
GEFs enhance GTP-binding by stabilizing the nucleotide free transition state during the exchange of GDP for GTP.
As suggested by their name, GTPases can themselves hydrolyze the bound GTP to GDP. GAPs enhance this intrinsic
GTPases activity. Several small GTPases have been implicated in regulating neutrophil function. Activation of Ras 66
and Rap1 67 by both cytokines and chemoattractants has been reported in human neutrophils, while Ral is only
activated upon chemoattractant stimulation via GPCRs 68. Ras has been shown to activate MAPK and PI3K, both of
which are thought to be important in granulocyte function  66; 69; 70. Additionally, a role for Rap1 in activating the
respiratory burst has been postulated, possibly by playing a role in the correct targeting or assembly of the NADPH
oxidase complex 67. Within the Rho family, Rac2 is highly expressed in human neutrophils and is activated upon
stimulation of serpentine receptors but not by stimulation with GM-CSF or TNF 71. Rac2 has also been shown to be
present in the NADPH oxidase complex of human neutrophils where it is critical in the production of reactive
oxygen species (ROS) 72-75. Additionally, a role for the Rho family of GTPases in actin polymerization and migration
has been demonstrated 64. Rac is known to regulate actin assembly in a variety of cells, resulting in cell spreading
and the formation of lamellipodia 76. RhoA activity has been suggested to play a role in the generation of stress fibers
or focal adhesions. In leukocytes however, focal adhesions and stress fibers are not formed. Additionally, RhoA has
been implicated in generation of actomyosin-based contractility, via the activation of Rho kinase (ROCK) 64 and in
Introduction
16
human granulocytes, a role for RhoA and ROCK in the detachment of migrating granulocytes has recently been
demonstrated 77.
4.2   Mitogen Activated Protein Kinases
Mitogen-activated protein kinases (MAPKs) form a three-component kinase module, consisting of a MAPK, an
upstream MAPK kinase and a MAPK kinase kinase (Fig. 2). MAPKs can be subdivided into three families: the
Extracellular Regulatory Kinases (ERKs), p38 kinases and c-Jun amino-terminal Kinases (JNKs) 78. For activation,
MAPKs require phosphorylation on a tyrosine and threonine residue by MAPKKs, which are characteristically dual
specificity kinases catalyzing the phosphorylation of both sites 70.
Figure 2:  MAPK regulated pathway
The best characterized MAPK cascade consists of Raf isoforms (MAPKKK), MEK1/2 (MAPKK) and ERK1/2
(MAPK) and is regulated by the Ras small GTPase 79. This pathway is thought to be important for growth and
differentiation of various cell types. However, in terminally differentiated, non-dividing cells, such as neutrophils
this pathway may play an additional role. p38 MAPK and JNK tend to be activated by cellular stress including heat
shock, osmotic shock, cytokines, anti-oxidants, UV and DNA damage. JNK is thought to be involved in mitogenic or
anti-apoptotic signals, while p38 has been found to play a role in stress induced apoptosis. 78. In neutrophils, LPS,
fMLP, PAF and GM-CSF can all activate ERK1/2 80; 81. In general, TNFα fails to activate ERK1/2, although
contradictory findings have been reported 66; 82; 83. p38 activation is also widely induced by agonist stimulation of the
various receptor classes, although GM-CSF induced p38 activity is minimal 82. JNK has been demonstrated to be
activated by GM-CSF, IL-3, IL-5 and TNFα in human and mouse hematopoietic cell lines 80. However, stimulation
of JNK activity in human granulocytes has so far not been demonstrated 81; 82.
4.3   Phosphatidylinositol 3-kinase
Another signal transduction pathway playing a critical role in both the priming and activation of human neutrophils
involves a lipid kinase, phosphatidylinositol 3-kinase (PI3K). This enzyme phosphorylates the D-3 position of the
inositol ring of phosphatidylinositol (PI), PI(4)phosphate and PI(4,5)diphosphate. PI3K consist of two subunits, a
catalytic subunit and an adaptor subunit and can be divided into several classes. Class I PI3K can be subdivided into
two groups according to the associated subunits 84. Class 1A PI3Ks (p110α/β) associate with adaptor subunits
containing Src homology-2 (SH2) domains and are activated by binding to phosphorylated tyrosine residues. Class
1B PI3Ks (p110γ) however, are stimulated by G-protein βγ subunits, and do not interact with the SH2-domain-
containing adaptors, but associate with the adaptor molecule p101 85 (Fig. 3A). It has been demonstrated that GM-
CSF, PAF and fMLP all stimulate PI3K activity 66; 86. Interestingly, in neutrophils, GPCRs are capable of activating
both, Class 1A and 1B 66; 87; 88. PI3Ks themselves can regulate a diverse group of downstream serine/threonine
kinases including PKC isoforms, p70 S6 kinase and Protein Kinase B (PKB) 89. Phosphorylation of PI(4)P or
PI(4,5)P2 by PI3K leads to formation of PI(3,4)P2 and PI(3,4,5)P3. These lipid products form docking sites for
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proteins containing a PH domain. PKB was one of first the proteins identified as containing a PH domain, and a firm
link between PI3K and PKB activation has been established 90. Activation of PI3K results in PKB translocation to the
membrane (Fig. 3A). However for full activation, PKB needs additional phosphorylation on threonine 308, localized
in the kinase domain and on serine 473 in the C-terminal regulatory region of PKB (Fig. 3B). Phosphoinositide-
dependent kinase-1 (PDK1) was identified by its ability to phosphorylate PKB at threonine 308 in vitro in the
presence of PI(3,4)P2 or PI(3,4,5)P3 91. Integrin linked kinase (ILK) has been shown to phosphorylate PKB on Ser
473 in vitro and when over expressed in cells 92. However, other studies have indicated that ILK may not directly
phosphorylate PKB at Ser473 93. Other findings have shown that PDK1 can interact with a region of the C-terminus
of the protein kinase C-related kinase-2 (PRK2), termed the PDK1-interacting fragment (PIF) 94. This interaction
converts PDK1 from an enzyme that phosphorylates PKB on only Thr308, to a kinase that phosphorylates both
Thr308 and Ser473 of PKB. However, a more recent report has suggested that the PIF-binding pocket in PDK1 is not
actually required for PKB phosphorylation 95, thus it remains unclear which kinase is responsible for Ser473
phosphorylation in vivo. Additionally, agonists that increase intracellular Ca2+ levels have been reported to activate
PKB in a PI3K-dependent manner. PKB phosphorylation was reported to be mediated by Ca2+/calmodulin dependent
kinase kinase (CaMKK) on threonine 308 96 (Fig. 3B). PKB activity correlates with survival signals in many cell
types, and it has been shown that it can inactivate pro-apoptotic molecules, such as glycogen synthase kinase 3
(GSK-3) and forkhead transcription factors 97. In human neutrophils, activation of PI3K and PKB can occur upon
stimulation of almost all cytokines, chemoattractants and chemokines 98 and a role for PI3K in the neutrophil effector
functions has been proposed in many studies 66; 87;  99.
Figure 3: PI3K regulated pathway
Activation of PI3K can occur via activation of serpentine receptors or cytokine receptors. In general PI3Kγ can be activated by
GPCRs via the βγ subunit of G-protein. PI3Kα can be activated by upon activation of cytokine receptors. Activated PI3K
phosphorylates lipids in the membrane thereby creating a docking site for PH domain containing proteins such as PKB (A). For
full activation PKB needs to be phosphorylated on Threonine 308 and Serine 473. Ser 473 is phosphorylated by PDK1 which is
similarly recruited to the membrane. Phosphorylation of Thr 308 possibly occurs via the PIF domain of PRK2 generating a PDK1
which can phosphorylate both sites or directly via CaMKK or ILK (B).
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4.4   Ca 2+, calmodulin and Ca2+-Calmodulin dependent kinases
In resting cells, the intracellular Ca2+ concentration ([Ca2+]i) is kept low (approximately 10-100 nM). It is transported
out of the cytosol by Ca2+-ATPases in the plasma membrane or in the intracellular stores such as the endoplasmatic
reticulum. Upon stimulation of G-protein-coupled receptors by agonists such as fMLP, IL-8, C5a and PAF, or
engagement of integrins and Fc-receptors, activation of phospholipase-C (PLC)β or PLCγ occurs 100. PLCβ and
PLCγ catalyze the conversion of phosphatidylinositol 4,5,-biphosphate (PIP2) into diacylglycerol (DAG) and inositol
1,4,5-trisphosphate (IP3). DAG activates protein kinase C, and IP3 induces Ca2+ release from stores by binding to IP3
receptors 101. The fast release from the internal stores is followed by a later entry of extracellular Ca2+ across the cell
plasma-membrane. Both, duration and localization of changes in [Ca2+]i, and the intracellular distribution of Ca2+
effector proteins can determine the effect of Ca2+ on cellular functions.
The effects induced by changes in [Ca2+]i are mediated by EF-hand motif containing proteins, such as calmodulin
102. Calmodulin is a 17 kDa, ubiquitously expressed molecule which undergoes a conformational change upon
binding of four Ca2+ ions 103. Ca2+-bound calmodulin targets downstream effector molecules by binding to their
calmodulin binding domain (CBD) and inducing activation of these targets (Fig. 4A). An important group of
Ca2+/Calmodulin-dependent proteins are the CaM kinases, which include CaMKI, II, IV and CaMKK 104. As well as
the CBD, CaMKs contain an autoinhibitory domain (AID). In an inactive state, the autoinhibitory domain functions
as a pseudo-substrate, interacting with the more N-terminal kinase domain. Upon calmodulin binding, the kinase
undergoes a conformational change, whereby the interaction of the AID with the kinase domain is lost (Fig. 4B).
CaMKII is the best studied member of the CaMK family. It is ubiquitously expressed, and has been reported to
phosphorylate a variety of substrates 105. Four isoforms of CaMKII exist, as well as splice variants of CaMKII α, β, γ
and δ 106. The γ and δ isoforms are expressed in most cells whereas the α and β isoforms are predominantly
expressed in neural tissue, where they regulate long term potentiation and neurotransmitter release 105. CaMKII is an
oligomeric protein consisting of twelve subunits 107. Its activation occurs by Ca2+/calmodulin binding, and is
followed by immediate autophosphorylation on threonine 286 and 306 by intra- and inter-subunit catalysis 108; 109.
This autophosphorylation decreases the dissociation rate for Ca2+/calmodulin when the intracellular Ca2+
concentration diminishes. Furthermore, even after dissociation of Ca2+/calmodulin, CaMKII stays partially active,
resulting in a prolonged response to transient elevation of intracellular Ca2+ levels. CaMKII is localized in both the
nucleus and the cytosol. In the nucleus, it has been suggested to play a role in regulation of gene transcription by
phosphorylation the transcription factor CREB 110.
CaMKI and CaMKIV are closely related monomeric protein kinases, but their distribution in tissues and cells is
different. CaMKI is cytosolic and is ubiquitously expressed. CaMKIV is predominantly present in the nucleus and is
expressed in neural tissue, T-cells and testis 104. Both are activated by binding of Ca2+/calmodulin and their activity is
enhanced after phosphorylation by CaMKK (Fig. 5). CaMKIV becomes additionally autophosphorylated on Ser-12
and Ser-13 111. CaMKIV has been suggested to stimulate gene transcription by direct phosphorylation of CREB,
activating transcription factor 1 (ATF-1) and serum response factor (SRF) 112, possibly via Ca2+-dependent activation
of the MAPK pathway 113. The role of CaMKI is less clear, but in vitro it is able to stimulate the phosphorylation of
CREB and ATF-1 114, and of synapsin-1 and synapsin-2 115. The mechanism of CaMKK activation is comparable to
that of other CaMK family members. It has a Ca2+/calmodulin binding domain and is autophosphorylated. However,
CaMKK activity is not completely dependent on Ca2+/calmodulin binding, but rather it enhances its activity 116. The
two known isoforms, CaMKKα and β, do not seem to differ in function. However, based on similar tissue
distribution, it has been suggested that CaMKKβ is more specifically involved in regulation of CaMKIV activity 117.
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Figure 4: Activation model of calmodulin and Ca2+/calmodulin dependent kinases
(A) When Ca2+ levels rise in the cytoplasm, calmodulin undergoes a conformational change by binding four Ca2+ ions. Activated
calmodulin is then able to bind target molecules that contain a calmodulin Binding Domain (CBD), such as the family of
Ca2+/calmodulin dependent kinases. (B) CaMKs contain a catalytic domain, an autoinhibitory domain (AID) and a calmodulin
binding domain (CBD). In an inactive state, the AID acts as a pseudo-substrate by interacting with the catalytic kinase domain.
Upon calmodulin binding the kinase undergoes a conformational change and the interaction of the AID with the catalytic domain
is lost. CaMKI and IV are known to be further activated by CaMK kinase (CaMKK).
5   Granulocyte effector functions
The activation of specific intracellular pathways by the various receptor classes leads to regulation of specific
granulocyte effector functions. The molecular mechanisms involved in priming, migration, ROS formation and
apoptosis are discussed in this section.
5.1   Priming
Granulocyte functioning can be rapidly amplified by environmental factors through a mechanism termed 'priming',
which is independent of protein synthesis. For example, traces of bacterial lipopolysaccharide (LPS), which by itself
does not cause activation of the respiratory burst, induces an enhanced formation of reactive oxygen species (ROS)
upon subsequent stimulation with chemotactic factors such as fMLP 118. Activation refers to processes that lead to a
measurable alteration in cells, for example degranulation. Priming, however, refers to a process whereby the
response of cells to a subsequent (activating) stimulus is amplified if these cells were pre-exposed to a (priming)
stimulus (Fig. 5). Neutrophils are normally not activated by formyl peptides in the context of respiratory burst
activation 119. However, addition of platelet activating factor (PAF), GM-CSF and TNFα to human granulocytes
primes the generation of ROS-release upon a subsequent activation with chemoattractant 80; 120-122. Priming effects
can have distinct activation profiles depending on the agonist employed. For example, priming by LPS or GM-CSF
requires several minutes and is maximal for 30-60 minutes, whereas priming by PAF occurs very rapidly and is
maximal within a few minutes 123.
A role for Ca2+ has been suggested in certain aspects of the priming process. Indeed a transient increase in [Ca2+]i is
itself sufficient to prime human granulocytes as demonstrated by the addition of ionomycin, a calcium ionophore 124.
However, cytokines such as GM-CSF and IL-5 can induce priming without inducing a rise in [Ca2+]i. This priming
activity is accompanied by induction of protein tyrosine phosphorylation. Priming has indeed been shown to be
inhibited by protein tyrosine kinase inhibitors 125-127. MAPKs appear to be activated by almost all granulocyte
priming agents 66; 128-130, and a role for ERKs in priming the respiratory burst has been suggested 128 although this has
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not been confirmed by all studies 66; 131-134. PI3K is also thought to play a role in priming of granulocyte effector
functions. Several studies have demonstrated that addition of the PI3K inhibitors wortmannin or LY294002 to
neutrophils results in an inhibition of fMLP-stimulated respiratory burst 66; 80; 131-137. Recently it has been proposed
that the priming action of GM-CSF on neutrophil respiratory burst may involve phosphorylation of p47phox, a
component of the cytosolic NADPH oxidase complex. This phosphorylation was inhibited by wortmannin suggesting
a role for PI3K in this process 138.
Figure 5: Priming
Inflammatory factors such as PAF (released by phagocytes), GM-CSF or TNFα (released by mononuclear cells) or LPS (bacterial
component) can bring granulocytes in a pre-activated or primed state. Unprimed cells are not able to respond on for example
fMLP treatment, whereas primed cells can perform granulocyte effector functions upon fMLP treatment, such as degranulation
and respiratory burst.
5.2    Migration
Chemoattractant-induced activation leads to firm adhesion and spreading of granulocytes on the endothelium. This is
mediated by integrins expressed on their surface which interact with ligands on endothelial cells 139; 140.
Subsequently, cells migrate through the endothelial layer, towards the inflammatory site, in a process termed
diapedesis (Fig. 6). It has been suggested that neutrophils may not migrate “between” endothelial cells but actually
pass “through” cells, although this is still controversial 141. After diapedesis through the endothelium, cells migrate
towards the site of inflammation by sensing a chemotactic gradient and interacting with proteins (collagens and
fibronectin) that form the extracellular matrix 142. Signals generated by chemoattractants and cross-linking of
integrins, leads to extension of the leading front of the cells called the lamellipodium, and contraction of the rear of
the cell, the uropod. fMLP, C5a and IL-8 are potent chemotactic factors for neutrophils.
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Figure 6: Migration
During inflammation granulocytes adhere and spread to the endothelium, followed by migration through the endothelium layer
termed “diapedesis”. Sensing a chemotactic gradient, granulocytes migrate to the site of inflammation by extension of the leading
front, the lamellipodium and contraction of the rear of the cell, the uropod.
Chemoattractants can induce two types of movement; chemotaxis, which is “directed” movement, and chemokinesis
which is “non-directional” or “random” movement. Chemotaxis is predominantly induced by chemoattractants such
as fMLP and IL-8, whereas cytokines such as GM-CSF induce chemokinesis 66; 143. The signaling pathways
regulating migration have been characterized to a preliminary degree. For example, the role of ERK and PI3K has
been studied by the use of pharmacological inhibitors. Utilising boyden chemotaxis chambers, the MAPK kinase
(MEK) inhibitor PD98059 was found to have no effect on movement by cytokines or chemoattractants 66. However,
when studied in agarose migration assays, PD98059 was found to inhibit migration 144. p38 has also been implicated
indirectly in fMLP induced chemotaxis 145. However, p38 activation was not required for IL-8 induced migration 146.
In terms of a role for PI3K in migration, many contradictory findings have been reported. Inhibitors of PI3K prevent
neutrophil migration induced by GM-CSF, however no inhibition of migration is observed after stimulation with
PAF or fMLP 66. This suggests that PI3K is involved in regulating chemokinesis rather than chemotaxis. However,
another study demonstrated that IL-8 induced chemotaxis was inhibited by both wortmannin and LY294002 146.
Furthermore, knockout mice lacking PI3Kγ demonstrated an inhibited response to chemoattractant induced migration
147-149. This apparent discrepancy between human, and mouse neutrophils could be due to the involvement of other
PI3K isoforms in human neutrophils, or possibly to the use of different assay systems/conditions. Recently, it has
been suggested that PI3K effects directionality rather than motility 150. Several reports have suggested a role of
[Ca2+]i in neutrophil migration. Integrins are translocated from the uropod to the leading edge via endosomes 151 and
this appears to be a Ca2+ dependent process, since buffering of [Ca2+]i has been shown to inhibit the recycling of the
integrins. Moreover, it has been shown that eosinophils have low [Ca2+]i concentrations in the front of the cell and
high [Ca2+]i in the uropod 152. Although this has not be demonstrated in neutrophils 153, such Ca2+ distribution might
enable release of cell attachments in the uropod, since it has been proposed that uropod retraction of migrating
neutrophils requires myosin II, which is activated by a Ca2+ dependent mechanism 154.
5.3   Respiratory burst
When neutrophils have been mobilized to the site of inflammation, pathogens are removed through phagocytosis and
generation of anti-microbial oxidants by the NADPH oxidase complex in the so called “respiratory burst”. The
NADPH oxidase is a multicomponent enzyme complex that is dormant in resting cells but becomes highly active
during the phagocytosis of invading pathogens. The activated NADPH oxidase is composed of five components:
flavocytochrome b558, p47phox, and p67phox, p40phox and the small GTPase Rac2 155. Cytochrome b558 itself is
composed of two subunits, gp91phox and p22phox. In the resting state, the subunits of NADPH oxidase are localized on
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the membrane of specific granules (gp91phox and p22phox) and the cytoplasm (p47phox and p67phox and p40phox). In
response to stimulation with inflammatory mediators, the cytosolic subunits translocate to the membrane and
associate with the membrane-bound subunits to form an activated enzyme complex (Fig. 7). The core part of the
active enzyme is formed by p67phox, Rac2 and cytochrome b558. p47phox is required for the assembly of the active
enzyme complex acting as an adaptor for p67phox 156-158. The role of p40phox is thought to be a regulator of p67phox
translocation 159-161. However p40phox has also been shown to be critical for the function of the NADPH oxidase 162.
fMLP can effectively induce activation of the respiratory burst, however it requires prior priming of the cells with
cytokines, chemoattractants or lipopolysaccharides 4. It has been shown that fMLP induces translocation of p47phox to
the plasma membrane, possibly by enhancing its phosphorylation state 138. A role for the MAPKs in this
phosphorylation induced translocation has been proposed, since p47phox contains a consensus phosphorylation site for
MAPKs 138. However, most studies utilizing PD98059 have demonstrated that ERKs do not appear to play a crucial
role, since inhibition of MEK did not effect fMLP induced respiratory burst in cells primed with GM-CSF, TNFα or
PAF 66. On the other hand, inhibitors of PI3K can potently inhibit fMLP-induced respiratory burst in GM-CSF, PAF
and TNFα primed cells 66. Recently, a direct role for PI3K in the respiratory burst has been demonstrated. The Phox
homology (PX) domains of p47phox and p40phox have been found to bind to phosphorylated phosphatidylinositol-
lipids which are products of PI3K activity 162; 163. A critical role for changes in [Ca2+]i in the activation of the
respiratory burst has also been described 4; 155. Depletion of [Ca2+]i completely abolishes fMLP induced superoxide
production, while addition of Ca2+-ionophore primes fMLP induced NADPH oxidase activation 124. The mechanism
by which [Ca2+]i regulates oxidase activity still remains unclear.
Figure 7: Respiratory burst
In a resting state, the subunits of NADPH oxidase are localized to the membrane of specific granules (gp91phox and p22phox) and
the cytoplasm (p47phox, p67phox, p40phox and Rac2). In response to inflammatory mediators, cytosolic subunits translocate to the
membrane and fuse with the membrane-bound subunits to form an activated enzyme complex, which then can lead to the
formation of reactive oxygen species.
5.4   Apoptosis
Granulocyte apoptosis and the subsequent recognition and removal of apoptotic cells by phagocytes is critical in the
rapid resolution of inflammation 6. This is necessary to avoid unwanted tissue damage through the release of granule
proteases from necrotic granulocytes. In vivo and in vitro granulocytes undergo apoptosis spontaneously, however
granulocytes present at inflammatory sites have an increased life span 3. The molecular mechanisms underlying the
control of granulocyte apoptosis remain largely unknown. In culture 50-70% of neutrophils undergo constitutive
apoptosis within 20 hours; with eosinophils it can take up to two days to achieve equivalent rates of apoptosis 164; 165.
Priming agents such as GM-CSF and bacterial products such as LPS can enhance the life-span of human neutrophils.
GM-CSF induces a rapid activation of Lyn, a Src family tyrosine kinase, and Lyn-antisense treatment of neutrophils
reverses the survival-promoting effect of GM-CSF 166; 167.
Control of apoptosis in various cell types correlates with the expression of BCL-2 family proteins. The BCL-2
family includes both pro- and anti-apoptotic molecules. The ratio between these two subsets helps to determine, in
part, the susceptibility of cells to a death signal 168. Pro-apoptotic members of the BCL-2 family are thought to
control mitochondrial permeability transitions allowing the release of cytochrome c and apoptosis inducing factor
(AIF), which are both involved in the execution phase of apoptosis. Anti-apoptotic members are localized in the
membrane of the mitochiondria and are thought to act as “guardians of the mitochondria” 169. Mature human
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neutrophils do not express the anti-apoptotic protein Bcl-2, but do constitutively express the pro-apoptotic proteins
Bax, Bid, Bak and Bad 170. Eosinophils have been found to contain the pro-apoptotic Bax, but also express the anti-
apoptotic protein Bcl-xL and low levels of Bcl-2 171. This might explain differences in the rate of spontaneous
apoptosis between neutrophils and eosinophils. Expression of several anti-apoptotic family members in neutrophils
has been shown, although contradictory results have been reported 170. The expression of the anti-apoptotic Mcl-1
protein has been shown to be decreased upon the onset of apoptosis. Treatment of neutrophils with agents that delay
apoptosis increase or maintain the Mcl-1 levels, providing a mechanism to explain cytokine-mediated increased
survival 172.
Thus far, the intracellular signaling pathways regulating neutrophil apoptosis, and the expression of A1 and Mcl-1
are undefined. Within the MAPK family, a role for ERK in regulating apoptosis has been suggested, since PD98059
can inhibit GM-CSF induced survival 173. p38-dependent signaling pathways have also been implicated in regulating
neutrophil apoptosis. Apoptosis induced by stress stimuli such as UV, hyperosmolarity or sphingosine are thought to
require p38 activity 174. In contrast, Fas-induced apoptosis or spontaneous apoptosis can occur independently of p38
activation. Both pathways have been shown to utilize members of the caspase family 174. Few studies so far have
analyzed the role of PI3K in the regulation of neutrophil apoptosis. However, initial data suggests that in neutrophils,
like many other cell-types, PI3K activity is critical for cytokine-mediated rescue from spontaneous apoptosis 167; 173.
PI3K can activate PKB which in turn may phosphorylate Bad, thereby decreasing its pro-apoptotic effect 175; 176. Ca2+
may also play a role in neutrophil survival, since transient elevations in cytosolic free Ca2+ have been shown to retard
subsequent apoptosis 177. A potential mechanism for this has been suggested by the recent observation that Ca2+ can
promote cell-survival by directly activating PKB through CaMK kinase 96, although thus far this has not been
confirmed in human neutrophils.
6   Specificity in granulocyte signal transduction
As described above, granulocytes exhibit specific effector functions. However, extracellular factors, which can lead
to priming or activation of human neutrophils by binding to specific receptors activate a plethora of overlapping
intracellular signaling pathways in these cells. How then is specificity obtained in intracellular signal transduction,
resulting in regulation of granulocyte effector functions? First of all, specificity in intracellular signaling can be
achieved by the restricted expression patterns of receptors, molecular signaling molecules and/or transcription
factors. For example, expression of the IL-8 Receptor (CXCL8) is restricted to neutrophils. Similarly, the
components of the NADPH oxidase, regulating the respiratory burst, are highly expressed in human granulocytes.
Secondly, strength of activation signals can create specificity. Whereas low concentration of IL-3 in combination
with GM-CSF or EPO results in differentiation of progenitor cells towards granulocytes or erythrocytes, high
concentrations of IL-3 in the presence of the other growth factors does not lead to differentiation, but rather promotes
self renewal 178; 179. Additionally, the strength and kinetics of intracellular signaling molecules can be critical. For
example, in the PC12 cell line , transient ERK activation by EGF results in proliferation, whereas sustained ERK
activation induced by NGF results in differentiation 180. Thirdly, localization of the signaling molecules are of
obvious importance in mediating signaling specificity. Molecules which are needed for cell migration are recruited
actively to the lamellipodium and activation of the respiratory burst needs translocation of several subunits to the
membrane of the phagosome. Changes in localization can therefore dramatically effect granulocyte effector
functions. Thus specificity can be reached by regulation of expression, duration of activation, activation-strength and
localization of specific signaling molecules. Figure 8 shows an overview of the signaling molecules which are
thought to be involved in the regulation of the specific granulocyte effector functions.
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Figure 8: Signaling molecules involved in granulocyte effector functions
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7   Scope of this thesis
Human granulocytes play an important role in host defense by mediating inflammatory responses to invading
microorganisms. Defects in granulocyte differentiation or improper functioning of these cells can lead to disease
pathogenesis. Granulocyte maturation, priming and activation are under the control of cytokines and
chemoattractants. This study focuses on the intracellular signaling mechanism regulating granulocyte differentiation
and functioning. To address this, several points of research or questions were investigated.
1) What are the roles of intracellular pathways in the cytokine induced maturation of hematopoietic progenitors
towards granulocytes ?
To address this question, an in ex-vivo differentiation model was developed, in which isolated umbilical cord blood
CD34+ progenitors were differentiated towards neutrophils. In Chapter 2 we have investigated the differences in the
maturation program induced by G-CSF or a combination of IL-3 and G-CSF. By using pharmacological inhibitors
we demonstrate the importance of PI3K and MEK in the maturation process of hematopoietic progenitors towards
neutrophils.
2) Identification of novel kinases present in human granulocytes.
Since granulocytes have specific effector functions we hypothesized that specific signaling molecules could be
present in these cell. To this purpose we describe in Chapter 3 polymerase chain reaction analysis using degenerate
primers against conserved regions of kinases, leading to the identification of CKLiK. We characterize CKLiK as a
Ca2+ and calmodulin dependent kinase, whose expression is restricted to granulocytes. For analysis of the role of
CKLiK in granulocyte functioning, we describe in Chapter 4 the role of Ca2+ and calmodulin regulated pathways by
using a Ca2+ ionophore and a calmodulin antagonist. In Chapter 5 we describe the regulation and functional
characterization of CKLiK in human granulocytes, by using an antibody against CKLiK and an cell permeable
inhibitory peptide.
3) What genes are regulated by cytokines in human granulocytes?
Exposure of inflammatory mediators, such as GM-CSF, to mature granulocytes leads to a pre-activated or primed
phenotype. In Chapter 6 we identified GM-CSF regulated genes, by a differential display technology, in which the
gene encoding 5-lipoxygenase activating protein was identified as a cytokine regulated gene in vitro as well as in
vivo (Chapter 6).
Taken together this thesis provides novel insights into granulocyte signal transduction pathways and identifies
new signals that can control granulocyte maturation, priming, activation and functioning.
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Abstract
The production of mature blood cells, termed hematopoiesis, is a carefully orchestrated series of events involving
self-renewal and differentiation of primitive pluripotent stem cells. Dysregulation of this complex process can result
in severe clinical conditions ranging from aplasia of the bone marrow to leukemia. Differentiation is mediated by
processes that are initiated by specific cytokine receptors, as well as processes that are intrinsically present in stem
cells. To investigate the role of cytokine-activated signaling pathways in myeloid differentiation, we developed an
ex-vivo maturation model. In this system, human umbilical cord blood CD34+ progenitor cells can be differentiated to
mature neutrophils by addition of granulocyte-colony stimulating factor (G-CSF). First, we compared the effects of a
combined cytokine-treatment utilizing interleukin (IL)-3/G-CSF, versus only G-CSF, on proliferation and
differentiation. Maturation in the presence of IL-3 resulted in enhanced proliferation compared to G-CSF treatment
alone. However, G-CSF induced differentiation in the absence of IL-3 resulted in a greater number of terminally
differentiated neutrophils, as measured by lactoferrin- and CD11b expression, morphology, and capacity to produce
reactive oxygen species (ROS). We then investigated the role of phosphatidylinositol 3-kinase (PI3K) and mitogen
activated protein kinase kinase (MEK) in G-CSF induced CD34+ cell maturation using the specific pharmacological
inhibitors LY294002 and PD98059 respectively. Inhibition of PI3K induced cell cycle arrest, but interestingly also
resulted in impaired differentiation as was apparent by a reduction of lactoferrin positive cells and histological
staining. In contrast, inhibition of MEK resulted in reduced proliferation, without significantly effecting G-CSF
induced differentiation. These results demonstrate critical roles for both PI3K and MEK in the cytokine induced
maturation of human CD34+ progenitor cells towards neutrophils. Furthermore, our data suggest that cell cycle arrest
per se does not result in induction of an intrinsic neutrophil differentiation program.
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Introduction
Hematopoiesis is a complex and carefully orchestrated series of events involving self-renewal and differentiation of
primitive pluripotent stem cells 1. Dysregulation of hematopoietic differentiation can result in the development of a
variety of pathological conditions ranging from aplasia of the bone marrow to aberrant differentiation of myeloid
progenitors in diseases such as myelodysplastic syndromes and leukemia. The molecular mechanisms underlying
how hematopoietic cytokines exert lineage-dominant effects on the differentiation process in vivo are not completely
understood. The “inductive model” postulates that specific extracellular signals force stem cells to commit to a
particular hematopoietic lineage. This model requires that the intracellular signals generated by cytokine-stimulation
are specific and non-interchangeable 2. However, other studies have reached alternative conclusions favoring a
“stochastic model” 3. This predicts that hematopoietic stem cell fate decisions are independent of extracellular signals
and the role of cytokines is to provide non-specific survival and proliferation signals. That is, cytokines simply
permit the survival, proliferation and development of intrinsically committed cells.
The effects of cytokine-stimulation are mediated by cell surface receptors belonging to the cytokine receptor
superfamily, which signal by activating JAK tyrosine kinases 4. Interaction of cytokines with their cognate receptors
expressed on hematopoietic progenitor cells, results in activation of a plethora of intracellular signaling pathways
that are thought to control hematopoiesis by regulation of transcription 5-7. Activation of members of the STAT
transcription factor family by multiple cytokines is thought to play a critical role in the control of hematopoietic cell
growth and differentiation (reviewed in 8). For example, using a mouse myeloid cell line, LGM-1, exogenously
expressing the G-CSFR, STAT3 has been shown critical for neutrophil differentiation 9. Addition of G-CSF to these
cells resulted in a block in proliferation, down-regulation of c-myc, and differentiation into cells with lobed nuclei.
These changes were blocked by introduction of a dominant-negative STAT3 mutant. Several additional intracellular
signaling molecules are activated by multiple cytokines, including phosphatidylinositol-3 kinase (PI3K) and Mitogen
Activated Protein Kinase Kinase (MAPKK or MEK). Both signaling molecules pathways have been shown to be
induced by a variety of hematopoietic cytokines including IL-3, GM-CSF and G-CSF 10 11 12.
PI3K has been shown to be involved in growth factor dependent survival and proliferation of a variety of cell lines
13. PI3K knockout mice lacking the p110α catalytic subunit die around embryonic day 9.5, which corresponds with a
failure of the embryonic cells to proliferate 14. One mechanism for this is suggested by studies demonstrating that
PI3K is involved in the regulation of the cell cycle through transcriptional induction of cyclin D 15-17. Additionally,
the stabilization of cyclin D protein has been suggested to be PI3K-dependent 18; 19. Furthermore, PI3K appears to
play a role in down-regulation of the cyclin-dependent kinase inhibitors (CDKIs), such as p27KIP1. This is thought to
be mediated, at least in part, via inactivation of the members of the Forkhead family of transcription factors 20; 21 22.
PI3K has also been linked with survival signals 23. Transgenic mice expressing an active form of PI3K have
increased numbers of T lymphocytes exhibiting reduced apoptosis, and develop lymphoproliferative disorders 24.
Cytokine receptor activation also results in activation of the small GTPase Ras, which in turn can activate the
protein kinase Raf. Raf activates the dual-specific MAPK Kinase (MEK), which then can phosphorylate
Extracellular Regulated Kinase (ERK). Ras plays a critical role in regulating cell cycle control, possibly through
down regulation of p27KIP1 and the up regulation of cyclin D1 expression 25-29. A direct role for MEK-ERK in cell
cycle control has been proposed since treatment of cells with a pharmacological inhibitor of MEK (PD98059) or
transfection of dominant-negative ERK correlates with decreased cyclin D1 expression 30; 31.
The function of PI3K- and MEK-mediated signaling in the processes driving hematopoiesis remains unclear. In this
study we developed an ex-vivo model system based on the cytokine induced differentiation of human umbilical cord
blood stem cells towards neutrophils. Cytokines and colony stimulating factors including FLT-3 ligand, Stem Cell
Factor (SCF), Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF), Interleukin-3 (IL-3) and
Granulocyte-Colony Stimulating Factor (G-CSF) have been demonstrated to be important for granulocyte maturation
32-34. G-CSF has been demonstrated to play a critical role, as is exemplified by the neutropenia found in G-CSF
deficient mice 35. Here we investigate a role for PI3K and MEK in the cytokine-induced proliferation and
differentiation of primary human CD34+ progenitor cells towards neutrophils. We have compared maturation of
isolated primary umbilical cord blood CD34+ stem cells in the presence of either a combination of IL-3 and G-CSF,
or G-CSF alone. Differentiation in the presence of IL-3 increased the expansion of cells but reduced the number of
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mature, functional neutrophils compared to G-CSF alone. Inhibition of PI3K during G-CSF induced maturation of
CD34+ stem cells resulted in a block in proliferation and furthermore the capacity of these progenitor cells to
differentiate was also abrogated. In contrast, addition of the MEK inhibitor PD98059 during the maturation process
resulted in decreased proliferation, but no effect on differentiation. These data delineate critical roles for PI3K and
MEK in cytokine driven differentiation and proliferation of primary hematopoietic cells towards neutrophils.
Furthermore, our data suggest that cell cycle arrest per se does not result in induction of an intrinsic neutrophil
differentiation program.
Materials and Methods
Reagents
Human growth factors and cytokines were used to induce differentiation. Stem Cell Factor (SCF) and FLT-3 ligand
were purchased from Peprotech (Rocky Hill, NJ), IL-3 and G-CSF were obtained from Strathmann (Hamburg,
Germany) and GM-CSF was purchased from Endogen (Woburn, MA). The pharmacological inhibitors PD98059 and
LY294002 were purchased from Biomol (Plymouth Meeting, PA). The PE-conjugated antibody against lactoferrin
was obtained from Beckman Coulter (Mijdrecht, The Netherlands) and Monoclonal antibody against CD11b (44A)
was obtained from American Type Culture Collection (Rockville, MD).
Isolation of CD34+ stem cells and culturing towards neutrophils
CD34+ cells were isolated as previously described 36. In brief, mononuclear cells were isolated from umbilical cord
blood by density centrifugation over isotonic ficoll solution (Pharmacia, Uppsula, Sweden). Immunomagnetic
selection with hapten conjugated antibody against CD34 was used to isolate CD34+ cells (Miltenyi Biotech, Auburn,
USA). CD34+ cells were cultured in Iscove’s Modified Dulbecco’s Medium (Gibco, Paisley, UK) supplemented with
10% FCS, 50 µM β-mercaptoethanol, 10 U/ml penicillin, 10 µg/ml streptamycin, and 2mM glutamine at a density of
2-3x105 cells/ml. Cells were differentiated towards neutrophils upon addition of SCF (50 ng/ml), FLT-3 (50 ng/ml),
GM-CSF (0.1 nmol/l), IL-3 (0.1 nmol/l), and G-CSF (30 ng/ml). Every 3-4 days, cells were counted and fresh
medium was added to a density of 5x105 cells/ml. After 3 days of differentiation, cells were cultured further with IL-
3 and G-CSF and from day 7 cells were cultured in the presence of G-CSF or with G-CSF and IL-3 as indicated. In
some experiments, inhibitors were added upon isolation, and similar to the cytokines, refreshed every 3-4 days.
Morphological analysis of differentiating stem cells
Morphology of differentiating stem cells was analyzed by May-Grünwald Giemsa staining. During the maturation
process cytospins were prepared from 105 cells. Slides were dried and fixed for 10 minutes in 100% methanol and
May-Grünwald Giemsa staining was performed. In short, cytospins were stained in a 50% Eosin Methylene Blue
solution for 20 minutes according to May-Grünwald (Sigma-Aldrich GmbH, Seelze, Germany). These were
subsequently rinsed in water for 5 seconds, and the nuclei were counter-stained with 10% Giemsa solution (Merck,
Darmstadt, Germany) for 15 minutes. Cells were imbedded in entellan (Merck, Darmstadt, Germany) and covered by
a glass coverslip for preservation. Based on cytoplasmic staining and morphology of the nuclei, cells were counted as
belonging to: 1) premature cells (which include blast cell and promyelocytes); 2) myelocytes (which include
myelocytes and banded cells); 3) segmented cells, and 4) highly segmented cells.
Analysis of neutrophil differentiation markers
Lactoferrin positive cells were detected using a PE-conjugated antibody against lactoferrin (Beckman Coulter,
Mijdrecht, The Netherlands). Staining was performed as described in the manufacture's protocol, although adapted
for stem cells. In brief, 3x105 cells were first washed in PBS and resuspended in 100 µl IntraPrep fixation reagent.
After 15 minutes of incubation at room temperature, cells were washed and gently resuspended in 100 µl IntraPrep
permeabilisation reagent. After 5 minutes of incubation, anti-lactoferrin-PE was added and incubated for another 15
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minutes. Cells were washed and resuspended in PBS containing 0.5% formaldehyde. Number of lactoferrin positive
cells were detected by FACS analysis (FACSvantage, Becton Dickinson).
CD11b positive cells were analyzed using the mouse monoclonal antibody 44A against CD11b. 105 cells were
collected and washed in cold PBS2+ (PBS, 10% GPO, 10% sodium citrate). Cells were incubated for 30 minutes on
ice with anti-CD11b. Subsequently, cells were washed, and incubation was performed with a secondary goat anti
mouse FITC labeled antibody (Becton Dickinson, San Jose, CA) for 30 minutes on ice. Cells were washed and
CD11b positive cells were detected by FACS analysis (FACSvantage, Becton Dickinson).
Analysis of respiratory burst
The production of reactive oxygen species was measured by dihydrorhodamine staining. 400 µl of 1.25x106 cells/ml
were as indicated first primed with GM-CSF (10-10M) for 20 minutes at 370C. Dihydrorhodamine 123 (DHR123)
(Molecular Probes, Eugene, OR, USA) was added to a final concentration of 100 ng/ml and incubated for 10 minutes
at 370C. Respiratory burst was initiated by fMLP (10-6M) or PMA (100ng/ml). Stimulation was stopped by washing
with cold PBS2+. Cells were resuspended in PBS2+ and analyzed by FACS.
Measurement of apoptosis and proliferation.
Apoptosis of differentiating stem cells was measured by analyzing Annexin V-fluorescein isothiocyanate (FITC)
binding (Bender Medsystems; Vienna, Austria). 105 cells were washed with PBS and resuspended in binding buffer
(10 mM HEPES NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). Subsequently cells were incubated with Annexin V-
FITC for 15 minutes at room temperature in the dark, washed with PBS and resuspended in binding buffer.
Propidium iodide was added (1µg/ml) and the percentage of apoptotic cells were detected by FACS analysis
(FACSvantage, Becton Dickinson). For proliferation assays, the number of viable cells were counted by trypan blue
exclusion. Cell cycle analysis was determined as previously described 22. 3x105 cells were fixed in 70% ethanol at –
200C for 2 hours. Cells were gently spun down and permeabilized in 200µl 0.1% Triton X-100, 45mM Na2HPO4 and
25mM sodium citrate at 370C for 20 minutes. Next, 750µl of 0.1% Triton X-100, 10mM PIPES, 2mM MgCl2,
40µg/ml RNase and 20µg/ml propidium iodide, was added and incubated for 30 minutes in the dark. DNA content
was analyzed by FACS.
Results
G-CSF delays proliferation and enhances neutrophil differentiation
To investigate the role of different cytokine-activated signaling pathways in human neutrophil maturation, we
developed a system in which myeloid progenitor cells can be differentiated to mature neutrophils ex-vivo. CD34+
hematopoietic stem cells (HSCs), enriched from human umbilical cord blood (UCB), were cultured as described in
Material and Methods. Cells were passaged at day six and differentiated towards neutrophils in the presence of IL-
3/G-CSF, or G-CSF alone and the effect on both proliferation and differentiation was analyzed. Culturing HSCs with
IL-3/G-CSF resulted in a 565.2 ± 79.7 fold increase in cell number at day 16. However, treatment with G-CSF alone,
resulted in greatly reduced proliferation of CD34+ stem cells (348.1 ± 29.0) (Fig. 1A).
To quantify the neutrophilic differentiation of stem cells treated with IL-3/G-CSF, or G-CSF alone, we analyzed
the percentage of lactoferrin positive cells, a neutrophil specific granule protein, and CD11b expression on the cell
surface of neutrophils. Treatment of G-CSF compared to the combined treatment of IL-3/G-CSF resulted in a
dramatic increase in lactoferrin positive cells to 36.7%, compared with 18.6% at day 13 (Fig. 1B). The amount of
lactoferrin positive cells in the G-CSF treated population further increased to 46.7% at day 16, whereas in the
combined treatment the number of lactoferrin positive cells did notincrease further. Analysis of CD11b expression
demonstrated greatly enhanced levels at day 16 when cells were treated with G-CSF alone, compared to the
population treated with IL-3/G-CSF (Fig. 1C).
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Figure 1: Effect of cytokine treatment on the maturation of HSCs towards neutrophils.
CD34+ cells isolated from cord blood were cultured for the first three days with a cocktail of cytokines as described in Materials
and Methods. At day three only IL-3 and G-CSF were added, at day six cells were divided and cultured further with IL-3 and G-
CSF or with G-CSF alone. (A) Proliferation was analyzed by counting number of viable cells every 3-4 days and fold
proliferation was calculated. (B) Differentiation was analyzed by detection of lactoferrin positive cells at day 9, 13, and 16 as
described in Materials and Methods. The percentage of highly lactoferrin positive cells, gated as shown, was determined by FACS
analysis at 9, 13 and 16 days as described in Materials and Methods. (C) Expression of CD11b on the cell surface of
differentiating cells was detected by FACS analysis. The percentage of CD11b positive cells, gated as shown in the first figure,
are indicated (D) Determination of differentiation stage was analyzed by May-Grunwald Giemsa staining and cells were counted
as described in Materials and Methods. Representative pictures of differentiated cells at day 16 are also depicted. Graphs represent
mean percentage cells of different stages. All data represent the mean of four independent experiments.
Histological analysis of neutrophil differentiation was determined by May-Grunwald Giemsa staining as described in
Materials and Methods. Stem cells treated with G-CSF alone exhibited a maturer neutrophil phenotype, including
segmented and highly segmented cells, which represented almost 53.7% of the total population (Fig. 1D). In contrast,
cells treated with IL-3/G-CSF contained only 26.7% of mature neutrophilic cells (Fig. 1D). In Figure 1D
representative pictures of cells after 16 days of differentiation are depicted for both conditions. These results
demonstrate that the combined IL-3 and G-CSF treatment drives the expansion of the HCS more efficiently than G-
CSF, whereas G-CSF treatment gives rise to more terminally differentiated neutrophils.
Production of reactive oxygen species correlates with enhanced differentiation
Although we have demonstrated that treatment with G-CSF alone enhances neutrophil differentiation of HSC, as
determined by the expression of granulocytic markers, and histological staining, this doesn’t measure functional
maturity of these cells. Thus, we further analyzed the ability of differentiated neutrophils to produce reactive oxygen
species (ROS). ROS production by the so-called “respiratory burst” is a complex process that requires correct
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assembly of the NADPH oxidase enzyme complex. The NADPH oxidase is a multi-subunit complex composed of
five components: flavocytochrome b558, p47phox and p67phox and p40phox and the small GTPase Rac2, which all have
to be present for ROS production 37. We first tested Phorbol Myristate Acetate (PMA) induced ROS production, as
an indication of the functionality of the NADPH oxidase complex. After six days of differentiation, no ROS
production was observed in response to addition of PMA (Fig. 2A). However by day nine, the required components
of the NADPH oxidase complex were apparently present since PMA-treatment resulted in ROS production (Fig.
2A). Comparison of cells differentiated with the different cytokine combinations demonstrated greatly enhanced
ROS production with G-CSF treatment alone compared to combined IL-3/G-CSF treatment, suggesting terminal
neutrophilic differentiation. A more physiological method of inducing the respiratory burst was tested utilizing the
chemoattractant fMLP, a potent activator of ROS formation in pre-activated or “primed” neutrophils 38.
Differentiated cells were first primed with GM-CSF for 20 minutes prior to stimulation with fMLP. HSCs
differentiated towards neutrophils in the presence of G-CSF alone showed a greatly increased response to fMLP
treatment compared to treatment with both IL-3/G-CSF (Fig. 2B). In conclusion, G-CSF regulates the differentiation
of HCS towards functionally mature neutrophils more efficiently when IL-3 induced signaling pathways are not
concomitantly activated.
Figure 2: Analysis of the production of reactive oxygen species.
The ability of differentiated cells to produce reactive oxygen species was analyzed by DHR123 staining as described in Materials
and Methods. Cells were differentiated for 16 days with IL-3/G-CSF or G-CSF. (A) PMA induced formation of reactive oxygen
species during differentiation. Unstimulated cells of the same day were used as a control. (B) Respiratory burst induced by fMLP
at day 16. Cells were pre-activated with GM-CSF for 20 minutes prior to addition of fMLP. Values below graphs indicate the
median difference of PMA or fMLP treated cells versus untreated cells of the same population. Data are representative of three
independent experiments.
Inhibition of PI3K induces cell cycle arrest and blocks differentiation to neutrophils.
PI3K has been linked to regulation of proliferation and survival in many cell systems 23; 39 40; 41. However, little is
known concerning the role of PI3K in the differentiation of human hematopoietic cells. We investigated the role of
PI3K on G-CSF induced maturation of CD34+ stem cells utilizing the specific pharmacological inhibitor LY294002
42. Differentiation towards the myeloid lineage was initiated by a cytokine cocktail as described in Materials and
Methods. Treatment with LY294002, totally abrogated proliferation (Fig. 3A) and this was not due to enhanced cell
death since we observed only a very modest elevation in the amount of apoptotic cells as analyzed by annexin-V
binding (Fig. 3B). Analysis of the DNA content of cells demonstrated a decrease in the number of dividing cells in
the presence of LY294002 within 24 hours of treatment (Fig. 3C). Additionally we analyzed whether the arrested
cells were still able to undergo differentiation induced by G-CSF. Cells were cultured for 13 days and lactoferrin
expression and histological staining were analyzed. No lactoferrin positive cells were observed in the LY294002
treated cells (Fig. 3C). Histological staining demonstrated a lack of mature neutrophils (Fig. 3D). Taken together
these results indicate that PI3K activity is critical for regulating proliferation as opposed to survival of CD34+ stem
cells, as well as playing an important role in the maturation towards neutrophils.
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Figure 3: The effect of LY294002 on the proliferation and differentiation of hematopoietic progenitor cells.
CD34+ stem cells were cultured in the absence or presence of 20 µM LY294002. (A) Proliferation of CD34+ stem cells was
analyzed by counting viable cells after 24, 48 and 72 hours. (B) The percentage of apoptotic progenitor cells was determined after
24, 48 and 72 hours. Percentage of early apoptotic cells (annexin-V positive, PI negative) and percentage of late apoptotic cells
(annexin-V and PI positive) are indicated. Numbers of viable cells are indicated as annexin-negative cells (right panel). (C) Cell
cycle profiles are depicted of cells cultured for 24 and 48 hours with or without LY294002. (D) The effect of LY294002 on the
differentiation of HCS towards neutrophils. Hematopoietic progenitor cells were cultured for 15 days without (control) or with
LY294002. Representative dotplots of lactoferrin staining, as gated in Figure 1B, are indicated. Graphs represent the mean
percentage of lactoferrin positive cells of three independent experiments (E) Determination of differentiation stage was analyzed
by May-Grunwald Giemsa staining as described in Figure 1D. Graphs represent the mean percentage cells of the different stages.
All data are representing the mean of three independent experiments.
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Figure 4: Effect of PD89059 on the maturation of HCS towards neutrophils.
CD34+ stem cells were differentiated with G-CSF and cultured in the absence or presence of 20µM PD89059. (A) Proliferation of
CD34+ stem cells was analyzed by counting viable cell numbers (B) Differentiation was analyzed by lactoferrin staining.
Representative dotplots showing he percentage of lactoferrin positive cells, as gated in Figure 1B, are shown. Graphs represent the
mean percentage of lactoferrin positive cells of three independent experiments (E) Determination of differentiation stage was
analyzed by May-Grunwald Giemsa staining as described in Figure 1D. Graphs represent the percentage cells of the different
stages. All data represent at least three independent experiments.
Inhibition of MEK reduces proliferation without effecting neutrophil differentiation
Another well-characterized signaling pathway downstream of multiple cytokine receptors is the Ras-Raf-MEK-
MAPK pathway 43. It has been suggested that this pathway is involved in the G-CSF induced regulation of the cell
cycle in myeloid cell lines 44-46. However, little is known concerning the role of this pathway in the differentiation of
human hematopoietic progenitors towards neutrophils. For this purpose, we differentiated CD34+ stem cells with G-
CSF in the presence or absence of the specific MEK inhibitor PD98059. We observed a growth inhibitory effect of
PD89059 on treated cells, with a reduction to about 30% of the number of cells compared to the control at day 16
(Fig. 4A). Analysis of the role of MEK inhibition on differentiation demonstrated no significant differences in the
percentage of lactoferrin positive cells (Fig. 4B) or the number of CD11b positive cells (data not shown).
Morphologic analysis by May-Grunwald Giemsa staining in the PD89059 treated cells compared to the control cells
also demonstrated no reduction in the number of mature, differentiated cells (Fig. 4C). Taken together these data
suggest a role for MEK in regulating proliferation, but no significant role in the differentiation of hematopoietic
progenitors towards neutrophils.
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Discussion
The production of mature blood cells, hematopoiesis, involves a carefully orchestrated series of events involving
self-renewal and differentiation of primitive pluripotent stem cells. There is a growing understanding of the
complexity of the intrinsic and extrinsic controls built into this system to maintain its integrity. The external
influences are many and diverse, encompassing interactions of developing hematopoietic cells with extracellular
matrix molecules, a variety of stromal cell types and with growth factors. A large family of hematopoietic cytokines
is able to control the proliferation, differentiation and survival of progenitor cells. Interleukin (IL)-3, for example,
stimulates the growth of multipotential progenitor cells that will eventually differentiate into granulocytes,
macrophages, megakaryocytes and erythrocytes. Their ability to stimulate proliferation works primarily during early
hematopoiesis without specifying the final differentiation fate of the progenitor. Other cytokines act at a later stage to
direct the final fate of a cell. G-CSF is, for example, critical for the terminal differentiation of myeloid progenitors to
neutrophils, and granulocyte-macrophage colony-stimulating factor  (GM-CSF) has its actions restricted primarily to
neutrophil and monocyte lineages. These late acting cytokines are thought to initially stimulate cellular proliferation
followed by differentiation to a non-proliferating mature cell. It is the combinations of cytokines acting on a
particular hematopoietic progenitor that will initiate a specific developmental program determining the final
differentiation fate of the target cell. These signals result in the activation of distinct downstream signal transduction
pathways resulting in changes in the regulation of expression, or activation of several families of transcription
factors.
In this study, we developed an ex-vivo model system in which cytokine induced differentiation of human
hematopoietic progenitors towards neutrophils could be investigated. Maturation in the presence of IL-3 together
with G-CSF resulted in increased cell expansion, however under these conditions the number of mature neutrophils
was considerable lower, compared to cells treated with G-CSF alone (Fig. 1). This suggests that these two cytokines
induce distinct signaling pathways regulating proliferation and/or differentiation. However, data from various cell
lines have shown that the intracellular pathways activated by the G-CSF receptor and the IL-3 receptor are highly
overlapping 8; 47-50. The differences observed between these two cytokines could be explained due to differences in
signal strength, or possibly the duration of activation of various intracellular signaling pathways. These differences
have been observed in the rat pheocchromocytoma PC12 cell line stimulated with either epidermal growth factor
(EGF) or nerve growth factor (NGF) (reviewed in 51 and 52). Both factors induce similar intracellular signal
transduction pathways, however EGF induces proliferation, while NGF induces differentiation. However, in this
system NGF induces a sustained, whereas EGF induces transient ERK activation. This has led to the proposal that
the duration of ERK activation is important for determining whether a particular stimulus may result in a
differentiation or proliferation response. Since both IL-3 and G-CSF induce PI3K activation but only G-CSF triggers
neutrophil differentiation, a similar mechanism might be possible.
The results obtained from the comparison of G-CSF treatment versus a combined IL-3/G-CSF treatment suggests
that decreased proliferation is linked to increased differentiation and vice versa. Indeed it has been reported that over-
expression of CDK inhibitors p27kip1 and p21Cip1 in the absence of differentiation agents can lead to terminal
differentiation of promonocytic cells (U937) 53. Furthermore, myeloid progenitor cells isolated from p27kip1-deficient
mice show significantly increased proliferation and reduced differentiation in response to G-CSF 54. Additionally, it
has been described that retinoic acid induced differentiation of human myeloid cell lines correlates with cell cycle
arrest, associated with sequential down regulation of cyclin E, c-myc and upregulation of p27kip1 55. However our
data, utilizing the PI3K inhibitor LY294002, demonstrate that a cell cycle arrest per se is not in itself sufficient to
induce differentiation (Fig. 3). In the maturation of megakaryocytes, thrombopoietin or c-kit ligand can promote
proliferation and differentiation at the same time 56; 57. An additional study demonstrated that Insulin Growth factor 1
(IGF-1) increased the early development of vitamin D3 induced macrophage differentiation, which was associated
with elevated cyclin E levels, hyperphosphorylated Rb protein, and suppression of p27Kip1 levels 58. These data,
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together with our findings suggest that the initial steps of differentiation can occur concomitantly with the
progression through the cell cycle.
Although a role for PI3K in cellular proliferation has been well established (reviewed in 40), little is known
concerning the potential role of PI3K in differentiation. Mice lacking the regulatory p85α subunit of PI3K have
reduced numbers of mature B-cells 59 60. One mechanism by which PI3K might regulate differentiation is through
regulation of the Retinoblastoma protein (Rb) during the maturation process. Rb mediates a block in the G1-phase of
the cell cycle by inhibiting the E2F family of transcription factors, thereby preventing transcription of genes
necessary for further progression in the cell cycle 61. Phosphorylation of Rb results in release of Rb from E2F and
transcription can proceed. While having a clearly defined role in transcriptional regulation of the cell cycle, Rb
proteins have also been shown to direct the differentiation program in myoblasts, adipocytes and hematopoietic cells,
since these cells fail to differentiate in the absence of Rb 62. Furthermore, high levels of Rb are induced and sustained
during erythroid differentiation while Rb is down regulated during granulocytic maturation 63. PI3K has been
previously implicated in regulating E2F-mediated transcription through Rb 64-66. Additionally, a link between PI3K
and p130 Rb-like protein levels has been described 67. In this manner PI3K might be able to regulated differentiation
through regulation of Rb phosphorylation and protein levels. Figure 5, schematically represents the role for PI3K in
both proliferation and differentiation during the maturation process. While multiple cytokines and growth factors,
such as IL-3, are unable to induce differentiation, they are potent in activating PI3K. Therefore PI3K activity alone is
unlikely to be sufficient to induce differentiation.
We have also demonstrated a role for MEK in regulating the proliferation of human CD34+ progenitors towards
neutrophils. A potential mechanism underlying this observation for MEK is through the upregulation of cyclin D1
expression 30. Sustained activation of ERK1 by MEK was demonstrated to be required for the continued expression
of cyclin D1 in the G1 phase of the cell cycle. Another possible target for MEK is the transcription factor c-myc,
which is a critical regulator of cellular proliferation 68. Indeed, it has previously been demonstrated that MEK is
required for CSF-1 mediated c-myc transcription and cytokine induced proliferation 69. Activation of ERK by MEK
also results in the direct phosphorylation of c-myc, which acts to stabilize the protein 70. c-myc stability can also be
increased through PI3K by inhibiting GSK-3, a kinase which itself can phosphorylates c-myc, targeting it for
ubiquitination 70. A recent study has analyzed the effect of mutation of tyrosine 764 in the intracellular region of the
G-CSF in primary mouse bone marrow cells. Cells expressing this G-CSFR mutant responded with reduced
proliferation in response to G-CSF, without having an effect upon differentiation 71. This mutation was also
associated with a reduced ERK activity, further supporting a critical role for the MEK-ERK pathway in proliferation
(Fig. 5).
In this study, we have analyzed the role of various cytokine-induced intracellular signaling pathways in an ex-vivo
differentiation model utilizing primary human hematopoietic stem cells. We have demonstrated critical roles for
PI3K and MEK in neutrophil maturation, a process involving control of both proliferation and differentiation.
Importantly, we have identified PI3K as a novel player in the process of myeloid differentiation. Our data also
suggest that cell cycle arrest per se does not result in induction of an intrinsic neutrophil differentiation program.
Further work will be required to understand the molecular mechanisms underlying these observations.
Figure 5.   Schematic representation of the role of PI3K and MEK in maturation of hematopoietic stem cells. PI3K has a critical
role in both proliferation and differentiation. Although PI3K is necessary in these processes, it is probably not sufficient to induce
differentiation. MEK has a significant role only in proliferation.
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Abstract
Human granulocytes are characterized by a variety of specific effector functions involved in host defense. Several
widely expressed protein kinases have been implicated in the regulation of these effector functions. We employed a
PCR-based strategy to identify novel granulocyte specific kinases. A novel protein kinase cDNA with an open
reading frame of 357 amino acids was identified with homology to calcium-calmodulin-dependent kinase I
(CaMKI). We have termed it CaMKI-like kinase (CKLiK). Analysis of CKLiK mRNA expression in hematopoietic
cells demonstrated an almost exclusive expression in human polymorphonuclear leukocytes (PMN). Upregulation of
CKLiK mRNA occurs during neutrophilic differentiation of CD34+ stem cells. CKLiK kinase activity was
dependent on Ca2+ and calmodulin as analysed by in vitro phosphorylation of cAMP responsive element modulator
(CREM). Furthermore, CKLiK transfected cells treated with ionomycin demonstrated an induction of CRE binding
protein (CREB) transcriptional activity compared to control cells. Additionally, CaMK-kinaseα enhanced CKLiK
activity. In vivo activation of CKLiK was shown by addition of IL-8 to a myeloid cell line stably expressing CKLiK.
Furthermore inducible activation of CKLiK was sufficient to induce ERK MAP kinase activity. These data identify a
novel Ca2+/calmodulin-dependent PMN specific kinase that may play a role in Ca2+-mediated regulation of human
granulocyte functions.
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Introduction
Human polymorphonuclear leukocytes (PMN), which include neutrophilic and eosinophilic granulocytes, play an
important role in host defense against invading microorganisms1. Recruitment and activation of these cells in vivo
occurs in a multistep process that involves many different membrane bound receptors activating an array of diverse
intracellular signaling molecules. In short, PMNs in the peripheral blood enter a pre-activated state by interacting
with cytokines liberated from the inflammatory locus. This is followed by attachment to the endothelium, which is
mediated by the interaction with adhesion molecules expressed on the surface of activated endothelial cells. Release
of chemokines at the site of inflammation is responsible for the migration of PMNs to this locus. Finally upon
recognition of the inciting agent by PMNs, phagocytosis, secretion of toxic proteins and activation of membrane
bound NADPH-oxidase generating reactive oxygen intermediates ensues 2;3. Furthermore, rapid induction of
apoptosis in PMNs and subsequent removal of apoptotic cells are important in the rapid resolution of inflammation 4;
5. An unfortunate consequence of activation in vivo is tissue damage during acute inflammation and, therefore, the
activity of granulocytes is under tight control.
PMNs express a wide variety of receptors on their plasma membrane steering the process of priming and
activation. Upon binding of inflammatory mediators, such as formyl peptides, lipopolysaccharides, chemokines or
cytokines, the receptor transmits a signal to the cell interior resulting in the initiation of a cascade of intracellular
events. Phosphorylation of effector molecules by kinases is critical for transducing intracellular signals. Thus far
several classes of kinases including (i) serine kinases, such as mitogen activated (MAP) kinases; (ii) lipid kinases
such as phosphatidylinositol-3 kinase (PI-3K); (iii) tyrosine kinases including the src kinases; (iv) cAMP-dependent
kinases, and (v) Ca2+-dependent kinases, are activated in response to inflammatory mediators in human granulocytes.
A role for these widely expressed kinases in neutrophil functions has been intensively studied utilising
pharmacological inhibitors. A role for MAP kinases, p42ERK1 and p42ERK2 in chemotaxis, respiratory burst and PAF
release is suggested, although the use of a pharmacological inhibitor for MEK has resulted in contradictory findings6;
7. A clearer role for PI-3K in neutrophil migration and respiratory burst has been demonstrated by use of PI-3K
inhibitors wortmannin and LY2940027-11. A role for PKC has also been postulated in a variety of granulocyte
effector functions and PKA is suggested to be involved in down-regulating the respiratory burst12; 13. Recently a role
for src kinases in adhesion-dependent degranulation has also been described14. Although inhibitory studies support a
role for these kinases in regulating neutrophil functions, their activation is not specific for these granulocyte effector
functions since they are widely expressed. Furthermore pharmacological inhibitors are often limited in their
specificity, making the interpretation of data more complex15.
Changes in cytosolic free Ca2+ are described during activation of several neutrophil responses, such as
degranulation, respiratory burst and adhesion. An important role for Ca2+ in these processes has been suggested16; 17
and, therefore, Ca2+-dependent kinases may well be involved. In addition a role for the Ca2+-dependent phosphatase,
calcineurin has been shown in the Ca2+-dependent recycling of integrins to the front of migrating neutrophils18, while
a role for calmodulin and CaMKII is suggested in O2- production19.
In this report we describe the identification of a novel protein kinase, which we have termed CKLiK (CaMKI-like
kinase). This kinase is predominantly expressed in human PMNs and is regulated by Ca2+ and calmodulin.
Interleukin-8 (IL-8), which is a potent activator of neutrophil effector functions, induces activation of CKLiK and
we show that an inducible active mutant of CKLiK induces ERK MAP kinase activation. These data identify a novel
Ca2+/calmodulin-dependent protein kinase expressed in PMNs that may play a role in transducing chemokine-
induced signals regulating human granulocyte functions.
Materials and Methods
Cells, reagents and antibodies
COS cells were cultured in Dulbecco’s Modified Eagle Medium (Life Technologies, Breda, The Netherlands)
supplemented with 8% heat-inactivated FCS. CD34+ stem cells were cultured in Iscoves Modified Dulbecco medium
(IMDM) supplemented with 2 mM glutamine, 8% Hyclone and cytokines. Murine myeloid 32D cells were cultured
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in RPMI 1640-glutamate supplemented with 8% Hyclone serum (Life Technologies, Breda, The Netherlands) and
mouse IL-320. 32D cells were stably transfected with pBabe-HA_CKLiK by electroporation (0.26 V, 1000 msec,
100µFD) and selected with puromycin (1µg/ml; Sigma, Zwijndrecht, The Netherlands) at concentration of 1µg/ml.
Ionomycin was purchased from Calbiochem (La Lolla, CA, USA). Calmodulin was a kind gift of Dr. R. de Groot.
Monoclonal antibodies, 12CA5 against HA epitope were purchased from Boehringer Mannheim Biochemicals
(Almere, The Netherlands). Polyclonal anti-VSV tag antibodies were obtained from Medical & Biological
Laboratories (MBL, Japan). Human interleukin-8 (IL-8), Trombopoetin (TPO), fms like tyrosine kinase-3 (FLT-3)
ligand and stem cell factor were purchased from PeproTech (Rocky Hill, NJ, USA). Human interleukin-3 (IL-3) and
granulocyte colony stimulating factor (G-CSF) were purchased from Strathmann Biotech (Hamburg, Germany) and
IL-6 was purchased from Roche Molecular Biochemicals (Indianapolis, IN). Phospho-CREB-Ser133 antibodies
were obtained from New England Biolabs Inc. (Beverly, MA, USA). 4-hydroxy-tamoxifen and W7 were purchased
from Sigma (Zwijndrecht, The Netherlands) while PD98059 was purchased from Biomol (Plymouth Meeting, PA).
Identification and cloning of granulocyte kinases
For the identification of novel kinases in human granulocytes PCR was performed using degenerate primers as
previously described 21. Forward primers were based around the consensus amino acid sequence HRDLKPEN,
which corresponded to the conserved regions in the serine/threonine protein kinase catalytic domain.
Oligonucleotides were also designed against the DXWXXG amino acid motif approximately 65 amino acids
downstream and used as reverse primers. PCR was performed on granulocyte cDNA with Taq polymerase (Perkin
Elmer, Roche Molecular Systems Inc, Branchburg, New Jersey, USA) using excess of degenerate primers (1µg)
under conditions of 10mM TRIS-Cl pH 8.3, 50mM KCl, 0.2mM dNTPs and 0.8mM MgCl2. Denaturation, annealing
and extension temperatures of 940C, 520C and 720C respectively were used. PCR products of approximately 200 bp
were cloned into pGEM-T vector (Promega Corporation, Madison, WI, USA) and sequenced. The identified
sequences were screened against the BLAST database (http://www.ncbi.nlm. nih.gov /BLAST).
Full-length cDNA was obtained by screening a λZAPII eosinophilic library 22 with the amplified PCR fragment as
a probe. After plaque purification, the pBluescript SK- phagemids containing positive inserts were isolated by in
vivo excision using M13K07 helper phages (Promega Corporation, Madison, WI, USA), and subsequently
characterized by restriction mapping and sequencing.
Isolation human leukocytes
Blood was obtained from healthy volunteers at the donor service of the University Medical Center (Utrecht the
Netherlands). Granulocytes were isolated from 0.4% (wt/vol) trisodium citrate (pH 7.4) treated blood as previously
described23. In short, mononuclear cells were removed from granulocytes by centrifugation over isotonic Ficoll from
Pharmacia (Uppsula, Sweden). After lysis of the erythrocytes in an isotonic NH4Cl solution, neutrophils were
washed and resuspended in incubation buffer (20mM HEPES, 132mM NaCl, 6mM KCl, 1mM MgSO4, 1.2mM
KH2PO4, 5mM glucose, 1mM CaCl2). Granulocytes were incubated for 30 minutes at 370C before experiments were
performed. Monocytes were further separated from mononuclear lymphocytes by elutriation as described
previously24.
Isolation and differentiation of CD34+ stem cells
CD34+ cells were isolated using the MACS CD34+ progenitor cells isolation kit from Miltenyi Biotech (Auburn,
CA). First mononuclear cells were isolated from human umbilical cord blood cells by density centrifugation over a
Ficoll solution. Cells were blocked and additionally incubated with a CD34 antibody in a phosphate buffer
containing 2mM EDTA and 0,5% BSA (Buffer M). Magnetic beads recognizing the CD34 antibody were added and
the suspension was applied to an MS+ separation column placed in the magnetic cell separator MiniMACS. CD34-
cells were allowed to pass through the column by three wash steps with buffer M. CD34+ cells were eluted with
buffer M by removal of the column from the separator. To obtain a pure CD34+ cell population the magnetic
separation step was repeated on a second column. After final elution stem cells were counted and cultured. Before
differentiation, CD34+ stem cells were proliferated for one week in the presence of TPO (10ng/ml), SCF (50ng/ml),
FLT-3 ligand (50ng/ml) and IL-6 (2ng/ml). At day 0 differentiation was started by addition of SCF, FLT-3 ligand,
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IL-3 (10ng/ml) and G-CSF (30ng/ml). At day 3, 7, 10, 14 and 17 IL-3 and G-CSF were added and at day 21 only G-
CSF was added to the cells. At each point cells were counted, diluted to 0.5*106 cells/ml and if possible samples
were taken for mRNA isolation.   
RNaseProtection
Total mRNA from human monocytes, lymphocytes, granulocytes and hematopoietic cell lines HL60, U937 and
THP1 were isolated. In short, 108 cells were lysed in 2ml GIT-C solution (6M guanidine thiocyanate, 25mM
sodiumcitrate, 0.5%N’Lauroyl-sacosine, 100mM β-mercapto-ethanol) and RNAs were further isolated by phenol
extraction and ethanol precipitation.  32P-UTP labelled antisense RNA transcript, corresponding to the original PCR
fragment coding the catalytic domain of CKLiK, was generated using the Riboprobe in vitro Transcription system
(Promega Corporation, Madison, WI, USA) and used as a RNA-probe. As internal control a 90 bp antisense RNA
probe of GAPDH was used. Total RNAs samples (10µg) were lyophilised and resuspended in 2µl DEPC water.
Hybridisation was performed with 105 cpm of each antisense RNA probe in 25µl 80% formamide, 40mM PIPES pH
6.4, 400mM NaCl and 1mM EDTA overnight at 450C. Subsequently probes were incubated for 1 hour in RNAse
buffer (10mM Tris-Cl pH 7.5, 5mM EDTA, 300mM NaCl supplemented with 0.15µl/ml T1 RNase) at 370C to
degrade unhybridised RNA. The reaction was stopped by addition of 10µl proteinase K (5mg/ml) and 10% SDS.
Hybridised (double stranded) RNA was purified by phenol-extraction and ethanol precipitation. The remaining pellet
was resuspended in 2µl DEPC water and 2µl RNA loading buffer (80% formamide, 10mM EDTA, 1 mg/ml xylene
cyanol, 1 mg/ml bromphenol blue). Samples were heated for 5 minutes at 950C and analyzed by polyacrylamide gel
electrophoresis.
DNA constructs
Epitope-tagged CKLiK was generated by PCR using the oligonucleotides forward XhoI; 5’-
CCGCTCGAGTATGGCCCGGGAGAACGGC-3’ and reverse KpnI; 5’-CCGGTACCCAAGTAG-
CTGACATTACAGG-5’) and ligated by XhoI/KpnI digest into pMT-HA. HA_CKLiK-309 and HA_CKLiK-296
were also generated by PCR using reverse primers introducing a stopcodon at amino acid 310 or 297 (309:5’-
GCATTTCATGCTTGGCACCATT-3’,296; 5’-GCTCTAGATCACTGGGCGCTGACG GACTC-3 ’). PCR
products were cloned into pGEM-T vector and subcloned into pMT2-HA vector. GFP-tagged CKLiK was generated
by PCR and recloned in frame into pEGFP-C2 vector (Clontech Laboratories Inc., California, USA). HA_CKLiK
was cloned from pMT-HA into pBabe25 by BamHI/ EcoRI digest. Untagged CKLiK-296 was obtained by PCR
cloned and into pSG526. VSV tagged CaMKKα was generated by PCR on rat brain tissue cDNA using the
oligonucleotides 5’-CAGTCGACCAGGAATATCC ACGGACTGA-3’ and 5’-
ATAGCGGCCGCCGGATGCAGCCTCATCTTC-3’ and cloned into the pMT2-VSV vector. Tamoxifen inducible
CKLiK construct, ER_CKLiK-296 was generated by PCR and cloned into the pCDNA3-ER-N vector. The
constructs for HA_PKB and HA_ERK have been previously described 27. CREB_GAL4, CREBS133A_GAL4,
GAL4CAT constructs were previously described in 28.
In vitro kinase assay
COS cells were transiently transfected with 10µg of HA-tagged CKLiK-WT, CKLiK-309 or CKLiK-296 using
calcium phosphate precipitation and the medium refreshed 16 hours later. For the CKLiK kinase assay, 24 hours
later cells were stimulated with or without ionomycin for 5 minutes, washed twice with cold PBS and lysed in a
buffer containing, 1% NP-40, 20mM Tris-Cl pH 7.5, 150mM NaCl, 10% glycerol and 10mM MgCl2 supplemented
with 10µg/ml aprotinin, 1mM leupeptin, 1mM PMSF, 1mM benzamidine and 1mM Na3VO4. 32D cells stably
expressing CKLiK-WT, were mIL-3 and serum starved for 4 hours and stimulated with hIL-8 (10-7M).  Cells were
washed and lysed as buffer described above. Lysates were pre-cleared for 20 min with protein-A beads and
immunoprecipitated with 12CA5 antibody. Immunoprecipitates were washed twice in lysis buffer and twice in
dilution buffer containing 10mM Tris-Cl pH 7.4 and 20mM MgCl2. Kinase assay was performed in the presence
10mM Tris-Cl pH7.4, 20mM MgCl2, 1mM DTT, 50µM ATP, 0.1µl γ-32P-dATP in the presence or absence of 1mM
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CaCl2 and 0.5µg calmodulin, 5µg CREMβ (33kDa) or mutated CREMτ-S117A (42kDa) as substrate 29. PKB and
ERK kinase assay were performed as described previously27.
CAT assay
COS cells were transiently transfected with 4µg CKLiK-WT, -309 or -296, together with 2µg CREB_GAL4 or
CREB-S133A_GAL4 fusion expression plasmids and 2µg GAL4CAT reporter construct using calcium phosphate
precipitation. After 16 hours cells were washed twice and medium refreshed. Eight hours later cells were incubated
overnight with 1µM ionomycin. Cells were lysed by repeated freeze-thawing in 100 µl 250mM Tris-Cl pH7.4 and
25mM EDTA. 50µl of cellular extract was incubated in a total volume of 100µl containing 250mM Tris-Cl 7.4, 2%
glycerol, 0.3mM Butyryl Coenzyme A and 0.05µCi 14C-Chloramphenicol for 2 hours at 370C. Reaction products
were extracted using 400µl xylene/pristane (1:2) and the percentage of acetylated products was determined using
liquid scintillation counting. A lacZ reporter was used to correct for transfection efficiency. Data represent at least 3
independent experiments ± SEM.
Detection of GFP fusion-protein localization
Plasmids encoding CKLiK and active CKLiK-296 containing N-terminal enhanced Green Fluorescent were
transiently transfected in COS cells which were grown on coverslips. 36 hours after transfection COS cells were
washed with PBS, fixed with 70 % ice-cold methanol, and examined by fluorescence microscopy.
Western blotting
After stimulation 106 neutrophils/point were lysed in 1x Laemmli sample buffer. Protein samples were separated by
SDS-PAGE and transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore). The membranes
were probed with anti-phospho-CREB-Ser133 antibodies (New England Biolabs Inc., Beverly, MA, USA) and
swine anti-rabbit peroxidase-conjugated antibodies (DAKO, Denmark), following detection by enhanced
chemiluminescence (ECL, Amersham). Protein kinase expression controls were performed by utilizing 12CA5 and
rabbit anti-mouse peroxidase conjugated antibodies (DAKO, Denmark) to detect HA_CKLiK, HA_ERK and
HA_PKB. Detection of CaMKK-VSV was performed with anti-VSV antibodies and swine anti-rabbit peroxidase-
conjugated antibodies. Hybridization's were followed by detection with enhanced chemiluminescence (ECL,
Amersham).
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Results
Cloning and expression of CKLiK
While several kinases have been implicated in the control of granulocyte effector functions12; 30, most of these
proteins are widely expressed. To identify novel granulocyte specific kinases, degenerate primers against conserved
kinase catalytic domains were utilized as previously described21. The central core of the catalytic domain consists of
subdomains VI and IX and contains two well-conserved amino acid triplets APE and DGF31.  Degenerate
oligonucleotides were designed against subdomains VI and IX and used in a PCR on cDNA of human PMNs. Under
stringent conditions PCR products of approximately 200bp were amplified, cloned and sequenced. All cloned PCR
products contained the two conserved amino acid triplets and many were identical to previously identified kinases
(data not shown). However one clone exhibited homology with Calcium/Calmodulin-dependent kinase I (CaMKI)
and subsequently termed CKLiK (CaMKI Like Kinase).
To isolate full-length CKLiK cDNA, a human eosinophil library was screened with the amplified PMN cDNA PCR
fragment. Several positive clones were isolated and sequenced, and one cDNA of 1.7 kb contained a 357 amino acid
open reading frame encoding a protein of 40 kDa as determined by in vitro transcription/translation (data not
shown). In Figure 1 the complete cDNA and the translated amino acid sequence is depicted. The context of the ATG
codon was in good agreement with eukaryotic translation start-sites32. As shown in Figure 2a comparison of the
predicted CKLiK protein sequence in BLAST database revealed a 77% homology of CKLiK with CaMKI on amino
acid level. The greatest divergence between the two sequences occurs at the N- and C-terminus.
To determine the distribution of CKLiK expression we analyzed mRNA levels in primary human leukocytes and
hematopoietic cell lines by RNase protection (Fig. 2b). mRNA from lymphocytes, which includes T and B-cells,
monocytes and PMNs were analyzed. Additionally three myeloid cell lines HL60 (promyelocytic leukemia), U937
(histiocytic lymphoma) and THP1 (acute monocytic leukemia) were analysed for CKLiK expression. As an internal
control we utilized a GAPDH probe (Fig 2b; lower panel). Human PMNs contain high levels of CKLiK (Fig.2b; lane
3), while little to no expression was observed in monocytes and lymphocytes (Fig. 2b; lane 1-2).  In the different
lymphoid and myeloid cell lines we couldn’t detect CKLiK (Fig. 2b; lane 4-6). Since CKLiK expression is
apparently only detected in mature myeloid cells, we analyzed the expression of CKLiK during differentiation of
CD34+ cord blood stem cells towards the neutrophilic lineage. Although after ten days of differentiation CKLiK
mRNA was present, increased mRNA levels are indeed detected during terminal differentiation at day 28 (Fig 2c).
Similar results were obtained during the differentiation towards eosinophils in the presence of interleukin-5 (data not
shown).
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Figure 1: CaMKI-like kinase, CKLiK, nucleotide sequence and open reading frame.
Full-length sequence of the novel kinase was obtained by screening an eosinophil cDNA λZAPII phage library using the initial
degenerate PCR product as a probe. Sequencing was performed and the open reading frame was analyzed.
          ---t cccgccgcct ctgcgcccgcgccg cgcccccgg cgccccc
         tccca gcgcgccccc ggccgctcctccgc gccgcgctc gtcggcc
       1 atggc ccgggagaac ggcgagagcagctc ctcctggaa aaagcaa
         M  A  R  E  N   G  E  S  S  S  S  W  K  K  Q
      46 gctga agacatcaag aagatcttcgagtt caaagagac cctcgga
         A  E  D  I  K   K  I  F  E  F  K  E  T  L  G
      91 accgg ggccttttcc gaagtggttttagc tgaagagaa ggcaact
         T  G  A  F  S   E  V  V  L  A  E  E  K  A  T
     136 ggcaa gctctttgct gtgaagtgtatccc taagaaggc gctgaag
         G  K  L  F  A   V  K  C  I  P  K  K  A  L  K
     181 ggcaa ggaaagcagc atagagaatgagat agccgtcct gagaaag
         G  K  E  S  S   I  E  N  E  I  A  V  L  R  K
     226 attaa gcatgaaaat attgttgccctgga agacattta tgaaagc
         I  K  H  E  N   I  V  A  L  E  D  I  Y  E  S
     271 ccaaa tcacctgtac ttggtcatgcagct ggtgtccgg tggagag
         P  N  H  L  Y   L  V  M  Q  L  V  S  G  G  E
     316 ctgtt tgaccggata gtggagaaggggtt ttatacaga gaaggat
         L  F  D  R  I   V  E  K  G  F  Y  T  E  K  D
     361 gccag cactctgatc cgccaagtcttgga cgccgtgta ctatctc
         A  S  T  L  I   R  Q  V  L  D  A  V  Y  Y  L
     406 cacag aatgggcatc gtccacagagacct caagcccga aaatctc
         H  R  M  G  I   V  H  R  D  L  K  P  E  N  L
     451 ttgta ctacagtcaa gatgaggagtccaa aataatgat cagtgac
         L  Y  Y  S  Q   D  E  E  S  K  I  M  I  S  D
     496 tttgg attgtcaaaa atggagggcaaagg agatgtgat gtccact
         F  G  L  S  K   M  E  G  K  G  D  V  M  S  T
     541 gcctg tggaactcca ggctatgtcgctcc tgaagtcct cgcccag
         A  C  G  T  P   G  Y  V  A  P  E  V  L  A  Q
     586 aaacc ttacagcaaa gccgttgactgctg gtccatcgg agtgatt
         K  P  Y  S  K   A  V  D  C  W  S  I  G  V  I
     631 gccta catcttgctc tgcggctaccctcc tttttatga tgaaaat
         A  Y  I  L  L   C  G  Y  P  P  F  Y  D  E  N
     676 gactc caagctcttt gagcagatcctcaa ggcggaata tgagttt
         D  S  K  L  F   E  Q  I  L  K  A  E  Y  E  F
     721 gactc tccctactgg gatgacatctccga ctctgcaaa agacttc
         D  S  P  Y  W   D  D  I  S  D  S  A  K  D  F
     766 attcg gaacctgatg gagaaggacccgaa taaaagata cacgtgt
         I  R  N  L  M   E  K  D  P  N  K  R  Y  T  C
     811 gagca ggcagctcgg cacccatggatcgc tggtgacac agccctc
         E  Q  A  A  R   H  P  W  I  A  G  D  T  A  L
     856 aacaa aaacatccac gagtccgtcagcgc ccagatccg gaaaaac
         N  K  N  I  H   E  S  V  S  A  Q  I  R  K  N
     901 tttgc caagagcaaa tggagacaagcatt taatgccac ggccgtc
         F  A  K  S  K   W  R  Q  A  F  N  A  T  A  V
     946 gtgag acatatgaga aaactacacctcgg cagcagcct ggacagt
         V  R  H  M  R   K  L  H  L  G  S  S  L  D  S
     991 tcaaa tgcaagtgtt tcgagcagcctcag tttggccag ccaaaaa
         S  N  A  S  V   S  S  S  L  S  L  A  S  Q  K
    1036 gact gtgcgtatgt agcaaaaccagaat ccctcagct ga 1071
         D  C  A   Y  V  A  K  P  E  S  L  S  *
         ctgaa gacgagcctg gggtggagaggagg gagccggca tctgccg
         agcac ctcctgtttg ccaggcgctttcta tacttaatc ccatgtc
         atgcg accctaggac tttttttaacatgt aatcactgg gctgggt
         gcagt ggctcacgcc tgtaatcccaacac tttgggagg ctgaggc
         aggag gactgtttga gttcaggagtttta agaccagcc tgaccaa
         catgg tgaaacccca tctctactaaaata taaaaatta gccgggt
         gtggt ggcgagcacc tgtaatgtcagcta cttgggagg ctgaggc
         aggag aatcacttga acccaggaagcgga ggttgcaat cagctga
         gatca caccactgca ctccagcctgggtg acagattga gactccc
         tct caaaaaaa- -------
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Figure 2: CKLiK is homologous to CaMKI and highly expressed in human granulocytes.
(A) Alignment of CKLiK with CaMKI. Residues identical to CaMKI are indicated by a “ * ” and gaps in the alignment are
indicated with a dash (-).The amino acid sequence is indicated on the right. (B) Distribution of CKLiK was determined by RNase
Protection. The PCR product encoding the catalytic domain of CKLiK was used to generate a radiolabeled  RNA probe. RNA
isolated from primary hematopoietic cells and cell-lines were hybridized for CKLiK expression. A GAPDH probe was used as a
control. Lanes 1-3 represent primary leukocytes (1; lymphocytes, 2; monocytes, 3; PMNs) and lane 4-6 represent lymphoid and
myeloid cell lines as indicated. (C) Expression of CKLiK in cord blood derived CD34+ stem cells during differentiation towards
neutrophils was analyzed by RNase Protection as in (B). Timepoints indicate the number of days differentiated towards
neutrophilic lineage in the presence of G-CSF.
CKLiK kinase activity is dependent on Ca2+/calmodulin and can regulate CREM and CREB
As mentioned, CKLiK has homology with the Ca2+/calmodulin-dependent kinase family. The CaM kinases belong to
the serine/threonine class of kinases and include CaMKI, CaMKIV and the upstream CaMKK33. To investigate
whether Ca2+ and calmodulin regulated CKLiK we utilized CRE binding protein (CREB) or CRE modulator
(CREM) as downstream targets. CREB and CREM belong to the basic-leucine-zipper (bZip) class of transcription
factors. Serine 133 for CREB and serine 117 for CREM have been shown to be phosphorylated by several kinases
including CaMKI in vitro2 8; 34, resulting in interaction with transcriptional co-activators and induction of
transcription 35.
CKLiK kinase activity was analyzed by in vitro kinase assay, utilizing CREM as a substrate and by transcriptional
reporter assays utilizing CREB_GAL4 fusion constructs 28. CKLiK was immunoprecipitated from transfected COS
cell lysates and immunecomplex kinase assays performed (Fig 3a). CREMβ (33kDa) or a mutant CREMτ (42kDa)
which has a serine to an alanine substitution on position 117 (CREMτ-S117A), were utilized as substrates (Fig. 3a).
Due to the different size of the two isoforms, this allows the specific phosphorylation of Ser-117 to be analyzed
within a single assay. The assay was performed in the absence or presence of Ca2+ and calmodulin. As a positive
control for this assay we utilized recombinant CaMKI, which potently phopshorylated CREMβ. Due to the high
level of recombinant CaMKI, some background phosphorylation of the mutated form of CREM (CREMτ-S117A)
C KL iK
-M ARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL   59
      *     * ******  *  *   ***** **** *** * * ** * *** * **
C aM KI MLGAVEG---PRW-KQAEDIRDIYDFRDVLGTGA FSEVILAEDKRTQKLVAIKCIAKEAL   56
C KL iK KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK   119
 *** * ******* **** ***** *****  **** *********************
C aM KI EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGH LYLIMQLVSGGELFDRIVEKGFYTER   116
C KL iK DASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYY RQDEESKIMISDFGLSKMEGKGDVMS   179
*** ** ****** ***  ***************  ** **************  * * *
C aM KI DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY SLDEDSKIMISDFGLSKMEDPGSVLS   176
C KL iK TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI LLCGYPPFYDENDSKLFEQILKAEYE   239
********************************** ************* ************
C aM KI TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP PFYDENDAKLFEQILKAEYE   236
C KL iK FDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQA ARHPWIAGDTGLNKNIHESVSAQIRK   299
****************** ****** ** *****   ******** * **** *** ** *
C aM KI FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA LQHPWIAGDTALDKNIHQSVSEQIKK   296
C KL iK N FAKSKWSQAFNATAVVRHMRKLHLGSSLDSSNASVSSSL SLASQ----------KDCAY   349
 *********************** ** *        *    *              **
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was detected. A clear phosphorylation of CREMβ but not CREMτ-S117A by CKLiK was observed in the presence
of Ca2+/Calmodulin and this was enhanced by prior ionomycin treatment (Fig. 3a). A small activation of CKLiK was
also observed by ionomycin treatment in the absence of Ca2+/Calmodulin during the kinase assay (data not shown).
For transcriptional reporter assays, cells were transfected with HA_CKLiK, a GAL4-CAT reporter construct in
combination with a CREB_GAL4 fusion construct or a mutant thereof, in which the phosphorylation site (serine-
133) is substituted by an alanine (CREB-S133A_GAL4) (Fig. 3b). Ionomycin treatment resulted in a 5-fold
induction of reporter-activity in cells expressing CKLiK with only a modest increase in control cells (Fig. 3b; left
panel). CKLiK had no effect when using the mutant form of CREB (Fig 3b; right panel). These results demonstrate
that CKLiK is regulated by Ca2+/calmodulin and that active CKLiK can directly phosphorylate CREM, and activate
CREB enhancing it’s transactivation capacity.
C-terminal truncation of CKLiK results in a constitutively active mutant
Sequence alignment with CaMKI and the results described above suggests that CKLiK contains a calmodulin
binding domain regulating its activity. To investigate this hypothesis we generated two truncation mutants (Fig. 4a).
Truncation of the predicted calmodulin-binding domain (CKLiK-309) should result in an inactive kinase. Indeed
mutant CKLiK-309, lacking residues 310-357, remains inactive even in the presence of Ca2+/calmodulin, unable to
phosphorylate CREM (Fig. 4b) or to activate CREB mediated transcription after ionomycin stimulation (Fig. 4c).
However, if CKLiK also contains an auto-inhibitory domain similar to CaMKI then, removal of this domain
(CKLiK-296) should generate a constitutively active kinase. As was predicted truncation of residues 297-357
generated a constitutively active CKLiK. CREM was phosphorylated by CKLiK-296 in the absence of
Ca2+/calmodulin (Fig. 4b) and CKLiK-296 greatly enhanced CREB mediated transcription, which was not further
enhanced by ionomycin addition (Fig 4c). Since we demonstrated that activated CKLiK could phosphorylate CREM
and activate CREB mediated transcription we were interested to determine whether CKLiK was located in the
cytoplasm or nucleus. We generated Green
Figure 3: CKLiK activity requires Ca2+/Calmodulin and regulates the transcription factors CREM and CREB.
(A) COS cells were transfected with 10µg HA_CKLiK. Recombinant CaMKI was used as a positive control. Cells were
stimulated with or without 1µM ionomycin as indicated. HA_CKLiK was immunoprecipitated from whole cell lysates and kinase
assays were performed in the presence or absence of Ca2+/calmodulin as indicated. CREMβ-WT (33kDa) and mutated CREMτ-
S117A (42kDa) were used as substrate. Data represent one of four independent experiments. (B) Cells transfected with GAL4-
CAT reporter construct (2µg) and fusion construct of CREB_GAL4 or CREB-S133A_GAL4 (2µg) (indicated as CREB-WT and
CREB-S133A respectively), were co-transfected, with CKLiK (4µg) or with control vector as indicated. Stimulation with or
without 1µM ionomycin and CAT reporter assays were performed as described in Materials and Methods. Data are indicated as
counts per minute (cpm) and represent at least three independent experiments ± S.E.M.
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Figure 4: A constitutively active CKLiK mutant activates CREB and CREM independently of Ca2+ /Calmodulin.
(A) Schematic representation of the predicted calmodulin binding domain (CBD) and the autoinhibitory domain (AID) of CKLiK.
Truncation mutants of these two domains are indicated. In CKLiK-309 the predicted CBD and in CKLiK-296 the predicted CBD
and AID were deleted. (B) In vitro kinase assays. COS cells were transfected with 10µg HA_CKLiK-WT (wt), HA_CKLiK-309
(309) or HA_CKLiK-296 (296) as indicated. Immunoprecipitations were performed and CREM phosphorylation was detected in
the presence or absence of Ca2+/calmodulin as indicated. Expression of the different forms of CKLiK was detected by western
blotting of cell lysates with 12CA5 antibody. (C) Reporter assays. Cells were transfected with GAL4-CAT reporter construct,
CREB-GAL4 (2µg) and co-transfected, with CKLiK-WT or mutated CKLiK-309 or CKLiK-296 (4µg) as indicated. 18 hours
prior to harvesting cells were stimulated with (grey bars) or without (white bars) 1µM ionomycin and reporter-assays were
performed. Data represent at least three independent experiments ± S.E.M, and was corrected for transfection efficiency. (D)
Active CKLiK is localized in the nucleus. Cells were grown on coverslips and transfected with CKLiK and active CKLiK-296
containing N-terminal enhanced Green Fluorescent Protein (eGFP). 36 hours after transfection cells were examined by
fluorescence microscopy for CKLiK localization.
Fluorescent Protein (GFP) containing fusion constructs of CKLiK-wt and the active CKLiK-296. COS cells were
grown on coverslips and transfected with CKLiK and CKLiK-296 containing N-terminal GFP fusion. Localization
was examined by fluorescence microscopy (Fig. 4d). GFP-CKLiK was clearly located in the cytoplasm, whereas the
active form of CKLiK exhibited a strong nuclear fluorescence. Since the active form of CKLiK is detected in the
nucleus it suggests that CKLiK may regulate transcription through nuclear localization.
Ca2+/calmodulin kinase kinaseα enhances CKLiK activity
Although the binding of Ca2+/calmodulin is known to activate CaM kinases, an additional activation of CaMKI and
CAMKIV by CAMK kinase (CAMKK) has previously been described36-38. CaMKK phosphorylates CAMKI and
CaMKIV in the activation-loop at position Thr-177 and Thr-196/Thr-200 respectively, stabilizing and thereby
enhancing kinase activity. CKLiK contains a threonine at position 180 in alignment with Thr-177 of CaMKI and
Thr-200 of CAMKIV. To investigate the effect of CAMKKα on the CKLiK activity we performed kinase and
reporter assays. Co-transfection of CaMKKα with CKLiK resulted in an enhanced CREM phosphorylation (Fig. 5a;
right panel). In the absence of Ca2+/calmodulin in the kinase assay, CaMKKα enhanced CKLiK induced CREM
phosphorylation (Fig. 5a; left panel). Similar results were found utilizing reporter assays (Fig. 5b). Co-transfection
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of CKLiK with CaMKKα resulted in an elevated reporter activity both in untreated (Fig. 5b; left panel) and
ionomycin treated cells (Fig. 5b; right panel). CaMKKα alone had no effect on CAT activity, suggesting that
CaMKKα cannot itself activate CREB directly. Interestingly CaMKKα can enhance CKLiK activity in the absence
of Ca2+ in the in vitro kinase assay. Indeed there are indications for CaMKKα induced CaMK activity in the absence
of Ca2+ and calmodulin 33; 39. However, since there is Ca2+/calmodulin present in the transfected cells,
phosphorylation of CKLiK by CaMKKα may lead to stabilization of the CKLiK-Ca2+-calmodulin complex resulting
in enhanced kinase activity.
Figure 5: CaMKKα enhances CKLiK activity.
(A) HA_CKLiK (8µg) was transfected in COS cells with or without CaMKKα_VSV (2µg). Prior to harvesting, cells were
stimulated with or without 1µM ionomycin as indicated. HA_CKLiK was immunoprecipitated and kinase assays were performed
using CREM as substrate in the presence or absence of Ca2+/calmodulin. Equal protein expression was demonstrated by western
blotting. For CKLiK antibody 12CA5 (middle panel) and for CaMKKα antibody anti-VSV (bottom panel) is used. (B)
CREB_GAL4 and CKLiK (4µg) were co-transfected without or with CaMKKα (2µg) as indicated. CaMKKα was transfected
without CKLiK as a negative control. 18 hours prior to harvesting, cells were stimulated with or without 1µM ionomycin and
reporter-assays were performed. Data represent at least three independent experiments ± S.E.M and are corrected for transfection
efficiency.
Activation of CKLiK by IL-8 in bone marrow derived myeloid precursor cells
Since agonist stimulation of G-protein coupled receptors results in changes of [Ca2+]i, these receptors are potential
activators of CKLiK. The IL-8 receptor is highly expressed on human neutrophils and IL-8 can activate neutrophil
effector functions, such as chemotaxis. In order to investigate whether IL-8 can activate CKLiK, we utilized a 32D
model system. 32D cells are IL-3-dependent bone marrow derived myeloid precursor cells 40. Since these cells
express endogenous IL-8R 41 we generated stable 32D cell lines expressing HA_CKLiK and used these cells to
measure IL-8 induced CKLiK activity. IL-8 was indeed able to induce an increase in intracellular Ca2+ in these cells
(Fig. 6a). IL-8 stimulation of HA_CKLiK expressing 32D cells, resulted in a rapid transient increased CKLiK
activation (Fig. 6b), whereas in Ca2+-depleted cells, IL-8 induced CKLiK activity was completely abolished (data not
shown). CKLiK activation parallels the rise in intracellular Ca2+ induced by IL-8 (Fig. 6a). Additionally, W7, an
antagonist of calmodulin completely inhibited the IL-8 induced CKLiK activity (Fig 6c). CKLiK activity was also
inhibited by W7 in the ionomycin treated cells, indicating that calmodulin is indeed critical for the CKLiK kinase
activity stimulated by agents, which induce a Ca2+ influx.  
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Figure 6: IL-8 stimulation of bone marrow derived myeloid precursor cells activates CKLiK
(A) Ca2+ response of 32D cells to hIL-8 (10-7M). Cell were incubated with INDO-AM for 45 minutes and washed twice. [Ca2+]i
concentrations were measured by dual excitation at a wavelength of 340nm and detected at 390nm using a Hitachi F4500 fluorescence
spectrophotometer. Digitonin was added for 100% [Ca2+]i as indicated. (B) IL-8 induces CREB phosphorylation in 32D cells stably
expressing wild type HA_CKLiK. Cells were starved for four hours and stimulated with IL-8 (10-7M) for indicated time periods. HA-
tagged CKLiK was immunoprecipitated and kinase assays performed in the absence of Ca2+/calmodulin utilizing CREM as a
substrate. Ionomycin treated and untransfected 32D cells were used as positive and negative controls respectively. Data represent one
of at least 3 independent experiments. (C) W7 inhibits CKLiK kinase activity. HA_CKLiK stable 32D cells were starved and treated
for 15 minutes with or without the calmodulin inhibitor W7 prior to IL-8 (10-7M) stimulation. Immunecomplex kinase assays were
performed as in (B).
Activation of downstream signaling pathways by CKLiK
To identify potential downstream targets of CKLiK, we analyzed the effect of CKLiK on the activation of the ERK1
MAP kinase and Protein kinase B (PKB), an effector of PI-3K. The regulation of ERKs and PKB by [Ca2+]i has been
demonstrated in several systems42; 43. Cells were transfected with HA-tagged-ERK or -PKB and co-transfected with
constitutively active CKLiK (CKLiK-296) or CaMKKα and immunecomplex kinase assays were performed.
Stimulation with 20% FCS for 10 minutes was used as a positive control. Co-transfection of CKLiK-296 had no
effect on PKB activity, while co-transfection of CaMKKα potently activated PKB similar to levels induced by 20%
FCS (Fig. 7a; upper panel). This is in agreement with the direct PKB phosphorylation by CaMKK described by
Yano et al.42. Interestingly however, co-transfection of
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Figure 7: CKLiK activates ERK1 MAP kinase but not PKB.
(A) HA_PKB or HA_ERK1 (2µg) were transfected in COS cells with or without CaMKKα (8µg) or CKLiK-296 (8µg) as
indicated. 20 hours prior to harvesting cells were serum starved. Unstimulated and 20%FCS treated cells were used as controls.
HA_PKB or HA_ERK were immune precipitated and kinase activity was measured using Histone 2B (H2B) or Myelin Basic
Protein (MBP) as a substrates. Data represent one of at least four independent experiments. (B) HA_ERK1 or HA_PKB (2µg)
were co-transfected with ER_CKLiK-296 (8µg) in COS cells. Prior to harvesting cells were stimulated with 4-OH tamoxifen (4-
OHT) for 2 or 10 minutes. Immunoprecipitations and kinase assays were performed as in (A) using H2B or MBP as a substrate.
Equal expression of HA_PKB and HA_ERK were analyzed by western blotting of whole cell lysates with 12CA5 antibody. (C)
PD098059 inhibits the CKLiK induced ERK activity. COS cells were transfected with HA_ERK1 (2µg) and ER_CKLiK-296
(8µg). Cells were treated with or without the MEK inhibitor PD098059 (50µM) for 15 minutes prior to stimulation with 4-OHT
for indicated time-periods. Cells were lysed and immunecomplex kinase assays were performed as previously described. Equal
expression of HA_ERK1 was analyzed by western blotting.
constitutively active CKLiK-296 resulted in an increase in ERK1 activation (Fig. 7a; lower panel). To avoid the
possibility of autocrine effects due to over-expression of active CKLiK, we constructed a tamoxifen-inducible active
CKLiK (ER_CKLiK-296).
When transfected into cells, ER_CKLiK-296 is actively repressed by binding of heat-shock proteins. Upon addition
of the oestrogen derivate, 4-hydroxy-tamoxifen (4-OHT), heat-shock proteins dissociate and CKLiK-296 is directly
activated 44. This system has been successfully utilized for other protein kinases 45. Cells were transfected with
ER_CKLiK-296 and HA epitope tagged ERK1 or PKB. Prior to harvesting cells were stimulated with 4-OHT and
ERK/PKB kinase activity was measured. After two minutes of treatment an increased ERK activation was detected,
whereas no PKB activation occurred  (Fig. 7b). The CKLiK induced ERK activity could be blocked by the MEK
inhibitor PD98059 (Fig. 7c), suggesting that CKLiK activates signaling molecules upstream in the MAPK pathway.
Thus, these results suggest a role for CKLiK in regulation of ERK MAPK kinases at the level of MEK or higher.
Discussion
In this paper we describe the identification and characterization of a novel protein serine kinase which is highly
expressed in human PMNs. These cells, which include neutrophils and eosinophils, are characterized by a variety of
specific effector functions that regulate host defense. While several protein kinases, have been previously postulated
to regulate some of these effector functions through pharmacological inhibition studies, these proteins are
ubiquitously expressed and thus more likely to be involved in general cellular processes. Furthermore the use of
pharmacological inhibitors is often complicated by aspecific effects 15; 46.
By utilizing degenerate PCR primers against conserved catalytic kinase domains in a polymerase chain reaction on
cDNA templates from human granulocytes, we have identified a novel protein kinase with an open reading frame of
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357 amino acids (Fig.1). This novel kinase shows homology with Calcium/calmodulin-dependent Kinase I (CaMKI)
and therefore we have termed this kinase CaMKI-like kinase (CKLiK). CaMKI belongs to the family of Ca2+ and
calmodulin-dependent kinases, which includes CaMK I, II and IV as well as myosin light chain kinase,
phosphorylase kinase and elongation factor 2 kinase 47; 48. CaMKI itself has a wide tissue distribution and can
phosphorylate a number of substrates in vitro, including the synaptic vesicle-associated proteins synapsin 1 and
synapsin 2 49 and cAMP response element binding protein (CREB)28. Interestingly, analysis of CKLiK mRNA in
hematopoietic cells, revealed high and almost exclusive expression levels in PMNs, suggesting a role for CKLiK in
human granulocytes (Fig. 2). Upregulation of CKLiK mRNA was also observed in cord blood CD34+ stem cells
differentiated towards neutrophils, which may indicate the importance  of this kinase  in terminally differentiated
myeloid cells. In granulocytes, changes in [Ca2+]i have been associated with multiple functions, including
degranulation, phagosome-lysosome fusion, regulation of cytoskeletal binding proteins and transcriptional control 16;
17. These are thus potential processes whereby CKLiK may play a role.
Based on crystal structure and mutational-analysis of CamKI a model has been proposed for CaM Kinases
regulation 50; 51. When Ca2+ levels rice within the cytosol, calmodulin binds Ca2+ and is capable of interacting with
calmodulin binding proteins such as CaMK. Inactive CaMKs are in a folded configuration whereby the N-terminus
acts as a pseudo-substrate by interacting with an auto-inhibitory domain. Upon Ca2+ recruitment, calmodulin binds to
the calmodulin-binding-domain located on the C-terminal of CaMK, which then results in unfolding and auto-
phosphorylation of CaMK. It appears that CKLiK is also similarly regulated, since truncation of the predicted
calmodulin binding domain or the auto-inhibitory domain resulted in an inactive and constitutively active CKLiK
respectively (Figure 4).
Additionally we show that CKLiK can directly activate two members of the CREB/ATF family of transcription
factors, CREM and CREB by phosphorylation of serine residues 117 and 133 respectively (Fig. 3). Although
CKLiK is located in the cytoplasm, the constitutively active mutant was clearly translocated to the nucleus (Fig. 4d).
Possibly this enhanced nuclear translocation uncouples CKLiK from normal regulation resulting in enhanced
transcriptional activation. For CaMKIV it has been suggested that it can phosphorylate CREB in vivo since it shows
nuclear localisation52. Although a role for CREB in myeloid cells has been proposed in mediating cytokine or
chemokine effector functions 53-56, it remains to be determined if CREB and CREM are physiological substrates for
CKLiK in human granulocytes. Indeed we were able to demonstrate CREB phosphorylation by IL-8 in human
PMNs (data not shown).
Co-transfection of CaMK kinase (CaMKKα) resulted in an enhanced CKLiK activity measured by in vitro
phosphorylation of CREM and in vivo CREB mediated transcription activation. Enhancement of CKLiK activity by
CaMKK is possible via phosphorylation of the threonine residue on position 180, since this is in consensus with
threonine residues 177 and 196/200 of CaMKI and CaMKIV respectively. Interestingly CaMKKα induced CKLiK
activity in the absence of Ca2+ in the in vitro kinase assay (Fig. 5). There is indication of the generation of Ca2+-
independent CaMKIV activity by CaMKKα, however this is not the case for CaMKI 33; 39. What the mechanism is
for generating this enhanced CKLiK activity is unclear, although this may be a relevant in vivo. As previously
mentioned it may be due to stabilization of the CKLiK-Ca2+- calmodulin complex allowing for example a prolonged
kinase activity similar to the regulation of CaMKII 57, which might be needed for regulation of transcription.
IL-8 induced CKLiK activation is very rapid and corresponded to the IL-8 induced rise in  [Ca2+]i (Fig. 6). The IL-
8 receptor is highly expressed on human neutrophils and could be a possible upstream physiological receptor for
CKLiK. IL-8 is known to induce chemotaxis, and recently a role for intracellular Ca2+ in IL-8 induced migration has
been described indicating a possible role of CKLiK in this process 58; 59. A role for Ca2+ and calmodulin-dependent
kinases in apoptosis has also been recently demonstrated, since CaMKK was found to directly activate PKB and
thereby rescue apoptosis42. While we found no activation of PKB by CKLiK, we demonstrated an elevated ERK
activity by inducing CKLiK activation, which could be blocked by the MEK inhibitor PD098059 (Fig. 7). As
previously eluded to, pharmacological inhibitory studies have suggested that ERK MAP kinases possibly play a role
in chemotaxis, or respiratory burst and PAF release 6; 7; 60. The mechanism by which CKLiK can activate ERKs
however remains to be resolved, although it presumably occurs upstream of ERK.
In conclusion the approach of degenerate PCR resulted in a successful isolation of a novel PMN protein kinase.
We have demonstrated that this kinase is highly and predominantly expressed in human PMNs and terminally
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differentiated myeloid stem cells and that Ca2+/calmodulin regulates its activity. IL-8, which is a potent activator of
neutrophil effector functions, is capable of activating CKLiK in bone marrow derived myeloid cells. Furthermore a
role for CKLiK is suggested in regulation ERK MAP kinases, since induced CKLiK activity was sufficient to
activate ERK1. Therefore the restricted expression of CKLiK in granulocytes can allow the transduction of
granulocyte specific signals induced by a general signal transduction event: the rise in [Ca2+]i, initiated by
inflammatory mediators.
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Abstract
In human neutrophils, both changes in intracellular Ca2+ concentrations ([Ca2+]i) and activation of
phosphatidylinositol-3 kinase (PI3K) have been proposed to play a role in regulating cellular function induced by
chemoattractants. In this study we have investigated the role of [Ca2+]i and its effector molecule calmodulin in human
neutrophils. Increased [Ca2+]i alone was sufficient to induce phosphorylation of extracellular signal-regulated protein
kinase 2 (ERK2), p38 mitogen activated kinase (p38 MAPK), Protein Kinase B (PKB) and Glycogen Synthase
Kinase-3 α (GSK-3α). Inhibition of calmodulin using a calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-
naphthalenesulfonamide (W-7), did not effect fMLP induced ERK, p38 or GSK-3 phosphorylation, but attenuated
fMLP induced PKB phosphorylation. PCR analysis of human neutrophil cDNA, demonstrated variable expression of
members of the Ca2+/calmodulin-dependent kinase family. The roles of calmodulin and PI3K in regulating neutrophil
effector functions were further compared. Neutrophil migration was abrogated by inhibition of calmodulin, while no
effect was observed when PI3K was inhibited. In contrast, production of reactive oxygen species was sensitive to
inhibition of both calmodulin and PI3K. Finally, we demonstrate that chemoattractants are unable to modulate
neutrophil survival, despite activation of PI3K and elevation [Ca2+]i. Taken together, our data indicate critical roles
for changes in [Ca2+]i and calmodulin in regulating neutrophil migration and respiratory burst and suggest that
chemoattractant induced PKB phosphorylation may be mediated by a Ca2+/calmodulin sensitive pathway in human
neutrophils.
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Introduction
Neutrophils form a first line of host defense in the human immune system being recruited to inflammatory sites in
response to infection or tissue injury. Here they phagocytose and kill invading pathogens [1-3]. One of the responses
of neutrophils to inflammatory mediators such as chemoattractants, is the migration towards the site of infection.
This migration involves firm adhesion and attachment to the endothelium, diapedesis and interaction with
extracellular matrix proteins [4]. Secondly, activated neutrophils initiate the NADPH oxidase system, which causes
reactive oxygen species (ROS) formation, resulting in efficient killing of pathogens [5]. For resolution of
inflammation, removal of neutrophils by programmed cell death is essential to avoid tissue damage, which can be
caused by excessive release of granule proteases or inappropriate production of ROS [6].
Chemoattractants are potent activators of neutrophil effector functions. In neutrophils they stimulate G-protein
coupled receptors (GPCRs) which in turn activate the trimeric G-proteins. Exchange of guanosine diphosphate
(GDP) with guanosine triphosphate (GTP) bound to the Gα subunit, results in dissociation of the Gβγ heterodimer,
which subsquently leads to the activation of phospholipase Cβ (PLCβ)2 and PLCβ3, resulting in hydrolysis of
PI(4,5)P2 (PIP2) into diacylglycerol (DAG) and inositol-3 phosphate (IP3) [7;8]. The dissociation of the Gβγ subunit
can also result in activation of phosphatidylinosytol-3-OH kinase gamma (PI3Kγ)  [9;10]. However it has also been
described that chemoattractant induced GPCR stimulation can also activate the p85-associated Class 1A PI3K,
through an as yet undefined mechanism [11;12].
Both PLCβ and PI3Ks have been described to be important in mediating chemoattractant induced activation of
neutrophil effector functions [7;8;10;11;13;14]. Upon neutrophil activation, PI3K is recruited to the membrane where
it can phosphorylate phosphoinositides (PI) at the D-3 position of the inositol ring. These phosphorylated lipids,
preferentially PI(3,4)P2 and PI(3,4,5)P3, act as second messengers forming docking sites for molecules that posses a
plextrin homology (PH) domain such as Protein Kinase B (PKB) [15-17]. As previously mentioned PLCβ hydrolyses
PI(4,5)P2 into DAG and IP3. IP3 initiates the release of Ca2+ from the endoplasmatic reticulum, resulting in a rise in
cytoplasmic Ca2+. Although their have been several suggested functions for this rise of the intracellular Ca2+
concentration ([Ca2+]i), a clear role for elevated [Ca2+]i in neutrophil function has not been resolved [18;19]. An
important downstream regulator of Ca2+ is the ubiquitously expressed protein calmodulin [20]. Calmodulin is
activated by binding of four Ca2+ ions, which results in a conformational change. Once calmodulin is activated it can
bind to downstream targets, such as the Ca2+/calmodulin-dependent kinases (CaMK) [21;22]. CaMKs form a family
of serine/threonine kinases which can be activated by binding of Ca2+/calmodulin and includes, CaMKI, CaMKII,
CaMKIV, CKLiK and CaMKK. Until now there is no evidence for a specific role of these kinases in human
granulocytes. However, recently we have demonstrated that CKLiK mRNA is highly specifically expressed in
human neutrophils [23].
Stimulation of human neutrophils with chemoattractant also regulates the activation of various intracellular protein
kinases. Downstream signal molecules such as extracellular regulated kinase (ERK), Protein Kinase B (PKB) and the
38 kD mitogen activated protein kinase (p38) have also been implicated in the regulation of neutrophil effector
functions [11;24;25]. However it has not been investigated whether the activation of these signaling molecules might
be mediated by either activation of PI3K or by a rise in [Ca2+]i or by both.
Here we show that that elevated [Ca2+]i induces phosphorylation of downstream signaling molecules similarly to
chemoattractants. Inhibition of calmodulin resulted in a diminished PKB phosphorylation, but had no effect on ERK,
p38 and GSK-3 phosphorylation. GPCR mediated migration of human neutrophils was found to be dependent on
calmodulin activity, but not on PI3K. However, fMLP induced respiratory burst demonstrated dependency on both
calmodulin and PI3K activity. These data demonstrate critical roles for changes in [Ca2+]i and calmodulin regulated
signaling pathways in chemoattractant induced neutrophil effector functions such as migration and formation of
reactive oxygen species.
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Materials and Methods
Reagents and antibodies
PAF (platelet-activating factor), fMLP (N-formyl-methionyl-leucyl-phenylalanine) and cytochrome c were
purchased from Sigma (St. Louis, MO). Recombinant human GM-CSF was obtained from Genzyme (Boston, MA).
Ionomycin was puchased from Calbiochem (La Lolla, CA) and human IL-8 from PrepoTech (Rocky Hill, NJ). N-(6-
aminohexyl)-5-chloro-1-naphtalenesulfonamide (W7) was obtained from Sigma (Zwijndrecht, The Netherlands).
LY294002 was purchased from Biomol (Plymouth Meeting, PA). Polyclonal phospho-p42/44 MAPK
(Thr202/Tyr204), phospho-p38 MAPK (Thr180/Thr182), phosphoPKB (Ser473) and phospho-GSK-3α/β (Ser21/9)
antibodies were obtained from Cell Signaling (Beverly, MA). ERK-2 (C-14), actin (I-19) and p38 (C20) antibodies
were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Isolation of human neutrophils
Blood was obtained from healthy volunteers at the donor service of the University Medical Center (Utrecht, The
Netherlands) anti-coagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4). Neutrophils were isolated as previously
described [26]. In short, mononuclear cells were depleted from neutrophils by centrifugation over isotonic Ficoll
from Pharmacia (Uppsula, Sweden). After lysis of the erythrocytes in an isotonic NH4Cl solution, neutrophils were
washed and resuspended in incubation buffer (20 mM Hepes, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2 mM
KH2PO4, 5 mM glucose, 1 mM CaCl2 and 0.5% HSA). Neutrophils were incubated for 30 minutes at 370C before
experiments were performed.
RNA isolation, cDNA synthesis and PCR
mRNA was isolated from neutrophils by lysing cells (25x106) in 400 µl GITC solution (4 M guanidine-
isothiocyanate, 25 mM sodium citrate, 1 mM β-mercaptoethanol, 0.5% sarkosyl and 0.1% antifoam). RNAs were
further isolated by phenol extraction and ethanol precipitation. To remove possible DNA contamination, the RNA
solution was treated with DNAse I (Clontech Laboratories, Palo Alto, CA) for 30 minutes at 37ºC and RT PCR was
performed with of purified RNA (1 µg). PCR was performed with primers (100 ng) of human CaM kinase family
members (CaM kinase I, II, IV, CKLiK and CaMK kinase). The following oligonucleotides were used: CaMKI
forward: 5’-CGGAGGACATTAGAGACA-3’, reverse: 5’-CTCGTCATAGAAGGGAGG-3’; CaMKII forward: 5’-
GGTTCACGGA-CGAGTATC-3’, reverse: 5’-TGGCATCAGCTTCACTGTA-3’; CaMKIV forward: 5’-
GATGAAAGAGGCGATCAG-3’, reverse: 5’-TAGGCCCTCCTCTAGTTC-3’; CKLiK forward: 5’-
GGCAAAGGAGATGTGATG-3’, reverse: 5’-CTGCTCGAAACACTTGC-3’ and CaMKK forward: 5’-
TCTCCATCACGGGTATGC-3’ and reverse: 5’-GCGTCACT-GCCCTTGAAT-3’. As a control β-actin primers
were used as described [27]. Taq polymerase was used under conditions of 10 mM Tris-Cl pH 8.3, 50 mM KCl, 0.2
mM dNTPs and 0.8 mM MgCl2 (Perkin Elmer, Roche Molecular Systems, Branchburg, NJ). PCR products were
visualized on a 1% agarose gel.
Cell lysates and western blotting
Neutrophils were stimulated with fMLP (1 µM), IL-8 (10-8 M) or ionomycin (1 µM) for several time points and pre-
treated if necessary with 5 to 50 µM W7 for 20 minutes at 37ºC. For Western blotting with phospho-ERK or
phospho-p38 antibodies, cells (106) were lysed in 40 µl sample buffer (60 mM Tris-HCl pH 6.8, 2% SDS, 10%
glycerol and 2% β-mercaptoethanol) and boiled for 5 minutes at 95ºC. For western blotting with phospho-PKB or
phospho-GSK-3 antibodies, cells (4x106) were lysed in 40 µl lysis buffer (50 mM Tris-HCl pH 8, 100 mM NaCl, 5
mM EDTA, 1% Triton X100, 1 mM Na3VO4, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 1 mM benzamidin, 1 mM
PMSF and 1 mM DFP). Lysates were spun down at 4ºC for 5 minutes and 5x sample buffer was added to the
supernatant before boiling the samples.
Analysis of neutrophil migration
Migration experiments were performed as described previously [28]. In short, glass coverslips were coated with a
Hepes buffer containing 0,5% human serum albumine (20 mM Hepes, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2
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mM KH2PO4, 5 mM glucose, 1 mM CaCl2). Purified neutrophils (106/ml Hepes buffer) were first incubated at 37ºC
for 20 minutes and pre-treated with W7 (50 µM) or LY294002 (20 µM) for 10 minutes. Neutrophils were allowed to
attach to the coverslip for 10-15 minutes at 37ºC. Medium was removed and the cells were washed two times with
Hepes buffer. The coverslip was then inverted in a droplet of medium containing 10-8M IL-8 and sealed with a
mixture of beeswax, paraffin, and petroleum jelly (1:1:1, wt/wt/wt). Cell tracking at 37ºC was monitored by time–
lapse microscopy and analyzed by custom-made macro (A.L.I.) in image analysis software (Optimas 6.2; Media
Cybernetics, Silver Spring, MD). Cell migration was followed for 10 minutes making a picture every 20 seconds.
Measurement of ROS production
Respiratory burst was measured by ROS induced cytochrome c reduction [29]. Assay was performed as previously
described [30]. Neutrophils (4x106 cells/ml) were pre-incubated with W7 (20 or 50 µM) or LY294002 (20 µM) for
20 minutes and GM-CSF (10-10M) to prime the cells. Cytochrome c (75 µM) was added and transferred to a
microtitre plate and placed in a thermostat-controlled plate reader (340 ATTC; SLT Lab Instruments, Salzburg,
Austria). ROS production was induced by stimulation with 1 µM fMLP. Cytochrome c reduction was immediately
measured every 12 seconds as an increase in absorbance at 550 nm.
Measurement of Apoptosis assay
Apoptosis was measured by analyzing Annexin V-fluorescein isothiocyanate (FITC)- binding (Bender Medsystems;
Vienna, Austria). In short neutrophils were resuspended in Hepes buffered RPMI containing 8% serum (Hyclone) at
a concentration of 106/ml and treated with GM-CSF (10-10 M) or IL-8 (10-7 M) and incubated at 37ºC for indicated
time periods. Cell were stored at 40C until last incubation timepoint had been reached. Cells were washed with PBS
and resuspended in binding buffer (10 mM Hepes/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2). Subsequently cells
were incubated with Annexin V-FITC for 15 minutes at room temperature in the dark, washed with PBS and
resuspended in binding buffer. Propidium iodide was added (1 µg/ml) and the percentage of apoptotic cells was
detected by FACS analysis (FACSvantage, Becton Dickinson).
Results
Comparison of intracellular signaling pathways activated by chemoattractants and elevated [Ca2+]i.
Stimulation of human neutrophils with chemoattractants has been reported to result in the activation of several
intracellular signaling pathways. It is of were interest to determine whether changes in [Ca2+]i alone could modulate
these responses. To this end, we analyzed if activation of several kinases could be induced by addition of the Ca2+
ionophore ionomycin, or the chemoattractant fMLP. The phosphorylation state of ERK1/2, p38, PKB and GSK-3
after stimulation of neutrophils with ionomycin or the chemoattractant fMLP was compared. Addition of fMLP
resulted in a rapid phosphorylation of ERK2 and p38, being optimal at approximately one minute after stimulation
(Fig. 1A, left panel). Elevation of [Ca2+]i, by ionomycin addition, was also sufficient to induce ERK2
phosphorylation (Fig. 1B, upper left panel). This was optimal after 30 seconds and was maintained for at least 15 to
30 minutes. Similarly, ionomycin also induced rapid phosphorylation of p38 (Fig. 1A, lower left panel).
PI3K activation results in the recruitment of PKB to the membrane were kinases, such as PDK1, phosphorylate
PKB. Recently it has been demonstrated that CaMKK phosphorylates PKB suggesting a role for Ca2+ in the
activation of PKB [31]. Treatment with ionomycin was indeed sufficient to induce PKB phosphorylation in human
neutrophils (Fig 1A, upper right panel). Additionally, GSK-3 a direct target of PKB mediated phosphorylation, was
also phosphorylated upon ionomycin treatment (Fig 1A, lower right panel). Both PKB and GSK-3α phosphorylation
after ionomycin treatment were still elevated after 30 minutes. Taken together, increased [Ca2+]i alone is sufficient to
induce phosphorylation of ERK2, p38, PKB and GSK-3α similar to receptor-mediated activation by
chemoattractants.
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Figure. 1:  Regulation of neutrophil signaling pathways, by fMLP and ionomycin..
Human neutrophils were isolated and stimulated with (A) 1 µM fMLP or (B) 1 µM ionomycin for indicated time points. Cells
were lysed and western blotting was performed as described in Materials and Methods. Phosphospecific antibodies were used for
ERK-P, p38-P, PKB-P and GSK3-P. The levels of ERK2, p38 and actin were determined as a control for equal loading of
proteins. Data are representative of three independent experiments.
Calmodulin is critical for chemoattractant mediated PKB phosphorylation in human neutrophils
Increased [Ca2+]i is sufficient to regulate multiple intracellular signaling pathways. Therefore the role of calmodulin,
the major downstream effector of Ca2+, in the regulation of intracellular signaling was analyzed by using the
calmodulin inhibitor W7 [32]. ERK2 phosphorylation was only partially inhibited at a concentration of 50 µM W7
(Fig. 2A, upper panel) and no effect was observed on the regulation of p38 when calmodulin was inhibited (Fig. 2A,
lower panel). A dramatic inhibition of fMLP induced PKB-phosphorylation was observed, which occurred in a
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concentration-dependent manner (Fig. 2B, upper panel). Surprisingly, GSK-3 that has been previously demonstrated
to be a downstream target of PKB in several cell types, exhibited no sensitivity to W7 (Fig. 2B, lower panel). In
conclusion, these results demonstrate that chemoattractant mediated PKB activation, unlike ERK2 and p38, is
dependent on calmodulin activity. Additionally, these data suggest that fMLP induced GSK-3 phosphorylation in
human neutrophils can occur in a PKB-independent manner.
Figure 2: Effect of calmodulin inhibitor W7 on protein phosphorylation in neutrophils after fMLP stimulation.
Isolated neutrophils were incubated with DMSO or increasing concentrations of W7 (5-50 µM) for 20 minutes before stimulation
with 1 µM fMLP for one minute. Cells were lysed and phosphorylated proteins detected by western blotting as described in
Materials and Methods. (A) ERK-P and p38-P. (B) PKB-P and GSK3-P. The levels of ERK2, p38 and actin were determined as a
control of equal loading. Data are representative of at least three independent experiments.
Expression of Ca2+/calmodulin-dependent kinases in human neutrophils
Binding of Ca2+ to calmodulin enables it to interact with and activate Ca2+/calmodulin-dependent kinases (CaMKs).
Previous reports have demonstrated that CaMKs can phosphorylate PKB, ERK and JNK in vitro [23;31;33].
However, little is known about the expression of kinases directly activated by changes in [Ca2+]i in human
neutrophils In order to identify CaMKs expressed in human neutrophils, RT-PCR was performed with neutrophil
cDNA and specific CaM kinase primers for CaMKI, CaMKII, CaMKIV, CKLiK and CaMKK. Expression of
CKLiK, CaMKK, CaMKII and low amounts of CaMIKI were detected. However, no CaMKIV expression was
observed (Fig. 3).
Figure 3: Expression of Ca2+/calmodulin dependent kinases in neutrophils.
cDNA was synthesized from neutrophil mRNA as described in Materials and Methods. PCR with specific primers for CaMKI, II,
IV, CKLiK, CaMKK was performed with 30, 35 or 40 reaction cycles. β-actin primers were as a control. PCR fragments were
visualized on gel. Data are representative of three independent experiments.
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Chemoattractant mediated neutrophil migration is abrogated by inhibition of calmodulin but not by inhibition of PI3K
In order to investigate the role of [Ca2+]i and calmodulin in neutrophil function, two processes involved in host
defense, migration and the generation of ROS were investigated. During neutrophil migration, activation of PI3K and
changes in [Ca2+]i occur as a results of chemoattractant induced GPCR activation. Although a specific role for [Ca2+]i
in regulating migration has not been defined, some aspects of the migration process have been shown to be at least
partially controlled by changes in [Ca2+]i [34]. Therefore, analysis of the role of calmodulin and PI3K in IL-8
induced neutrophil migration on albumin coated coverslips was performed. IL-8 is a known potent activator of
neutrophil migration and activates the GPCRs, CXCL1 and CXCL2, within the same family of the fMLP receptor
[35]. Migration of neutrophils was imaged in the presence of IL-8 for 10 minutes, and the effect of specific inhibitors
of calmodulin (W7) or PI3K (LY294002), were analyzed by recording migratory tracks (Fig. 4A, upper panels). To
obtain a better comparison, the tracks were centered in Figure 4A (lower panels). Upon IL-8 stimulation, neutrophil
migration was markedly increased. Both the migration distance and the migration speed is clearly elevated by IL-8
treatment from 1.68±0.35 to 7.08±1.33 µm per minute (Fig. 4B). Pre-incubation with W7 abrogated the IL-8 induced
migration completely, whereas inhibition of PI-3K with LY294002 showed no effect on the IL-8 induced migration
on albumin (see Fig. 4A+B). Similar results were also observed for fMLP induced migration (data not shown). These
results suggest that PI3K is not necessary for chemokine induced neutrophil migration and demonstrate a critical role
for calmodulin, and thus changes in [Ca2+]i, in IL-8 induced neutrophil migration on albumin coated surfaces.
Figure 4: Effect of W7 and LY294002 on IL-8 induced neutrophil migration.
Migration of neutrophils was monitored by video microscopy. Cells were pre-incubated as indicated with 50 µM W7 or 20 µM
LY294002 for 10 minutes, followed by attachment to albumine coated coverslips for 15 minutes. (A) Neutrophil migration was
induced by 10-8M IL-8 and imaged every 20 seconds for 10 min. (A, upper panels) Tracks and image of cells are shown as
migration tracks of individual cells. (A, lower panels) Centered tracks are depicted. (B) Average migration speed of at least three
independent experiments are calculated and expressed as µm per minute ± std.
Both calmodulin and PI3K are critical in generation of reactive oxygen species in human neutrophils
Stimulation of neutrophils with the chemoattractant fMLP induces the rapid formation of ROS. This process, termed
the respiratory burst, is initiated by the association of the intracellular multi-protein complex NADPH oxidase, which
catalyzes the production of ROS and results in efficient killing of invading pathogens [5]. The effect of the
calmodulin inhibitor W7 on fMLP induced ROS production was investigated and compared with the effect of the
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PI3K inhibitor LY294002. The respiratory burst is dependent on prior priming of cells with cytokines,
chemoattractants, or lipopolysaccharides [1;36]. Neutrophils were therefore pre-treated with GM-CSF. W7 or
LY294002 were added 20 minutes before stimulation with fMLP. As shown in Figure 5 unprimed cells were unable
to activate the respiratory burst upon fMLP stimulation. However cells first primed with GM-CSF induced a rapid
production of ROS. Pre-treatment with W7 resulted in a concentration dependent inhibition of ROS production,
which was also observed with the PI3K inhibitor LY294002, as we demonstrated before [11;30]. These data indicate
that both PI3K and calmodulin are necessary for optimal chemoattractant mediated ROS production in human
neutrophils.
Figure 5: Comparison of the effect of W7 and LY294002 on the respiratory burst in human neutrophils.
Cells were isolated and treated without (open mark) and with 10-10 M GM-CSF (closed marks) to prime the cells. Before initiation
of the respiratory burst with 1 µM fMLP, cells were pre-treated with DMSO, 20 µM W7, 50 µM W7 or 20 µM LY294002 for 20
minutes as indicated. ROS production was measured by cytochrome c reduction resulting in a change in absorption at a
wavelength of 550 nm. Average of three independent experiments are depicted.
Chemokines in contrast to cytokines play no role in regulating neutrophil survival
Neutrophil apoptosis, and recognition and removal of cells by macrophages is an essential event in the termination of
inflammation and prevention of damage to host tissue. Neutrophils are intrinsically committed to programmed cell
death, however inflammatory cytokines such as GM-CSF can delay this process [30;37;38]. Furthermore there are
some indications that other inflammatory mediators may be able to inhibit neutrophil apoptosis [39]. In this study,
we wished to determine whether indeed chemoattractants could protect human neutrophils from apoptosis. One of
the early events during apoptosis is the appearance of phosphatidylserine on the extracellular surface of cells.
Phosphatidylserine can bind to (FITC-labeled) annexin-V and in this way functions as a marker of programmed cell
death (Fig. 7A). After 16 hours, 78% of all neutrophils were annexin-V positive. Relative to this amount of apoptotic
cells (average of individual experiments, considered to be 100% in Fig. 7B), 35% of these cells were rescued from
apoptosis after treatment with GM-CSF. IL-8 however, showed no additional survival compared with the untreated
neutrophils. We hypothesized that IL-8 might possibly show an additional effect to GM-CSF in the delay of
apoptosis. However, also here no additional effect of IL-8 was observed when neutrophils were treated with both
GM-CSF and IL-8 (Fig. 7A+B). Therefore chemoattractant induced activation of PI3K and elevation of [Ca2+]i were
insufficient in the protection of neutrophils against apoptosis.
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Figure 6: Comparison of the effects of cytokines and chemokines on neutrophil survival.
Isolated neutrophils were pre-incubated at 37oC in Hepes buffered RPMI containing 8% serum. Cells were treated for 16 hours
with indicated 10-10M GM-CSF or/and 10-7M IL-8 or a combination. (A) The amount of apoptotic cells was analyzed by annexin-
V FITC and propidium iodide staining. FACS Dotplots of 0 and 16 hours are depicted and % of annexin-V positive cells are
displayed in tables. (B) Average of % annexin-V positive cells, of at least four independent experiments are depicted and error
bars (std.) are indicated. Total amount of apoptotic cells at 16 hours in untreated conditions were corrected to 100%.
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Discussion
In this study the role of Ca2+ and its downstream effector molecule calmodulin in GPCR regulated signaling
pathways in human neutrophils was investigated. Additionally, the role of calmodulin and PI3K, in chemoattractant
induced neutrophil effector functions, such as migration and respiratory burst were compared. Treatment of cells
with the calcium ionophore ionomycin, resulted in the phosphorylation of ERK2, p38, PKB and GSK-3α (Fig. 1).
This demonstrates that increased [Ca2+]i in itself is sufficient to activate these kinases and suggests that the elevated
[Ca2+]i generated by chemoattractants might be important in activation of downstream signaling events. Compared to
fMLP treatment, ionomycin illustrated a prolonged phosphorylation of ERK2, PKB and GSK-3α in these cells. This
might be due to the continuously elevated [Ca2+]i induced by ionomycin, or it may indicate that elevation of [Ca2+]i
alone is not sufficient to activate inhibitory signaling pathways normally responsible for ERK, PKB and GSK-3
dephosphorylation.
Analysis of the effect of calmodulin inhibition on signaling pathways induced by chemoattractants in human
neutrophils showed a minor inhibition of ERK- and a dramatic inhibition of PKB phosphorylation (Fig. 2). Although
there are some indications that CaMKIV and CKLiK may influence ERK activation in vivo [23;33], our data
suggests that calmodulin is at least not essential in GPCR regulated ERK activity. Importantly, PKB phosphorylation
was completely abolished by inhibition of W7 (Fig. 3b). In general, generation of PIP3 by PI3K initiates recruitment
of PKB though its PH domain to the membrane. However, for activation of PKB, phosphorylation on serine 473 and
threonine 308 are necessary and additional kinases are involved. It has been described that CaMKK can
phosphorylate PKB directly [31]. These data, together with our RT-PCR expression data, suggest that CaMKK could
play an important role in PKB activation in human neutrophils stimulated by chemoattractants. Whether CaMKK is
recruited to the membrane or can activate PKB cytosolically in human neutrophils still has to be elucidated.
Interestingly, GSK-3 which has previously been shown to be a downstream target of PKB in several cell types,
exhibited no sensitivity to calmodulin inhibition. Since we observed complete inhibition of PKB phosphorylation it
appears that PKB activation is not necessary for chemoattractant induced GSK-3 phosphorylation in human
neutrophils. GSK-3 phosphorylation has also been described to be mediated by protein kinases other then PKB. For
example growth factors can inhibit GSK-3 activity by means of the classical MAPK pathway [40]. There are also
indications that phosphorylation of GSK-3 can be mediated by Protein Kinase A or by a pathway that involves the
mammalian target of rapamycin (mTOR) [41;42]. In guinea pig neutrophils it has been demonstrated that GSK-3
phosphorylation could only be inhibited by dual treatment of the PI3K inhibitor wortmannin and the MEK inhibitor
PD98059 [43]. Furthermore, our data illustrate that fMLP induced GSK-3 phosphorylation is more sustained relative
to PKB phosphorylation, and the kinetics are rather similar to that fMLP induced ERK phosphorylation (see Fig. 1).
We demonstrate an inhibition of neutrophil migration by W7 (Fig. 4). A calmodulin-dependent kinase which might
be involved in this process is myosin light chain kinase (MLCK). This kinase phosphorylates the light chain of
myosin II which is thought to be important for contraction at the rear of the cell [44]. Furthermore Ca2+ is suggested
to play a role in the recycling of integrins, which involves cell adhesion and attachment [45]. Additionally it had
been described that CaMKII counteracts the calcineurin induced affinity switch of α5β1 integrin in CHO cells,
suggesting also a role for Ca2+/calmodulin-dependent molecules in regulating the affinity state of integrins on
neutrophils [46].
Although PI3K has been suggested to play a role in signaling to the actin cytoskeleton [9], no inhibitory effect of
LY294002 on chemoattractant induced migration was observed, suggesting a minor role for PI3K in chemoattractant
induced migration. Although we have demonstrated this before [11], contradictory results have also been described
[47]. Furthermore, it has been shown that neutrophils isolated from knockout mice lacking PI3Kγ demonstrated an
inhibited response to chemoattractant induced migration [8;14]. Therefore, a role for PI3K in neutrophils migration
cannot be ruled out. Recently, it has been described that PI3K rather affects directionality and not motility [48],
which might be in agreement with our findings, since our assays predominantly detects motility.
We also demonstrate that fMLP induced ROS production was dependent on both, calmodulin and PI3K. In guinea
pig neutrophils is has been demonstrated that inhibition of calmodulin results in inhibition of Rac and p21 activated
kinases (PAKs) [49]. Involvement of Rac in ROS production has been demonstrated [5] and a role for PAK has been
suggested in phosphorylation the 67 kDa subunit of the NADPH complex [50]. However in human neutrophils we
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have shown that Rac activation was independent of changes in [Ca2+]i [51]. A role for PKB has been suggested in
phosphorylation the 47 kDa subunit of the NADPH complex, p47phox, since membrane targeted PI3K leads to PKB
phosphorylation and p47phox phosphorylation [52]. Recently a role for PI3K in the respiratory burst has been shown,
since it has been demonstrated that the Phox homology (PX) domains in p47phox and p40phox binds to different
phosphorylated phosphatidylinositol [53;54]. Although direct activation of components in the multi-protein complex
by PKB has not been shown, it is possible that the inhibitory effect of W7 on the generation of ROS may be
mediated by PKB.
As demonstrated in Figure 6, neutrophil apoptosis was unaffected by chemokine stimulation. In previous reports
we have demonstrated a role for the PI3K-PKB pathway in cytokine-mediated delay of apoptosis in human
neutrophils [30]. Although IL-8 induces activation of PI3Kand PKB and increases [Ca2+]i, our results demonstrate
that it does not effect neutrophil survival. The divergence effects on apoptosis obtained by cytokines and chemokines
might be due to the difference in kinetics. Chemokines transduce rapid signaling events, while cytokines signaling is
relatively slow. Furthermore, no additional effect on GM-CSF delayed apoptosis by IL-8 could be observed. It has
been suggested that Ca2+-induced PKB phosphorylation might lead to survival [31]. However, here we demonstrate
that there is no role for chemoattractants and thus [Ca2+]i in regulating neutrophil apoptosis.
Taken together, we demonstrated that elevations of [Ca2+]i and calmodulin play central roles in chemoattractant
induced neutrophil effector functions, such as migration and respiratory burst, which partially overlaps with PI3K
regulated functions. A possible convergence of PI3K- and Ca2+/calmodulin regulated pathways might be at the level
of PKB activation, in which PI3K recruits PKB to the plasma membrane and calmodulin-regulated kinases mediate
its phosphorylation. Further work is necessary to determine precisely which CaMKs are important in the
Ca2+/calmodulin mediated effector functions of human neutrophils.
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Abstract
Human granulocytes, which include neutrophils and eosinophils, respond to inflammatory mediators by activating
specific effector functions, finally resulting in the elimination of invading microorganisms. Activation of these
granulocyte effector functions, such as induction of the respiratory burst, are regulated by a variety of ill-defined
signaling pathways. Recently, we identified a novel protein kinase cDNA with high homology to Ca2+-calmodulin-
dependent kinase I (CaMKI), termed CaMKI-like kinase (CKLiK), which showed restricted mRNA expression to
human granulocytes. In this study the expression, regulation and function of this novel protein kinase has been
investigated in human granulocytes. The CKLiK gene was found to be localized on chromosome 10. Antibodies
against the C-terminus of CKLiK, which demonstrates no homology with CaMKI. CKLiK was detected in CD34+
derived neutrophils and eosinophils, as well as in mature peripheral granulocytes. Analysis of CKLiK kinase activity
showed dependency on Ca2+ and calmodulin. Furthermore, activation of human granulocytes by inflammatory
mediators, such as N-formyl-methionyl-leucyl-phenylalanine (fMLP) and Platelet Activating Factor (PAF) resulted
in induction of CKLiK activity, in parallel with a rise of intracellular Ca2+ [Ca2+]i. In order to study the function of
CKLiK in human granulocytes, we generated a cell permeable CKLiK peptide inhibitor (CKLiK297-321). This
peptide was able to inhibit CKLiK kinase activity in a concentration-dependent manner. Since both production of
reactive oxygen species (ROS) in human granulocytes and migration have previous been shown to require Ca2+, we
investigated the effect of this peptide on these processes. fMLP-induced ROS production was potently inhibited by
CKLiK(297-321). Additionally, migration of neutrophils on albumin coated surfaces was perturbed. These findings
suggest a critical role for CKLiK in modulating functional responses in human granulocytes.
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Introduction
Human granulocytes play an important role in host defense against invading pathogens1. During inflammation,
granulocytes in the peripheral blood become primed or pre-activated, leave the bloodstream by diapedesis through
the endothelium and migrate towards the site of inflammation 2. At the inflammatory site granulocytes become
highly activated, secrete proteolytic enzymes by degranulation and form cytotoxic reactive oxygen species (ROS) to
eliminate invading microorganisms 3. Inflammatory mediators, such as chemokines and chemoattractants that
activate the G-protein coupled receptors (GPCR) initiate these granulocyte effector functions. Binding of ligand to
GPCRs results in activation of trimeric G-proteins and subsequent dissociation of the Gα and Gβγ subunits. The
dissociation of the Gβγ subunit can result in activation of phosphatidylinosytol-3-OH kinase (PI3K) and PLCβ.
PLCβ activation can in turn lead to the hydrolysis of phosphatidylinositol (4,5)phosphate (PIP2) producing
diacylglycerol (DAG) and inositol-3 phosphate (IP3) 4. Subsequently, IP3 binds to its receptor on the Ca2+ stores,
resulting in Ca2+ release into the cytoplasm. Elevation of intracellular Ca2+ ([Ca2+]i) in granulocytes has been
observed during activation of several granulocyte effector functions, for example in fMLP induced respiratory burst
5; 6. Additionally, Ca2+ has been implicated in the regulation of migration, since Ca2+ buffered neutrophils
demonstrated an abrogated integrin recycling and rear release 7 8. However very few specific proteins have been
identified that sense changes in [Ca2+]i and transduce these signals modulating granulocyte functions.
Recently we identified a novel protein kinase CKLiK, which mRNA is highly expressed in human granulocytes 9.
CKLiK is highly homologous with CaMKI, a member of the Ca2+/calmodulin-dependent kinase (CaMK) family 10 .
Based on the crystal structure of CaMKI a general model for the activation of CaMKs has been proposed 11. When
Ca2+ levels rise in the cytosol, calmodulin, a ubiquitously expressed Ca2+-binding protein, undergoes a
conformational change, which results in binding to the calmodulin binding domain present in CaMK family members
12. Inactive CaMKs are in a "folded" configuration whereby the autoinhibitory domain acts as a pseudosubstrate by
interacting with the N-terminal kinase domain. The calmodulin-binding domain is located on the C-terminus of
CaMK. Calmodulin binding results in "unfolding" and subsequent activation of CaMK 10. For CaMKII this activation
has been correlated with autophosphorylation 13. CaMKIV has also been proposed to be autophosphorylated, but not
in the activation loop which is the case for CaMKII 14. For CaMKI this remains to be proven. Full activity of CaMKI
and CaMKIV is obtained by phosphorylation of a threonine residue by CaMKK in their activation loop 15; 16; 17.
CKLiK activity is also enhanced by co-expression of CaMKK, and CKLiK indeed has a threonine residue in the
activation loop suggesting regulation by CaMKK 9.
In this study we characterized the expression, regulation and function of this novel Ca2+/calmodulin dependent
kinase in human neutrophils and eosinophils. We identified CKLiK as a gene located on chromosome 10 (10p14).
CKLiK expression was detected in human eosinophils and neutrophils by utilizing a novel antibody raised
specifically against CKLiK. Furthermore, we demonstrate that CKLiK can be activated by physiological relevant
inflammatory mediators which induce elevations of [Ca2+]i. By the generation of a cell permeable inhibitory peptide
for CKLiK we were able to investigate a role of CKLiK in granulocyte effector functions. Addition of this peptide
led to an inhibited respiratory burst and an abrogated migration, suggesting a role for CKLiK in these effector
functions in human granulocytes.
Materials and methods
Cells, reagents and antibodies
Murine myeloid 32D cells were cultured in RPMI 1640-glutamate supplemented with 8% Hyclone serum (Life
Technologies, Breda, The Netherlands) and mouse IL-3. Generation of 32D cells stably expressing pBabe-
HA_CKLiK has been described previously 9. Stemcell factor and hFLT-3 ligand were purchased from Peprotech
(Rocky Hill, NJ), hIL-3 and hG-CSF were obtained from Strathmann (Hamburg, Germany), GM-CSF was purchased
from Endogen (Woburn, MA, USA), hIL-5 was a kind gift of Dr. I. Uings (GlaxoSmithKline, Stevenage, UK). fMLP
(N-formyl-methionyl-leucyl-phenylalanine) was purchased from Sigma (St. Louis, MO). Calmodulin was a kind gift
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of Dr. R. de Groot. Monoclonal antibodies, 12CA5 against HA epitope were purchased from Boehringer Mannheim
Biochemicals (Almere, The Netherlands). Cell permeable CKLiK(297-321) was designed by linking it to the 11
amino acid sequence of the HIV tat protein (YGRKKRRQRRRIRKNFAKSKWRQAFNATAVVRHMRK). An
arbitrary tat-control peptide was used as a negative control
Generation of CKLiK antibody
Antibodies against the C-terminal part of CKLiK were generated by immunizing rabbits with an eleven amino acid
synthesized peptide specific for CKLiK, CAYVAKPESLS, coupled to Keyhole Limpet Hemocyanin. Antibody
purification was performed by affinity chromatography. In short, the immunogenic peptide was coupled to an
agarose carrier support utilizing a SulfoLink kit (Pierce, Rockford, IL, USA). Antibodies against were allowed to
bind to the peptide coupled beads, washed with 100 mM TRIS pH 8.0 and eluted with Glycine pH 3.0. Purified anti-
CKLiK was dialyzed against PBS and stored at 40C containing 0.02% sodium azide.
Isolation of human neutrophils and eosinophils.
Blood was obtained from healthy volunteers at the donor service of the University Medical Center (Utrecht, The
Netherlands). Granulocytes were isolated from 0.4% (wt/vol) trisodium citrate (pH 7.4) treated blood as previously
described 18. In short, mononuclear cells were depleted by centrifugation over isotonic Ficoll from Pharmacia
(Uppsula, Sweden). After lysis of the erythrocytes in an isotonic ice-cold NH4Cl solution, granulocytes were washed
and resuspended in incubation buffer (20 mM HEPES, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2 mM KH2PO4,
5 mM glucose, 1 mM CaCl2 and 0.5% HSA). Eosinophils were separated from neutrophils by negative
immunomagnetic selection with anti-CD16-conjugated microbeads (MACS Miltenyi Biotech, Auburn, USA) 19.
Purity of eosinophils was > 98%.
Isolation and culture of human CD34+ cells
CD34+ cells were isolated as previously described 20. In short, mononuclear cells were isolated from umbilical cord
blood by density centrifugation over isotonic ficoll solution (pharmacia, Uppsula, Sweden). Immunomagnetic
selection with hapten conjugated antibody against CD34 was used to isolate CD34+ cells (Miltenyi Biotech, Auburn,
USA). CD34+ cells were cultured in Iscove’s Modified Dulbecco’s Medium (Gibco, Paisley, UK) supplemented with
10% FCS, 50 µM β-mercaptoethanol, 10 U/ml penicillin, 10 µg/ml streptamycin, and 2mM glutamine at a density of
0.3 x 106 cells/ml. Cells were differentiated towards neutrophils or eosinophils upon addition of SCF (50 ng/ml),
FLT-3 (50 ng/ml), GM-CSF (0.1 nmol/l), IL-3 (0.1 nmol/l), and G-CSF (10 ng/ml) for neutrophils differentiation or
IL-5 (0.1 nmol/l) for eosinophil differentiation. Every 3 or 4 days, cells were counted and fresh medium was added to
a density of 0.5x106 cells/ml. After 3 days of differentiation, only IL-3 and G-SCF or IL-5 were added to the cells as
appropriate.
Analysis of CKLiK expression
CKLiK expression was analyzed by immunoprecipitation and western blotting. For this, cells were stimulated as
indicated and washed twice with cold PBS and lysed in a buffer containing; 1% NP-40, 20mM Tris-Cl pH 7.5,
150mM NaCl, 10% glycerol and 10mM MgCl2 supplemented with 10µg/ml aprotinin, 1mM leupeptin, 1mM phenyl-
methylsulfonylfluoride (PMSF), 1mM benzamidine 1mM Na3VO4 and 1mM diisopropyl-phosphorofluoride (DFP).
Lysates were pre-cleared for 20 min with protein-A sepharose and CKLiK was immunoprecipitated with anti-CKLiK
for 1-2 hours. Immunoprecipitates were washed twice in cold PBS and denaturated in sample buffer by boiling for 5
minutes. Samples were separated by a 12.5% SDS-PAGE and analyzed by western blotting. Membranes were
blocked with 5% low-fat milk for 1 hour before hybridizing anti-CKLiK in 0.5% low-fat milk for 2 hours and swine
anti-rabbit peroxidase-conjugated antibody (swarpo) or protein-A peroxidase-conjugated (protAhrp) in 0,5% milk for
1 hour.
CKLiK Kinase assay
CKLiK kinase assays were performed as previously described 9. In short, cells were stimulated as indicated, washed
with cold PBS and lysed in lysis buffer as described above. Lysates were pre-cleared for 20 min with protein-A
sepharose beads and immunoprecipitated with CKLiK polyclonal antibody. Immunoprecipitates were washed twice
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in lysis buffer and twice in dilution buffer containing 10mM Tris-Cl pH 7.4 and 20mM MgCl2. Kinase assay was
performed in the presence 10mM Tris-Cl pH 7.4, 20mM MgCl2, 1mM DTT, 50µM ATP, 0.1µl γ-32P-dATP in the
presence or absence of 1mM CaCl2 and 0.5µg calmodulin, 5µg CREMβ as substrate 21. After 20 minutes of
incubation at room temperature, reactions were stopped by adding Laemli protein sample buffer and then boiled for 3
minutes. Samples were separated on a 12.5% SDS-PAGE gel and analyzed by autoradiography.
Detection of [Ca2+]i
Cells (4x106 cells) were loaded with 1.25 µM Fura-2AM (Molecular probes, Eugene, OR, USA) for 15 minutes, then
washed and kept at room temperature. Cells were stimulated with indicated chemoattractants in a quartz cuvette (400
µl 2x106/ml). The fluorescence was measured under stirring conditions at 370C in a Hitachi F-4500 fluorescent
spectrophotometer (Hitachi Ltd, Tokyo, Japan), using a multi-wavelength timescan program. Fura-2 fluorescence
was measured at 340 nm (F1) and 380 nm (F2) at 510 emission.
Analysis of respiratory burst
Respiratory burst was measured by ROS-induced cytochrome c reduction 22. Assay was performed as previously
described 23. In short, granulocytes (4x106 cells/ml) were pre-incubated with CKLiK(297-321) or a tat-control
peptide for 20 minutes and with GM-CSF (10-10M) to prime the cells. Cytochrome c (75 µM) was added and samples
were transferred to a microtitre plate and placed in a thermostat-controlled plate reader (340 ATTC; SLT Lab
Instruments, Salzburg, Austria). ROS production was induced by stimulation with 1 µM fMLP. Cytochrome c
reduction was immediately measured every 12 seconds as an increase in absorbance at 550 nm.
Analysis of neutrophil migration
Migration experiments were performed as described previously 24. In short, glass coverslips were coated with a
Hepes buffer containing 0.5% human serum albumine (20 mM Hepes, 132 mM NaCl, 6 mM KCl, 1 mM MgSO4, 1.2
mM KH2PO4, 5 mM glucose, 1 mM CaCl2). Purified neutrophils (106/ml Hepes buffer) were allowed to attach to the
coverslip for 10-15 minutes at 37ºC. Medium was removed and the cells were washed two times with Hepes buffer.
The coverslip was then inverted in a droplet of medium containing 10-8M fMLP and sealed with a mixture of
beeswax, paraffin and petroleum jelly (1:1:1, wt/wt/wt). Cell tracking at 37ºC was monitored by time–lapse
microscopy and analyzed by custom-made macro (A.L.I.) in the image analysis software (Optimas 6.1; Media
Cybernetics, Silver Spring, MD). Cell migration was followed for 10 minutes making a picture every 20 seconds.
Results
CKLiK gene is located on chromosome 10
Recently the draft sequence of the human genome has been completed 25. It is of interested to determine the
chromosomal localization of the CKLiK gene. A screen of the genomic sequence (ncbi.nlm.nih.gov/BLAST)
identified the CKLiK gene as being located on chromosome 10 at position 10p14. The CKLiK gene consists of 10
exons forming the complete CKLiK mRNA. Exon 1 is localized at position 12950 K, and exon 10 ends at 13490 K,
encoding a region of 540,000 bp (Fig. 1A). As expected, CKLiK was found to contain a kinase domain an ATP
binding domain, a calmodulin binding domain and an autoinhibitory domain, as is found in all Ca2+/calmodulin-
dependent kinases. In order to define other potential domains we scanned the amino-acid sequence of CKLiK against
protein databases (scansite.mit.edu). Analysis suggested that the C-terminal sequence AYVAKPESLS of CKLiK
may form a recognition site for PDZ domain containing proteins. We know from our previous findings that CKLiK
shows high homology with CaMKI. In Figure 1B a phylogenetic tree of Ca2+/CaM dependent kinases is depicted,
and CKLiK is indeed most homologous with CaMKI. Also closely related are the kinases DJ27L16.1, also called
CaMK1G (ass.nr: NM_020439), and AMPK-Like (ass.nr: AAF74509). Both are recently sequenced kinases whose
specific functions are unknown.
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Figure 1: Chromosomal localization of CKLiK.
The CKLiK gene is located on chromosome 10 at position 10p14 (A). The gene overlaps a region of 530,000 bp and consist of 10
exons, which forms the CKLiK mRNA. CKLiK contains a catalytic domain, an ATP binding domain, an auto inhibitory domain
(AID), a calmodulin binding domain (CBD) and a hypothetical PDZ binding motif. (B) Localization of CKLiK within the
phylogenetic tree of the Ca2+/calmodulin regulated kinase family.
Characterization of CKLiK antibody
To study the expression of CKLiK in human granulocytes we generated a specific polyclonal antibody. A 10 amino
acid peptide derived from the C-terminal part of CKLiK was used to immunize rabbits. This sequence was found to
be specific for CKLiK and not for CaMKI or other CaMK family members (Fig. 2A). Purification of the antibody
was performed by affinity chromatography using the CKLiK-peptide coupled to agarose beads. In order to test the
antibody, we utilized 32D cells stably expressing epitope-tagged CKLiK (HA-CKLiK) 9 and checked whether the
anti-sera could be used for western blotting (Fig. 2B), immunoprecipitations (Fig. 2C) and immunecomplex kinase
assays (Fig 2D). Both, CKLiK in whole cell lysates, and immunoprecipitated CKLiK could be detected, but not in
the control 32D cells lacking CKLiK (Fig. 2B, C). Additionally, the functional kinase assays performed with the
anti-CKLiK, demonstrated comparable results obtained with anti-HA (Fig. 2D). Thus, the antibody appears to be
specific for CKLiK and can be used for analysis of protein levels and kinase activity in primary granulocytes.
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Figure 2: Characterization of CKLiK antibody.
(A) An antibody against the C-terminal portion of CKLiK was generated by immunizing rabbits with a KLH-coupled peptide as
indicated. (B) Western blots with CKLiK antisera were performed. 32D (106) cells stably expressing an N-terminal epitope tagged
CKLiK (32D HA-CKLiK) or control cells (32D) were lysed, seperated by SDS-PAGE and western blotting was performed as
described in Materials and Methods. (C) Immunoprecipitations were performed with CKLiK antibody. 32D (107) cells were lysed
and immuno-precipitations were performed with 1µl and 0.2µl purified CKLiK antibody (α-CKLiK) as indicated. (D)
Immunecomplex kinase assays were performed with or without Ca2+ and calmodulin using the CKLiK antibody and an antibody
against the epitope-tag (α-HA) as a control. CREMβ was used as a substrate.
CKLiK activity  in human granulocytes is dependent on Ca2+/calmodulin
We previously demonstrated high mRNA expression of CKLiK in human granulocytes 9. Here we analyzed CKLiK
protein expression in neutrophils and eosinophils derived by the differentiation of hematopoietic CD34+ stem cells
cultured with G-CSF or IL-5 respectively, and isolated peripheral blood granulocytes. In differentiated cells, CKLiK
was found present in both neutrophils and eosinophils (Fig. 3A, left panel). We observed a higher expression of
CKLiK in differentiated eosinophils then neutrophils. In peripheral blood neutrophils a low expression of CKLiK
was observed, compared to the expression in eosinophils (Fig. 3A, right panel). To demonstrate whether
immunoprecipitated CKLiK indeed requires Ca2+ and calmodulin for kinase activity we differentiated stem cells
towards neutrophils and eosinophils and performed immunoprecipitation, using CKLiK-antibody. CKLiK kinase
assays were performed utilizing CREMβ as a substrate. Indeed, only in the presence of Ca2+ and calmodulin CKLiK
kinase activity could be observed (Fig. 3B, upper panels). Using peripheral blood eosinophils and neutrophils we
observed elevated CKLiK kinase activity in the presence of Ca2+ and calmodulin (Fig. 3B, lower panels). A low
basal kinase activity was observed in the absence of Ca2+/calmodulin in peripheral neutrophils. It is possible that
neutrophils display a constitutively low CKLiK kinase activity, however we cannot exclude that CKLiK becomes
modestly activated during cell isolation.
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Figure 3: Expression and activation of CKLiK in human eosinophils and neutrophils.
(A) CKLiK was immunoprecipitated with CKLiK antibody from stem cells differentiated towards neutrophils (2.5x107 and
1.5x107 as indicated) and eosinophils (1.5x107) (left panel) and from peripheral blood neutrophils (2x107) and eosinophils (107)
(right panel, with a longer exposure below) and separated by SDS-PAGE,. Western blot analysis were performed with the CKLiK
antibody. Heavy and light chain of CKLiK antibody and immunoprecipitated CKLiK are indicated. (B) Kinase activity of CKLiK
is dependent on Ca2+/calmodulin. Kinase assays were performed in the absence or presence of Ca2+ and calmodulin with CKLiK
immunoprecipitated from stem cells differentiated towards neutrophils and eosinophils (upper panels) and with CKLiK obtained
from peripheral blood eosinophils and neutrophils (lower panels). Data are representative of three independent experiments.
Inflammatory mediators activate CKLiK  in human granulocytes.
Granulocytes can be activated by a variety of inflammatory mediators. Since CKLiK is activated by Ca2+ and
calmodulin the induction of CKLiK activity by physiologically relevant agents that induce a rise in [Ca2+]i was
investigated. Purified neutrophils were stimulated with fMLP, and eosinophils with PAF for the times indicated.
Subsequently, cells were lysed and CKLiK kinase assays were performed. Phosphorylation of CREMβ was observed
in neutrophils after only 30 seconds of stimulation with fMLP (Fig. 4A), while eosinophils reached a maximum
CKLiK activity after 1 minute (Fig. 4B). Activity of CKLiK in both neutrophils and eosinophils decreased after 2
minutes. This transient activation of CKLiK follows the rise of intracellular Ca2+ normally observed after activation
of G-protein-coupled receptors in these cells as demonstrated in Figure 4C .
Figure 4: CKLiK activity is induced by inflammatory mediators.
Peripheral blood neutrophils (A) and eosinophils (B) were isolated and stimulated with fMLP (10-6M) or PAF (10-6M)
respectively. Cells were lysed (3x107 cells/point), immunoprecipitated with CKLiK antibody and kinase assays performed without
addition of Ca2+ and calmodulin, except for positive controls. (C) Ca2+ response of neutrophils to fMLP. Cell were loaded with
Fura-2AM for 15 minutes and washed. Changes in [Ca2+]i were measured at 340 nm (F1) and 380 nm (F2) at 510 emission using a
Hitachi F4500 fluorescence spectrophotometer. Similar Ca2+ responses were obtained after PAF stimulation of eosinophils (data
not shown).
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Figure 5: CKLiK(297-321) inhibits CKLiK kinase activity and respiratory burst.
A cell permeable CKLiK peptide YGRKKRRQRRRIRKNFAKSKWRQAFNATAVVRHMRK was synthesized. (A) 32D cells
stably expressing HA-CKLiK were lysed and CKLiK was immunoprecipitated. CKLiK kinase assays was performed with
increasing concentrations of CKLiK(297-321) as indicated. CREMβ was used as a substrate. A non-relevant tat-control peptide
was used a negative control. (B) Effect of CKLiK(297-321) peptide on respiratory burst. Granulocytes were isolated and treated
GM-CSF (10-10M) to prime the cells. Cells were then treated without (-) or with increasing concentrations of CKLiK(297-321) or
a tat-control peptide for 20 minutes. Respiratory burst was initiated with fMLP (10-6M). ROS production was measured by
cytochrome c reduction resulting in a change in absorption at a wavelength of 550nm. Average of three independent experiments
are depicted.
CKLiK(297-321) reduces ROS production in human granulocytes.
While we have demonstrated expression and regulation of CKLiK in human granulocytes, a role for this kinase in
regulating granulocyte effector functions remains unclear. To investigate this question an inhibitory CKLiK peptide,
(297IRKNFAKSKWRQAF-NATAVVRHMRK321) was generated, based on previous findings 26. To study the
functional role of CKLiK in human granulocytes we linked this peptide to the 11-amino acid portion of the HIV tat
protein, generating a peptide capable of transducing primary cells 24; 27; 28. First, the ability of this peptide
CKLiK(297-321), to inhibit the kinase activity of CKLiK was investigated. Indeed we could demonstrate a dose-
dependent inhibitory effect of CKLiK(297-321) on the ability of CKLiK to phosphorylate the substrate CREMβ (Fig.
5A). This was not observed utilizing a control peptide. Further the effect of this CKLiK(297-321) on the production
of reactive oxygen species in human granulocytes was analyzed, since a role for Ca2+ in the respiratory burst has
been proposed 29. For optimal activation of the respiratory burst cells need to be pre-activated or "primed" 30.
Therefore, cells were first treated with GM-CSF or PAF, and initiation of the respiratory burst was induced by fMLP.
ROS production was dramatically inhibited by the CKLiK(297-321) in a concentration dependent manner (Fig. 5b),
while no inhibition was observed with 50 µM tat-control peptide. This indicates a potential role for CKLiK in the
regulation of the respiratory burst in human granulocytes.
CKLiK(297-321) inhibits migration of human granulocytes.
Although specific mechanisms by which changes in [Ca2+]i can regulate migration has not been defined, some
aspects of the migration process have been shown to be at least partially controlled by changes in [Ca2+]i 8; 31. The
effect of CKLiK(297-321) and tat-control peptides on the fMLP induced migration was investigated (Fig. 6A, upper
panels). Migration of fMLP stimulated neutrophils on albumine coated coverslips was measured by timelapse
imaging during 10 minutes. Migration distance is visualized in figure 6, showing the tracks of 40 cells (upper panels)
and the centered tracks (lower panels). Upon fMLP stimulation, neutrophil migration was markedly increased
compared to the untreated cells, which showed little or no movement (data not shown). fMLP treated cells migrated
with a speed of 6.71±0.48 µm/minute (Fig. 4B). Pre-incubation with CKLiK(297-321) strongly inhibited fMLP-
induced migration, as demonstrated by a reduction of the speed to 1.51±0.36 µm/minute. From the tracks in the
lower panel of Fig. 6A it can be concluded that most cells incubated with CKLiK(297-321) demonstrated a
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completely abrogated migration. Treatment with the tat-control peptide showed no significant inhibition. These
results demonstrate a role for CKLiK in granulocyte migration behavior.
Figure 6: CKLiK(297-321) abrogates fMLP induced migration.
Migration of granulocytes was monitored by time lapse analysis. Cells were first allowed to attach to albumine coated coverslips
for 15 minutes. Granulocytes were incubated as indicated with 50 µM CKLiK(297-321) or 50 µM tat control peptide. (A)
Neutrophil migration was induced by fMLP (10-8M) and imaged every 20 seconds for 10 min. Migration tracks of individual cells
are shown per cell (A, upper panel) and centered (A, lower panel) (B) Average migration speed of at least three independent
experiments are calculated and expressed as µm per minute ± SD.
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Discussion
In this report the protein expression, regulation and function of the recently identified protein kinase CKLiK in
primary human granulocytes was analyzed. Comparison of expression levels between neutrophils and eosinophils
shows higher CKLiK protein levels in human eosinophils. However, neutrophils derived by differentiation of
hematopoietic stem cells also demonstrate a high CKLiK expression (Fig. 3A). Low expression of CKLiK in
neutrophils might be due to proteolytic breakdown, since these cells contain greater protease activity then peripheral
blood eosinophils 32. Immunecomplex kinase assays of CKLiK in human granulocytes, confirm the Ca2+ and
calmodulin dependency expected of this protein kinase (Fig. 3B). We observed a higher basal level of CKLiK
activity in human neutrophils compared to eosinophils. This could indicate that CKLiK is already activated in
unstimulated neutrophils or that there is a low Ca2+/calmodulin- independent activity of CKLiK in human
neutrophils. Alternatively, isolation of neutrophils might induce some artificial cellular activation 33. For CaMKII
and CaMKV a Ca2+-independent activity has been demonstrated 34. For the closely related CaMKIV it has been
suggested that phosphorylation of Thr196 by CaMKK resulted in a Ca2+-independent activity 17. However, for
CaMKI this could not be demonstrated 10. Our previous findings with co-transfection studies of CKLiK and CaMKK
indeed demonstrated a small Ca2+-independent activity 9. PAF and fMLP are both inflammatory mediators that can
trigger a rise in [Ca2+]i, by binding to their respective G-protein-coupled receptors. PAF in eosinophils and fMLP in
neutrophils are potent inducers of granulocyte effector functions. Here we demonstrate that stimulation of
granulocytes with these inflammatory mediators results in induction of CKLiK kinase activity (Fig. 4). This
activation of CKLiK parallels the transient rise of Ca2+ observed upon fMLP stimulation, and is in line with the
observed Ca2+-dependent CKLiK activation.
Terminally differentiated cells such as granulocytes are difficult to manipulate by conventional transfection
methodologies. Thus far, most studies that describe the role of intracellular signaling pathways in granulocyte
functioning have been performed using pharmacological inhibitors. Recently, we demonstrated that eosinophils
could be transduced with dominant negative Ras or active Rho linked to an 11 amino sequence (YGRKKRRQRRR)
from the human immunodeficiency virus (HIV) Tat protein 28 24. This sequence has been found to be one of the most
efficient domains at allowing proteins to traverse cell membranes, probably in a receptor-independent fashion 35-37.
When expressed as a N-terminal peptide linked to an unrelated protein, this sequence renders the fusion protein
capable of entering cells in a time- and concentration- dependent manner into multiple cell types 35; 38; 39. In order to
investigate a role for CKLiK, we generated an inhibitory peptide containing amino acids 297 to 321 of CKLiK linked
to the tat protein transduction domain. A similar, but distinct sequence derived from CaMKI and CaMKII has
previously been shown to have an inhibitory effects on the kinase activity of CaMKI and CaMKII respectively 26; 40.
We were able to demonstrate a potent inhibitory effect of the CKLiK peptide on CKLiK kinase activity (Fig. 5A).
Based on the crystal structure of CaMKI and mutation analysis it has been suggested that in an inactive state, the
autoinhibitory domain (AID) of CKLiK acts as a pseudo-substrate by binding to the catalytic domain 11. Indeed, the
autoinhibitory domain of CKLiK is located in the sequence of the peptide, suggesting a mechanism by which this
peptide can block the catalytic domain of CKLiK. Additionally the AID and the CBD are in critically close
proximity and probably are overlapping 26, which indicates that this peptide may also act as a competitor of CKLiK
for calmodulin binding.
Production of reactive oxygen species by the NADPH oxidase is a critical granulocyte effector function required
for the elimination of invading pathogens. The importance of the NADPH oxidase is demonstrated in patients
suffering from chronic granulomatous disease, which is caused by a defect in one of components of the NADPH
oxidase 41. In resting cells, the subunits of NADPH oxidase are localized at the membrane of specific granules
(gp91phox and p22phox) and in the cytoplasm (p47phox and p67phox and p40phox) 3; 42. In response to stimulation with
inflammatory mediators, such as fMLP the cytosolic subunits and the small GTPases p21Rac and p21Rap are
activated and interact with the membrane-bound subunits to form an activated enzyme complex. It has been
described that formation of ROS in human granulocytes requires intracellular Ca2+ 6; 29. However, the mechanism by
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which Ca2+ is linked to the regulation of the respiratory burst is still unclear. Here, we demonstrate that incubation of
granulocytes with CKLiK(297-321) resulted in reduced ROS production in human granulocytes stimulated with
fMLP (Fig. 5B). One of the possible mechanisms by which CKLiK can influence the respiratory burst is via the
activation of the small GTPases Rac or Rap1. Rac has been found to be necessary in the respiratory burst 43, whereas
Rap1 co-purifies with flavocytochrome b558, but is not necessary for cell-free reconstitution of oxidase activity 44.
Both Rac and Rap1, have been shown to be activated by stimulation with the calcium ionophore ionomycin, or
thapsigargin, which both elevate [Ca2+]i 45; 46. However, in Ca2+-depleted cells GTP loaded active of Rac and Rap1,
could still be observed. It has been described that Rap1 can be phosphorylated directly by CaMKIV in vitro,
suggesting a link between Ca2+/calmodulin dependent signaling mechanism and small GTPase signaling 47.
Therefore, it might be possible that CKLiK exerts a similar effect towards Rap1 in human granulocytes. Also, several
findings support the involvement of Ca2+ in the activation of Rac. For example, in guinea pig neutrophils Rac GTP-
loading could be inhibited by calmodulin inhibitors 48. Furthermore, there are some indications that several guanine
exchange factors (GEFs), which activate small GTPases by the exchange of GDP to GTP, can be activated in a Ca2+-
dependent mechanism. For Rac, two exchange factors have been identified: Vav and Tiam 49; 50. Vav is
predominantly expressed in hematopoietic cells, and is activated by tyrosine phosporylation, which excludes a direct
role for CKLiK. Tiam1 on the other hand, has been shown to be phosphorylated by CaMKII, which results in
translocation of Tiam1 to the membrane 51; 52. It is still not clear which exchange factor is involved in the activation
of Rac2 in the NADPH complex in human granulocytes and there are contradictory findings concerning the Ca2+-
dependent activation of Rac. It is still a possibility that CKLiK regulates the activity or the translocation of a GEF
involved in small GTPase activation. Another potential role for CKLiK in regulating the respiratory burst involves
the phosphorylation of p47phox. Membrane translocation in intact cells is dependent on phosphorylation of multiple
serine residues of p47phox 53. p47phox phosphorylation occurs on multiple serine residues after neutrophil stimulation
with fMLP 54. These include some potential CKLiK phosphorylation sites For p47phox, as was identified by consensus
site comparison (data not shown). Activation of the respiratory burst in granulocytes requires priming for optimal
activation 30. In this study, we primed granulocytes with either GM-CSF or PAF. PAF is known to induce a Ca2+
signal and able to activate CKLiK (Fig. 4), whereas GM-CSF does not induce a rise of [Ca2+]i. We found, no
differences in the inhibitory effect of CKLiK(297-321) when cells were either primed with GM-CSF or PAF (data
not shown), indicating that CKLiK is probably not involved in the priming process, but rather is directly involved in
the induction of the ROS production by fMLP.
Treatment of neutrophils with CKLiK(297-321) also demonstrated a dramatic inhibitory effect on neutrophil
migration on albumin-coated surfaces. Several aspects of neutrophil migration have been suggested to be Ca2+-
dependent. Neutrophil movement on vitronectin and fibronectin, substrates that are encountered in the connected
tissue stroma, is abrogated in Ca2+-buffered conditions 7. On vitronectin this loss of motility is due to the clustering
of αvβ3 integrin in the rear of the Ca2+-buffered cells, and this could be mimicked by addition of inhibitors of the
Ca2+/calmodulin dependent phosphatase calcineurin. However the [Ca2+]i-sensitive motility of neutrophils on
fibronectin, which is predominantly mediated by α5β1, was not effected by calcineurin inhibitors 55; 56. From these
studies, an endocytotic recycling of integrins in motile neutrophils has been suggested. A role for CKLiK in Ca2+-
dependent recycling of integrins during migration is a possibility. The most abundant integrins found in neutrophils
are the β2 integrins. Blocking these integrins inhibits spreading and motility on glass surfaces, fibrin and fibronectin
56-58, suggesting an important role in adhesion. In our study, pretreatment of neutrophils with CKLiK(297-321)
before surface attachment, demonstrated less adherent cells (data not shown). This might be an indication for a role
of CKLiK in β2-mediated attachment. Furthermore, a role for Ca2+ in rear release has been suggested. During
migration neutrophils have to break adhesive contacts with the substratum at the rear of the cell and establish new
contacts at the leading edge. Buffering of [Ca2+]i results in impaired uropod retraction (data not shown, 7; 56; 59).
Myosin II activation was found to be necessary for uropod retraction 8. This was suggested to be mediated by myosin
light chain kinase (MLCK), since inhibitors against this kinase demonstrated a similar phenotype as cells buffered of
[Ca2+]i. MLCK belongs to the family of Ca2+/calmodulin dependent kinases similar as CKLiK, which might suggest a
similar role for CKLiK. Additionally, we recently demonstrated a role for RhoA in the detachment of the uropod
during migration 24. We found that a dominant negative form of the small GTPase RhoA, and inhibition of the
downstream kinase ROCK, abrogated granulocyte migration. ROCK leads to activation of the light chain of myosin
II and probably works cooperatively with MLCK. As mentioned above several guanine exchange factors (GEFs) for
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the small Rho GTPases are Ca2+- dependent, and thus a role for CKLiK in this process is a possibility. Since the
family of small Rho GTPases is involved in rearrangement of the cytoskeleton, migration and respiratory burst 60, it
is possible that regulation of Rho GEFs could be a general mechanism by which CKLiK regulates these processes.
Our data are consistent with the hypothesis that CKLiK is a Ca2+-calmodulin dependent kinase that couples G-
protein coupled receptor functioning to granulocyte functionality. This, together with the restricted expression of this
kinase, might make it an interesting drug target.
Functional characterization of CKLiK
122
Chapter 5
123
References
1. Haslett C, Savill JS, and Meagher L. The neutrophil. Curr Opin Immunol. 1989;2:10-18.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
3. Segal AW and Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem Sci. 1993;18:43-47.
4. Wu D, LaRosa GJ, and Simon MI. G protein-coupled signal transduction pathways for interleukin-8. Science. 1993;261:101-103.
5. Davies EV and Hallett MB. Cytosolic Ca2+ signalling in inflammatory neutrophils: implications for rheumatoid arthritis (Review). Int J
Mol Med. 1998;1:485-490.
6. Thelen M, Dewald B, and Baggiolini M. Neutrophil signal transduction and activation of the respiratory burst. Physiol Rev. 1993;73:797-
821.
7. Lawson MA and Maxfield FR. Ca(2+)- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature.
1995;377:75-79.
8. Eddy RJ, Pierini LM, Matsumura F, and Maxfield FR. Ca2+-dependent myosin II activation is required for uropod retraction during
neutrophil migration. J Cell Sci. 2000;113:1287-1298.
9. Verploegen S, Lammers JW, Koenderman L, and Coffer PJ. Identification and characterization of CKLiK, a novel granulocyte
Ca(++)/calmodulin-dependent kinase. Blood. 2000;96:3215-3223.
10. Soderling TR. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem Sci. 1999;24:232-236.
11. Goldberg J, Nairn AC, and Kuriyan J. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell.
1996;84:875-887.
12. Chin D and Means AR. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 2000;10:322-328.
13. Mukherji S and Soderling TR. Regulation of Ca2+/calmodulin-dependent protein kinase II by inter- and intrasubunit-catalyzed
autophosphorylations. J Biol Chem. 1994;269:13744-13747.
14. Chatila T, Anderson KA, Ho N, and Means AR. A unique phosphorylation-dependent mechanism for the activation of Ca2+/calmodulin-
dependent protein kinase type IV/GR. J Biol Chem. 1996;271:21542-21548.
15. Anderson KA, Means RL, Huang QH, et al. Components of a calmodulin-dependent protein kinase cascade. Molecular cloning,
functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J Biol Chem.
1998;273:31880-31889.
16. Haribabu B, Hook SS, Selbert MA, et al. Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and
activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. EMBO J. 1995;14:3679-3686.
17. Selbert MA, Anderson KA, Huang QH, Goldstein EG, Means AR, and Edelman AM. Phosphorylation and activation of Ca(2+)-
calmodulin-dependent protein kinase IV by Ca(2+)-calmodulin-dependent protein kinase Ia kinase. Phosphorylation of threonine 196 is
essential for activation. J Biol Chem. 1995;270:17616-17621.
18. Koenderman L, Kok PT, Hamelink ML, Verhoeven AJ, and Bruijnzeel PL. An improved method for the isolation of eosinophilic
granulocytes from peripheral blood of normal individuals. J Leukoc Biol. 1988;44:79-86.
19. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood
eosinophils. J Immunol Methods. 1991;145:105-110.
20. Caldenhoven E, van Dijk TB, Tijmensen A, et al. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF
during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells. Stem Cells. 1998;16:397-403.
21. De Groot RP, Delmas V, and Sassone-Corsi P. DNA bending by transcription factors CREM and CREB. Oncogene. 1994;9:463-468.
22. Pick E and Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture
using an automatic enzyme immunoassay reader. J Immunol Methods. 1981;46:211-226.
23. Nijhuis E, Lammers JW, Koenderman L, and Coffer PJ. Src kinases regulate PKB activation and modulate cytokine and chemoattractant-
controlled neutrophil functioning. J Leukoc Biol. 2002;71:115-124.
24. Alblas J, Ulfman L, Hordijk P, and Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes.
Mol Biol Cell. 2001;12:2137-2145.
25. McPherson JD, Marra M, Hillier L, et al. A physical map of the human genome. Nature. 2001;409:934-941.
26. Yokokura H, Picciotto MR, Nairn AC, and Hidaka H. The regulatory region of calcium/calmodulin-dependent protein kinase I contains
closely associated autoinhibitory and calmodulin-binding domains. J Biol Chem. 1995;270:23851-23859.
27. Vives E, Brodin P, and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and
accumulates in the cell nucleus. J Biol Chem. 1997;272:16010-16017.
28. Hall DJ, Cui J, Bates ME, et al. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-
regulated kinase activation and interleukin-5-mediated cell viability. Blood. 2001;98:2014-2021.
29. Koenderman L, Yazdanbakhsh M, Roos D, and Verhoeven AJ. Dual mechanisms in priming of the chemoattractant-induced respiratory
burst in human granulocytes. A Ca2+-dependent and a Ca2+-independent route. J Immunol. 1989;142:623-628.
30. Coffer PJ and Koenderman L. Granulocyte signal transduction and priming: cause without effect? Immunol Lett. 1997;57:27-31.
31. Marks PW and Maxfield FR. Transient increases in cytosolic free calcium appear to be required for the migration of adherent human
neutrophils. J Cell Biol. 1990;110:43-52.
32. McDonald PP, Bovolenta C, and Cassatella MA. Activation of distinct transcription factors in neutrophils by bacterial LPS, interferon-
gamma, and GM-CSF and the necessity to overcome the action of endogenous proteases. Biochemistry. 1998;37:13165-13173.
33. Kuijpers TW, Tool AT, van der Schoot CE, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface
markers for neutrophil activation. Blood. 1991;78:1105-1111.
34. Soderling TR. Structure and regulation of calcium/calmodulin-dependent protein kinases II and IV. Biochim Biophys Acta.
1996;1297:131-138.
35. Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A. 1994;91:664-668.
36. Chen LL, Frankel AD, Harder JL, Fawell S, Barsoum J, and Pepinsky B. Increased cellular uptake of the human immunodeficiency virus-
1 Tat protein after modification with biotin. Anal Biochem. 1995;227:168-175.
37. Frankel AD and Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988;55:1189-1193.
38. Nagahara H, A.M., Snyder EL, et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell
migration. Nat Med. 1998;4:1449-1452.
39. Schwarze SR, Ho A, Vocero-Akbani A, and Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the
mouse. Science. 1999;285:1569-1572.
40. Fukunaga K, Stoppini L, Miyamoto E, and Muller D. Long-term potentiation is associated with an increased activity of Ca2+/calmodulin-
dependent protein kinase II. J Biol Chem. 1993;268:7863-7867.
41. Segal AW. The NADPH oxidase and chronic granulomatous disease. Mol Med Today. 1996;2:129-135.
Functional characterization of CKLiK
124
42. DeLeo FR and Quinn MT. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol.
1996;60:677-691.
43. Bokoch GM. Regulation of the human neutrophil NADPH oxidase by the Rac GTP-binding proteins. Curr Opin Cell Biol. 1994;6:212-
218.
44. Quinn MT, Parkos CA, Walker L, Orkin SH, Dinauer MC, and Jesaitis AJ. Association of a Ras-related protein with cytochrome b of
human neutrophils. Nature. 1989;342:198-200.
45. Geijsen N, van Delft S, Raaijmakers JA, et al. Regulation of p21rac activation in human neutrophils. Blood. 1999;94:1121-1130.
46. M'rabet L, Coffer P, Zwartkruis F, et al. Activation of the small GTPase rap1 in human neutrophils. Blood. 1998;92:2133-2140.
47. Sahyoun N, McDonald OB, Farrell F, and Lapetina EG. Phosphorylation of a Ras-related GTP-binding protein, Rap-1b, by a neuronal
Ca2+/calmodulin-dependent protein kinase, CaM kinase Gr. Proc Natl Acad Sci U S A. 1991;88:2643-2647.
48. Lian JP, Crossley L, Zhan Q, et al. Antagonists of calcium fluxes and calmodulin block activation of the p21-activated protein kinases in
neutrophils. J Immunol. 2001;166:2643-2650.
49. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, and Bustelo XR. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange
by the vav proto-oncogene product. Nature. 1997;385:169-172.
50. Habets GG, Scholtes EH, Zuydgeest D, et al. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology
to GDP-GTP exchangers for Rho-like proteins. Cell. 1994;77:537-549.
51. Fleming IN, Elliott CM, Buchanan FG, Downes CP, and Exton JH. Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by
reversible protein phosphorylation. J Biol Chem. 1999;274:12753-12758.
52. Buchanan FG, Elliot CM, Gibbs M, and Exton JH. Translocation of the Rac1 guanine nucleotide exchange factor Tiam1 induced by
platelet-derived growth factor and lysophosphatidic acid. J Biol Chem. 2000;275:9742-9748.
53. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
54. el Benna J, Faust LP, and Babior BM. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil
activation. Phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J Biol Chem. 1994;269:23431-23436.
55. Hendey B, Klee CB, and Maxfield FR. Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science.
1992;258:296-299.
56. Pierini LM, Lawson MA, Eddy RJ, Hendey B, and Maxfield FR. Oriented endocytic recycling of alpha5beta1 in motile neutrophils.
Blood. 2000;95:2471-2480.
57. Jaconi ME, Theler JM, Schlegel W, Appel RD, Wright SD, and Lew PD. Multiple elevations of cytosolic-free Ca2+ in human
neutrophils: initiation by adherence receptors of the integrin family. J Cell Biol. 1991;112:1249-1257.
58. Loike JD, Cao L, Budhu S, et al. Differential regulation of beta1 integrins by chemoattractants regulates neutrophil migration through
fibrin. J Cell Biol. 1999;144:1047-1056.
59. Hendey B, Lawson M, Marcantonio EE, and Maxfield FR. Intracellular calcium and calcineurin regulate neutrophil motility on
vitronectin through a receptor identified by antibodies to integrins alphav and beta3. Blood. 1996;87:2038-2048.
60. Ridley AJ. Rho family proteins: coordinating cell responses. Trends Cell Biol. 2001;11:471-477.
Chapter 6
Identification of cytokine-regulated genes in
 human leukocytes in vivo
Cornelieke Pals, Sandra Verploegen, Jan A.M. Raaijmakers,
Jan-Willem J. Lammers, Leo Koenderman, and Paul J. Coffer
J Allergy Clin Immunol., 2000, 105(4),760-768
Identification of cytokine-regulated genes
132
Abstract
Background: Human polymorphic nuclear granulocytes (PMNs) such as neutrophils and eosinophils play a critical
role in mediating inflammatory responses to microbial and parasitic infection. Exposure of these leukocytes to
cytokines leads to an amplification of granulocyte effector functions by a mechanism termed “priming”. While many
studies have investigated the effects of granulocyte priming, little is known concerning the molecular mechanisms
that lead to this phenomenon.
Objective: The purpose of this study was to identify potential markers for granulocyte priming and thus also to gain
further insight into the pathogenesis of inflammatory responses.
Methods: We have utilized a modified differential display technique, Random Arbitrary Primed (RAP)-PCR to
identify genes regulated during the priming of human PMNs by GM-CSF in vitro. Genes identified were validated
by Northern blot analysis of in vitro and in vivo primed leukocytes.
Results: Several genes were identified and their expression characterized in vitro. One of these genes, 5-
lipoxygenase activating protein (FLAP), was also found to be upregulated in leukocytes isolated after allergen
challenge of allergic asthmatic patients.
Conclusion: The use of differential display technology is a rapid and effective means of identifying genes whose
expression is regulated by priming in vitro and in vivo. Further analysis will lead to a better understanding of the
priming phenotype and may provide further insight into the pathology of inflammatory processes.
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Introduction
Human polymorphic nuclear granulocytes such as neutrophils and eosinophils play a critical role in mediating
inflammatory responses to microbial and parasitic infection 1. At the site of infection, granulocytes participate in the
inflammatory reaction by phagocytosis, intracellular killing of bacteria, production of inflammatory mediators and
release of pre-formed cytotoxic enzymes and proteins. Environmental factors can quickly amplify these granulocyte
functions by a mechanism  termed “priming” which is independent of protein synthesis 2-4. Priming refers to a
process by which the response of cells to a subsequent (activating) stimulus is amplified if these cells were
previously exposed to a (priming) stimulus. This process is an important regulatory mechanism whereby phagocytes
can be controlled while responding to the local conditions of their environment. For example, prior exposure of
human eosinophils to either the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) or the
inflammatory mediator platelet-activating factor (PAF) will greatly enhance the ability of these cells to be activated
by subsequent exposure to opsonized particles 5;6. While many studies have analyzed the effects of granulocyte
priming, little is known concerning the molecular mechanisms that lead to this phenomenon. Recent studies have
demonstrated the cytokine-mediated activation of various intracellular signaling pathways in human granulocytes,
while the use of specific pharmacological inhibitors has implicated some of these events in the regulation of cell
effector functions 7-12. It is however unclear whether cytokine may also result in changes in granulocyte gene
expression that might correlate with this phenomenon. Indeed, cytokine-induced regulation of gene expression in
human granulocytes and the functional consequences thereof have not been studied in any detail.
In an attempt to gain further insight into the pathogenesis of inflammatory responses and also to identify potential
markers for granulocyte priming, we have utilized the technique of differential-display 13. This PCR-based technique
is allows the identification and cloning of genes that are differentially expressed in cells under pre-determined
conditions. The advantage of this technique lies in its ease of operation and the ability to process many samples at
one time unlike previous methodologies such as subtractive hybridization. Utilizing a modified differential display
technique, Random Arbitrary Primed (RAP)-PCR 14, we have analyzed the expression of genes either up- or down-
regulated in human PMNs after treatment with physiological concentrations of GM-CSF. Several known genes were
identified in vitro and their regulation by GM-CSF was confirmed by Northern blotting. Furthermore, we
demonstrate that one of the genes identified, 5-lipoxygenase activating protein (FLAP), was also up regulated in vivo
in peripheral blood leukocytes after allergen challenge.
These data confirm that differential-display technology can indeed be utilized to gain further insight into the
mechanisms of granulocyte priming and pathogenesis of inflammatory reactions.
Materials and Methods
Isolation of human granulocytes.
Blood was obtained from a healthy donor with no history of allergy or asthma . There was no relevant clinical
history (no allergy, no parasitic infection, no indications of other eosinophilic diseases). However, a persistent (>10
years) finding blood of slight leukocytosis (~8x109  leukocytes/liter) and 30% eosinophils in the granulocyte fraction
was observed. Apart from the elevated amount of eosinophils the remainder of the leukocyte population was within
the normal range. Total leukocytes 7.3x109/litre: 2% basophils, 18% eosinophils, 34% neutrophils, 35%
lymphocytes and 11% monocytes.
Mononuclear cells were removed by centrifugation over Ficoll-paque (density 1,077/cm3 ) , 1000xg, 20 min at RT.
The lower cell layer was collected and the remaining erythrocytes were lyzed by incubation in isotonic 115mM
ammonium chloride solution (pH 7.4) on ice for 20 min. After centrifugation the granulocytes were incubated in
RPMI-1640 (Life Technologies, Paisley, UK) containing 0.5% HSA (wt/vol) for 30 min at 37°C. Cells were washed
with PBS and half of the cells were stimulated with GM-CSF (10-10 M) for 3 hours in RPMI-medium supplemented
with 25mM Hepes, 8% fetal calf serum (FCS, Hyclone), 1 mg/ml penicillin and 1 mg/ml streptomycin in a CO2
incubator (5% CO2, 37°C).
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RNA isolation.
Total RNA was isolated as follows: 108 cells were resuspended in 500 µl sterile PBS and 10 µl of RNAsin
(Promega, Madison, WI) was added. The cells were lyzed in 20 ml of GIT solution (6M guanidine thiocyanate,
25mM sodium citrate, 0.5% N’Lauroyl sarcosine, 100mM β-mercaptoethanol). One volume of sodium acetate (2M,
pH 4.0) was added and an equal volume of phenol followed by vortexing. Half of the total volume of
chloroform/iso-amylalcohol was added to the solution and vortexed. The solution was incubated on ice for 15 min
and centrifuged at 4°C for 20 min at 10.000xg. The upper phase was extracted with half volume of chloroform/iso-
amylalcohol and centrifuged for 2 min. RNA was precipitated with an equal volume of 2-propanol and 200mg of
carrier glycogen at -20 °C for overnight. Samples were centrifuged at 81000 rpm for one hour, re-suspended in a
small volume and RNA was re-precipitated with ethanol. Poly A+ mRNA was extracted by Oligo-dT affinity
purification using Dynabeads Oligo(dT)25 (Dynal, Oslo, Norway). cDNA was synthesized using a ProStar First
Strand RT-PCR kit as described manufacturers protocol (Stratagene).
RAP PCR.
The differential display PCR reactions were performed with 1 µl of cDNA, 1x Goldstar reaction buffer, 1.5mM
MgCl2 , 200ng primer, 2mM dNTPs, 1µCi of [33P]dATP and 4 units of Goldstar Taq polymerase (Eurogentec,
Seraing, Belgium) per 20 µl reaction. Cycles were performed as follows: 3 min 96°C, 2x (1 min 96°C, 5 min 37°C, 5
min 37°C to 72°C), 30x (1 min 96°C, 2 min 50°C, 5 min 72°C) and 10 min 72°C. The annealing temperature was
increased stepwise from 37°C to 50°C allowing the arbitrary primer to bind over multiple homologous regions. From
the PCR reaction, 5µl was mixed with 5µl of 96% formamide loading buffer (0.05% (wt/vol) xylene cyanol, 0.05%
(wt/vol) bromophenol blue) and boiled for 2 min. The amplified cDNAs were loaded on a 6% sequencing gel and
subjected to electrophoresis. Gels were vacuum dried and autoradiographed with Biomax MR film (Eastman Kodak,
Rochester, NY) at -70°C. The dried gel and autoradiogram were orientated and cDNA bands of interest were excised
and immersed in 100µl TE. DNA was eluted by twice freezing and thawing in liquid N2 and vortexing. Samples
were extracted twice with phenol-chloroform-isoamylalcohol (25:24:1) and once with chloroform-iso-amylalcohol.
cDNA was re-amplified by using 5-10µl in a standard 50µl PCR reaction and utilizing the primer used for the
original differential display (annealing temperature, 50°C). The mixture was separated by agarose gel
electrophoresis, bands were excised, purified with Glassmax (Life Technologies Inc., Paisley, UK) and cloned in
pGEM-T (Promega, Madison, WI) or PCR-script (Stratagene, La Jolla, CA). Plasmid DNA was isolated from 5 to 8
colonies per excised band and inserts sequenced.
Northern blotting analysis.
PMNs (97% neutrophils; <3% eosinophils) were isolated from blood obtained from healthy volunteers from the Red
Cross Blood Bank, Utrecht, The Netherlands, as described above. Cells were incubated in the presence or absence of
GM-CSF (10-10 M) or TNFα (100 U/ml) in RPMI-medium (Life Technologies Inc., Paisley, UK) supplemented with
25mM Hepes, 8% fetal calf serum, 1mg/ml penicillin and 1mg/ml streptomycin in a CO2 incubator (5% CO2, 37°C).
Cells were washed twice with PBS and total RNA was isolated using the acid-phenol method 15. 20µg RNA was
lyophilized and separated on a 0.8% agarose formaldehyde gel.  RNA was transferred to Hybond-N membranes
(Amersham, Rainham, UK) by capillary transfer using 10x SSC (1.5M sodium chloride, 0.15M sodium citrate)
overnight. The blots were washed and baked for 2 hours at 80°C. Differential display fragments were used as probes
and were labeled with α[32P]-dCTP by Rediprime random priming according to manufacturer protocol (Amersham,
Rainham, UK). Blots were hybridized overnight at 42°C, washed subsequently with 2x SSC/0.1% SDS, 1x
SSC/0.1% SDS, 0.1x SSC/0.1% SDS, and exposed to film (Kodak, Rochester, NY). A 1.4kb cDNA fragment of the
human glyceraldehyde-3-phosphate dehydrogenase gene was used to control for equal loading.
Allergen challenge.
Patients used for this study had a history of periodic wheeze and demonstrated a reversibility of more than 15% in
forced expiratory volume in one second (FEV1), 15 minutes after inhalation of 400µg salbutamol from a pressurized
metered dose inhaler attached to an aerosol chamber (Volumatic®, Allen and Hanburys, Greenford, UK). None of
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them had used oral corticosteroids in maintenance dose during 12 months before the study. All subjects were
clinically stable at the time of the study and had no evidence of systemic or respiratory disease. On the day of the
experiment, the FEV1 value was >60% predicted. Furthermore, patients were required to show an increased
bronchial hyperresponsiveness to histamine with a provocative concentration causing a 20% fall in FEV1 of less than
4.0mg.mL-1 (PC20<4.0mg.ml-1), and a fall in FEV1 within 1 hour after allergen inhalation challenge of at least 20%.
All patients had blood eosinophilia (>5%) and raised levels of total serum IgE and specific IgE antibodies to either
house dust mite or cat. Patient data is summarized in Table 1.
Bronchial provocation with allergen was performed by 2 min inhalations (tidal breathing) with 10 min intervals.
Allergen provocation was preceded by an initial aerosol of buffer (2.5mg/ml NaHCO3 with 5mg/ml NaCl, 0,03%
HAS and 0.5% phenol) to which none of the patients reacted with a fall in FEV1. Increasing concentrations of
antigen aerosol were delivered through a nebulizer (model 646, de Vilbiss Co, Somerset, PA). House dust mite
antigen (10,000 biological units/ml; Allergy Laboratory Copenhagen, Denmark) and cat (10,000 biological units/ml;
Allergy Laboratory Copenhagen, Denmark) were diluted from stock solution and the dilution used for the first
inhalation was calculated from the skin-prick test and the pre-antigen PC20 for histamine according to Cockcroft et
al. 16. Inhalations were performed by stepwise doubling the dose of antigen until the FEV1 fell at least 20% from
baseline values. Blood was collected at various time points after allergen challenge as indicated via an intravenous
catheter and was anti-coagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4) and kept at 4 °C. Total leukocytes
were isolated after isotonic lysis of the erythrocytes in ice-cold ammonium chloride solution containing 155mM
NH4Cl, 10mM KHCO3, 0.1mM EDTA (pH 7.2). Total RNA isolation, blotting and hybridization were performed as
previously described.
Table 1: PC20 and effects of allergen inhalation challenge on lung function
Fall in PEF from baseline (%)
PC20 histamine Specific Fall in FEV1 from
Allergen  (mg.mL-1)  IgE (kU.L-1)  baseline <20 min (%) <20 min 3-8 hrs
Der p 0.21 57 29 28 30
Cat 0.16 59 27 18 13
Allergen inhalation challenge was performed with house dust mite (Dermatophagoides pteronyssinus; Der p) or cat allergen. After PC20 allergen challenge, perecntage
fall in FEV1 from baseline within 20 min and percentage fall in PEF from baseline within 20 min and 3-8 hrs were measured. PC20: provocative concentration
producing a 20% fall in FEV1; BU: biological units; PEF: peak expiratory flow.
Results
Method of differential screening for cytokine induced genes
Little is currently known concerning the regulation of genes expressed in response to cytokine-challenge of human
granulocytes. Genes that are regulated by cytokines may be utilized as potential markers for pre-activation or
“priming” of these phagocytes. Furthermore, these genes may provide greater insight into the pathogenesis of
inflammatory disorders. In order to identify differentially expressed genes several approaches have been previously
been utilized. For example, subtractive hybridization or differential hybridization is an approach based on removing
the common transcripts between different cell types or tissues, leaving the specific transcripts for further
manipulation and analysis. These are mainly qualitative methods and extremely time consuming. Secondly, nuclear
run-on transcription has been applied to analyze changes in the level of expression of mRNAs but this method can
only be applied to the detection of changes in the expression of known genes.
More recently a novel method of analyzing gene expression, termed differential display, has been described 13.
This technique provides a sensitive and flexible approach to the identification of genes that are differentially
expressed at the mRNA level. Differential display is based up on selective reverse transcription of expressed
mRNAs and subsequent amplification using PCR in which a radioactive label is included. For the PCR reaction an
anchored oligo-dT primer is utilized to selectively amplify a subset of mRNAs. The amplified, labeled PCR-
fragments can then be separated and compared on a polyacrylamide gel with cell specific band patterns. A
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modification of this technique termed Random Arbitrary Primed (RAP)-PCR has been utilized in this study 14, and
the procedure is represented schematically in Figure 1. In this modification, a single arbitrary primer is utilized in the
PCR cycles. Such an arbitrary primer can be selected with the criteria that it should be approximately 18bp long and
have roughly a 50% (A/T):(G/C) ratio and have an annealing temperature of around 50OC (see Table 2 and Ref 14).
Primers were also selected that generated between 20-50 bands per lane. This primer is allowed to anneal to the
reverse-transcribed PMN cDNA at low temperature, allowing it to act as both a forward and reverse primer. It thus
tends to select a subset of cDNAs with somewhat palindromic 5’- and 3’-sequences. A disadvantage of the original
anchored oligo-dT method was the identification of many 3’-untranslated regions of genes, which are difficult to
analyze. The RAP-PCR protocol does not restrict primer annealing to these untranslated regions and thus provides
greater opportunities to amplify the coding regions of differentially expressed genes. This leads to a more rapid
analysis of the identification of the cloned gene. Primers were tested for their suitability in this assay and were
selected by two criteria, the length should be around 18 base pairs and the annealing temperature should be above
50°C. Arbitrary primers were subsequently chosen that met these criteria and are listed in Table 2.
Figure 1: Flow diagram of RAP-PCR methodology.
Human PMNs are isolated from 500ml whole blood and cultured in the presence or absence of GM-CSF. Total RNA is isolated,
poly-A+ mRNA and cDNA prepared and subjected to RAP-PCR analysis. Up- or down-regulated bands were excised, cloned and
sequenced. See Materials and methods for full-details.
Table 2: Sequences of primers utilized for differential display reactions.
Primer Sequence Length (bp)
1 GGCCAGATGCATGTTCAA 18
2 CACAAGGTGGCAGGATGT 18
3 CTGTCGCCAGAGAAGATG 18
4 GGAAGCCTTCTCTCTCC 17
5 GGAGTCCTGTCTCCTCCG 18
6 GTCTCGACCGGCACCAAG 18
7 CTGCAGCTTCCGTTCTCA 18
Human leukocytes
Human PMNs
No treatment 3 hours GM-CSF
Analyze bands by PAGE
Excise bands, amplify and clone
Sequence and screen against database
Prepare total mRNA
Select polyA+ mRNA
Prepare cDNA
Perform RAP-PCR
Prepare total mRNA
Select polyA+ mRNA
Prepare cDNA
Perform RAP-PCR
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Identification of novel GM-CSF induced genes in human PMNs
RAP-PCR was performed on RNA isolated from human granulocytes treated with or without GM-CSF (10-10M) for
3 hours, as described in the Materials and Methods. Samples were analyzed by acrylamide gel electrophoresis as
shown in Figure 2. Around 30 fragments were found to be clearly differentially regulated and most of them
represented up-regulation in the presence of GM-CSF. Each differentially expressed band was excised from the gel
and amplified with the original primer used for differential display reactions. The fragments obtained were cloned
and partially sequenced. These sequences were then screened against available nucleotide databases and the results
of the sequence comparisons are outlined in Tables 3 and 4.
Interestingly, Five-Lipoxygenase Activating Protein (FLAP), an important regulator of the leukotriene synthesis was
identified as a gene up regulated by GM-CSF 17. Leukotrienes are potent lipid mediators of inflammatory responses
and have been implicated in the pathophysiology of both acute and chronic inflammatory diseases including asthma.
A second potentially interesting product was the Immunoglobulin-Like Transcript-2 (ILT-2). ILT-2 has a large
cytoplasmic tail which contains putative ITIMs (Immunoreceptor Tyrosine-based Inhibitory Motif) similar to those
found in Killer cell Inhibitory Receptors 18. These tyrosine-based motifs implicate ILT-2 in inhibitory signaling
pathways. Furthermore, the transcription factor c-fos was identified. c-Fos is transiently induced by a wide variety of
extracellular stimuli 19. Ferritin, another gene identified, is the major iron-storage protein in eukaryotes, also has a
potential role in the regulation of myelopoiesis and furthermore, has been implicated as a tumor marker 20.
Although we found several previously described genes many novel sequences were also identified that, at this time,
have no identity to either known genes or human Expressed Sequence Tags (EST) sequences (Table 4). The
percentage homology of these clones with EST clones is given along with the length of the insert obtained after
cloning the RAP-PCR product. Extensive work is now required to determine the identity of these coding sequences
and to correlate their expression with cytokine priming.
Figure 2: Identification of differentially regulated transcripts in PMNs after GM-CSF treatment.
 Human PMNs were isolated as indicated in the Materials and Methods. Cells were incubated with or without GM-CSF (10 -10M)
for 3 hours. Poly A+ mRNA was isolated and cDNA prepared for RAP-PCR analysis. Seven different arbitrary primers were
utilized as indicated. Lanes are labeled A-N to aid description. Indicated are the bands that were isolated, amplified, purified,
cloned and sequenced (see Table 3).
H4
J5d
J5b
J5c
D2
A1
J5a
1 2 3 4 5 6 7Primer #
+ + + + + + +
A B C D E F G H I J K L M N
GM-CSF
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               Table 3: cDNAs isolated and cloned from RAP-PCR reactions
Band Fragment
Code size (bp) Identity
A1 500 PECAM-1
D2 500 ADP/ATP Carrier Protein
H4 900 FLAP
J5a 550 Ferritin Heavy Chain
J5b 250 ILT-2
J5c 250 c-Fos
J5d 300 Cytochrome Oxidase-1
    ILT-2, Ig-Like transcript-2
    Table 4: Novel cDNAs cloned from RAP-PCR
Clone Size Primer Sequence EST Identity Strand
13 500 1 caagggacgtttgcatgagtccatggtatgttcaggtgtccaagagtgaa AA470449 71/104 (68%) Minus/Plus
20 750 1 aagactgagtggctgggtgcagtggctcacacctgtaatctcagtatttt THC83029 130/158 (82%) Minus/Plus
36 600 1 gcaaggtttgacaagcggcttacaaaattcctaaattcttcacaatcacc THC280785 93/147 (63%) Plus/Plus
42 450 1 ggcacagcacacactggggcaatggatggaaggagactggcccaaggaac W23538 46/60 (76%) Plus/Plus
79 350 4 gctgctctctgtctctttctctgctcaaggcttaaggccgtgtctcccca THC287677 53/73 (72%) Minus/Plus
90 500 5 agaggctcaaaaagcagccgggcctgaatttcattctgtttccaaagaga THC266464 61/92 (72%) Minus/Plus
93 600 5 cctgcctgtccccagcaccgcctggctcacgtcaccctggtaattgctcc THC101232 98/158 (62%) Minus/Plus
99 350 5 ttgaggttgcgtctgttagtagtatagtgatgccagcagctaggactggg THC197030 101/141 (78%) Minus/Plus
101 500 5 ggacagacaggaaatcgctgtgcagggcccctgcctgtgcccagcaccgc THC254052 54/73 (73%) Plus/Plus
103 400 5 gtcctcatggcctaggcagctgcagccgccagacagtgagcccggacaca R81083 50/67 (74%) Plus/Plus
113 450 5 gatccattcgtccatggatggatacttaagttgattccatatttcagtta AA084052 94/124 (75%) Minus/Plus
122 650 2 cagattggcttcttagtaatacatttgagtttctttcatggcttgacatc AA205247 65/85 (76%) Minus/Plus
129 650 5 tgattggcccctgggattcttcctccttgcctcctctccctgggttcatc THC292692 97/148 (65%) Plus/Plus
139 600 5 gtcctcagggcctaggcacctgcagccgccagacagtgagcccggacaca AI095822 97/152 (63%) Minus/Plus
148 500 6 tcaatacaggtagtctgatgactaacgagagggaacataaggaccctatg AA558722 65/91 (71%) Minus/Plus
238 300 2 gtcatcgttgaggctcaggtcggtcggataccgccaactggaacaccctg EST185621 62/87 (71%) Minus/Plus
244 650 2 aggatgtccagcccatatgaggagcttgttgaattgaattgcgtggagac EST68741 49/70 (70%) Plus/Plus
247 550 2 ggatgtgggacaaagtcaaagattattattaagctctaaggttttaatgt THC267228 131/176 (74%) Minus/Plus
249 600 2 aggatgtgtgtagcaacaggagctctcgttcacggctgctgggaacgcaa THC150192 90/127 (70%) Minus/Plus
255 650 2 gaccctcagagggacctagaaaagctggtccctccagtccctttgaggca THC269356 57/84 (67%) Plus/Plus
256 700 2 gtgccaggccttaggtcataccagacttggcaggggttgaggatcgaggg THC203964 68/94 (72%) Minus/Plus
262 400 3 ctgtcgccagagaagatgcccactttatgaataagcagaattaactacat THC270838 120/123 (97%) Plus/Plus
273 400 4 ctgtcgccagagaagatgtttatttgatgtaacaaaacaatacagttagt THC254502 120/125 (96%) Minus/Plus
286 600 5 ggacagacaggaaatcgctgtgcagggcccctgcctgtccccagcaccgc AA502694 46/64 (71%) Minus/Plus
294 350 5 gggcatgttgctcccactcaccagcttggccccatcacagagcttctccc THC282228 71/104 (68%) Plus/Plus
311 650 7 atattgattcagataggcataatctattcatttttcataatgaaatgtat THC212219 137/157 (87%) Minus/Plus
314 450 7 gggagctaaggagaaccatcatatgtgtccatctcttccgcatttacatg THC232302 114/154 (74%) Minus/Plus
320 400 7 cttccgttctcaggagttggccctgtggttttggtgaaaactctggcctt THC271399 73/112 (65%) Minus/Plus
Data were obtained by screening the Institute for Genome Research’s expresed sequence tag (EST) databases, which can be found at http:/www.tigr.com
Confirmation of GM-CSF-mediated induction of genes in human PMNs
To confirm that the genes isolated were indeed differentially expressed, Northern blots of total RNA from human
PMNs (97% neutrophils; <3% eosinophils) incubated with GM-CSF were probed with selected cDNAs. Figure 3a
shows a strong up-regulation of the FLAP gene after 3 hours treatment with GM-CSF. Similarly, ILT-2 mRNA was
also rapidly induced after 3 hours. Since c-fos mRNA is known to be very rapidly induced by extracellular stimuli 21,
we prepared a northern blot including a 30 minutes GM-CSF time point. Indeed, c-fos expression was extremely
rapidly and transiently up regulated, being optimally expressed after 30 min. Interestingly while c-fos appears to be
both rapidly and transiently up-regulated, as is characteristic of immediate early genes, both FLAP and ILT-2 are
slower, and levels remain high for at least 3 hours. Data was confirmed in at least three independent donors. These
data demonstrate that the genes identified as being differentially expressed by the RAP-PCR technique are indeed
upregulated in human PMNs stimulated with GM-CSF.
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Figure 3: GM-CSF induces the expression of RAP-PCR products in human PMNs.
Human PMNs were incubated for the indicated times with GM-CSF (10-10M). 20 µg of total RNA per lane was used for northern
blotting and blots were hybridized with the isolated RAP-PCR fragments (upper panels). (A) FLAP (Five-Lipoxygenase
Activating Protein) (B) ILT-2 (Immunoglobulin-Like Transcript-2) and (C) c-Fos. All blots were reprobed with GAPDH
(Glyceraldehyde Phosphate Dehydrogenase) to correct for equal loading (lower panels). The positions of 28S and 18S RNA are
indicated.
FLAP is rapidly induced in human PMNs by both GM-CSF and TNFα
To analyze the duration and extent of FLAP expression in human PMNs in detail, we prepared RNA from cells
stimulated for up to 6 hours with GM-CSF. Interestingly, while FLAP expression is rapidly induced, it remains high
for at least 6 hours (Fig. 4A). Since the “lifespan” of human neutrophils is rather short, even in the presence of
cytokines, it appears that once FLAP is upregulated, it remains highly expressed until the granulocyte apoptotic
program is induced. Thus, FLAP provides a somewhat permanent marker for the activation status of these
phagocytes. To determine if FLAP may be induced by other inflammatory stimuli and thus a general marker of
inflammation, we also stimulated human PMNs with TNF-α. Again, the expression of FLAP in PMNs treated with
TNF-α was increased and remained high for at least 6 hours (Fig. 4B). This suggests that at least some of the GM-
CSF-stimulated mRNAs are also markers of a common pool of inflammatory cytokine-induced genes.
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28 S
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Figure 4: FLAP mRNA expression is induced in GM-CSF and TNF-α stimulated PMNs.
Northern blots were prepared from RNA of PMNs stimulated with (A) GM-CSF (10-10M) and (B) TNF-α (100 U/ml) for the
indicated time points. 20 µg of total RNA per lane was loaded and blots were probed with the RAP-PCR fragment of FLAP. The
positions of 28S and 18S RNA are indicated.
Allergen challenge induces FLAP-expression in peripheral blood leukocytes in vivo
We wished to determine whether the increase in FLAP-expression we observed by in vitro stimulation of PMNs
could also be observed in vivo. To do this, we analyzed FLAP-expression in the total leukocyte population from
allergic asthma patients after allergen inhalation challenge. Total leukocytes were utilised and not PMNs for several
reasons: (1) it is not possible to isolate sufficient amounts of eosinophils and neutrophils from 10ml of blood to
obtain enough mRNA for northern blotting. (2) Isolation of cells takes at least 2 hrs (neutrophils) or 4 hrs
(eosinophils). These rather long isolation times can interfere with the detection of fast and transient-induced genes.
(3) By using total leukocytes, aspecific priming caused by the isolation procedures was minimized. Blood was
collected after allergen challenge and leukocytes isolated as indicated in detail in the Materials and Methods.
Northern blots of RNA from two patients who were allergic to either house-dust mite or cat were probed for FLAP
mRNA expression. The methodology used for allergen challenge is detailed in the Materials and Methods. The
expression of FLAP in vivo was also very rapidly induced, reaching a maximum level in both patients between 30
min and 1 hour, before decreasing to basal levels within 4-5 hours (Figure 5). This decrease to basal levels is in
contrast to what was observed in isolated PMNs stimulated in vitro with cytokines (see Figure 4). This discrepancy
is likely to reflect the fact that in these in vivo experiments the primed leukocytes will migrate out of the peripheral
blood after several hours. These data demonstrate that gene expression identified in vitro by cytokine challenge of
human PMNs reflects the in vivo situation after induction of an inflammatory response.
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Figure 5: FLAP expression is increased in leukocytes isolated from allergic asthmatics after allergen inhalation challenge.
Total RNA was prepared from total white cell fractions of blood taken from patients before (control) and after allergen challenge
at the times indicated. (A) House-dust mite allergen (10.000 biological units/ml) and (B) Cat allergen (10.000 biological units/ml)
were utilized. Inhalations were performed as previously described and samples were collected after the FEV1 was at least 20%
below baseline values. 10µg of total RNA per lane was loaded and blots were probed with the differential display fragment of
FLAP (upper panels). Blots were subsequently re-probed with GAPDH to correct for equal loading (lower panels).
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Discussion
Phagocytes (granulocytes and monocytes) in the peripheral blood are characterized by a non-primed phenotype that
is refractory to activation in the context of cytotoxic responses 2-4. This is a safeguard for the inappropriate activation
of these cells in the peripheral blood. In severe clinical conditions, such as septic shock, uncontrolled activation of
phagocytes can lead to multi organ failure and death. At inflammatory loci, such as bronchial tissue in allergic
asthma, eosinophils are attracted to the site of inflammation and become activated 1. The process of extravasation of
inflammatory cells to these loci is a tightly controlled multistep process. The first step involves the interaction of
phagocytes in the peripheral blood by cytokines liberated from the inflammatory locus. This results in pre-activation
or priming of cells, which is essential for their subsequent extravasation and the eventual activation of cytotoxic
responses upon interaction with activating stimuli. Therefore, the process of priming is critical for regulation of
phagocyte effector functions in vivo. This multistep paradigm of phagocyte activation predicts that cytokine-
mediated priming of peripheral blood granulocytes is a result of a local inflammatory reaction in a given organ.
Indeed, several studies have shown that inflammatory cells are characterized by a primed phenotype in the peripheral
blood of patients with allergic inflammatory conditions 22-25. Understanding the mechanisms of priming might be
useful in the development specific approaches to inhibit this phenomenon thereby preventing inflammatory cells
becoming optimally activated. Moreover, this in vivo primed phenotype of inflammatory cells in the peripheral blood
might be used to develop strategies to measure this phenotype as read out for the severity of inflammatory processes
localized in tissues. This diagnostic approach has been followed by Venge and colleagues who have measured the
release of eosinophil cationic protein by eosinophils in the blood of allergic asthmatics ex-vivo 26;27. This
phenomenon occurs during clotting of blood in samples of patients with various inflammatory diseases in particular
allergic asthma 28. The ability of eosinophils to release ECP under these conditions can be considered as an indirect
measure of eosinophil priming in vivo. We have tried to measure priming of isolated eosinophils as a measure of
changes in inflammatory processes in the lung during anti-inflammatory treatment (unpublished data.). Although
PAF-induced eosinophil chemotaxis is inhibited by this type of treatment, functional eosinophil responses such as
chemotaxis and activation of the respiratory burst cannot be routinely used for this type of study. The methodology
is too laborious and the data are too sensitive for variations in processing of the cells.
Despite recognition of  the importance of priming, very little is currently known as to the precise molecular
mechanisms of this phenomenon. Therefore, we set out experiments to find new determinants of cytokine-induced
priming utilizing the technique of differential display. This powerful PCR based technique has enabled us to define
several mRNAs that were either up- or down regulated during GM-CSF treatment of PMNs in vitro (see Table 3).
While utilizing RAP-PCR will not lead to the identification of all genes regulated by cytokine priming it does result
in the identification of a large subset of genes. In this article alone we describe around 25 unknown genes that must
now be subsequently characterized (Table 4). Interestingly, two of the genes identified, ferritin-H and cytochrome
oxidase, were also identified as allergen induced genes in monocytes isolated from mononuclear cells of patients
with allergic asthma 29. Ferritin-H plays an important role in iron storage and iron sequestration 20. Our data suggest
that in human PMNs, GM-CSF may play a role in regulating iron homeostasis through regulating the expression of
ferritin-H. Indeed it has been reported, in primary human myoblasts, that TNFα induces ferritin-H mRNA
independently of cellular iron concentrations and known iron-dependent regulatory pathways 30. This suggests that
regulation of iron homeostasis by inflammatory cytokines might be a general response of cells. Increased
sequestration of iron by increasing the levels of ferritin-H might serve the beneficial functions of, (a) making iron
unavailable to invading organisms or, (b) reducing free-radical tissue damage. The latter may play an important role
in phagocyte functioning, protecting cells against damage during the killing of microbial organisms by superoxide
production.
We have also identified the transcription factor c-fos as a rapidly upregulated gene in PMNs (Fig. 3c). This
transcription factor is a member of a family of immediate early response genes whose expression is regulated by a
variety of cytokines, growth factors and hormones 19. Once expressed, it is then able to bind and activate the
promoters of a diverse array of cellular genes. Thus, GM-CSF induced c-fos expression in human neutrophils may
be responsible for rapidly "switching on" relevant target genes needed for initiating a correct inflammatory response.
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Another GM-CSF regulated gene identified is the immunoglobulin-like transcript 2 (ILT-2; Fig. 3b), a
transmembrane protein that is expressed on many myeloid and lymphoid cells 18. This receptor binds MHC class I
molecules and delivers a negative signal that inhibits killing by NK and Tcells, as well as Ca2+-mobilization in B
cells triggered through the B-cell antigen receptor 31. Cytokine regulated expression of this gene has not previously
reported neither has its expression in neutrophils. Our finding that ILT-2 can be upregulated by GM-CSF suggest a
potentially novel mechanism for regulating cellular activation during an immune response.
5-lipoxygenase activating protein (FLAP) was identified as a gene potently upregulated in neutrophils treated with
GM-CSF and TNFα (Fig. 4). This protein is a critical component in the synthesis of leukotrienes 17. Leukotrienes are
secreted by neutrophils, eosinophils, mast cells and macrophages and potently stimulate bronchoconstriction and
mucous secretion, and cause vasodilatation with increases in postcapillary permeability 32. It is thus interesting that
through differential display we were able to identify FLAP as a marker of primed granulocytes in vitro. The
consequences of FLAP upregulation are thus likely to be an increased inflammatory response.
Differential display was utilized to find determinants of priming in the peripheral blood of allergic asthmatics. The
most prominent signal in vitro was found with the FLAP mRNA on Northern blots from cytokine treated
granulocytes. To confirm that genes identified in vitro were also relevant in vivo, mRNA was prepared from total
leukocytes isolated from allergic asthmatic patients before and after allergen challenge. Total leukocytes were
chosen over isolated PMNs, due to the relatively long time of isolation and the sensitivity of these granulocytes for
aspecific pre-activation during isolation 33. As can be seen from Figure 5, FLAP mRNA is rapidly induced after
allergen challenge and this increase is transient. These findings are consistent with a model that inflammatory blood
cells encounter priming signals in the peripheral blood. These cytokines modulate the transcription of several genes
including the induction of the FLAP gene. Moreover, these cells become much more responsive to chemotactic
factors 34. These primed cells are destined to leave the bloodstream and extravasate into the tissues leaving the
unprimed cells in the peripheral blood. The observation that FLAP is also upregulated in vivo validates our chosen
methodology. Further in vivo analysis of both the known and unknown genes identified in our screen may well lead
to the identification of novel markers of inflammation as well as further insight into immune regulation.
Concluding, differential display enables the characterization of genes that are differentially transcribed in response
to cytokines and are relevant for the pathogenesis of inflammatory diseases. This occurs in vitro and in vivo in
patients with symptomatic asthma. Characterization of novel genes will enable us to find new markers of
inflammatory diseases and will provide valuable information on the processes that occur early in the sequence
eventually leading to activation of inflammatory cells in the tissues.
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Neutrophils mature in the bone marrow to become functional phagocytotic cells. The main function of neutrophils is
to destroy invading microbial pathogens in order to protect the host from infections. During inflammation
chemoattractants and cytokines bind to specific receptors expressed on the neutrophil surface resulting in the
initiation of specific granulocyte effector functions, such as priming, adhesion, migration, respiratory burst and
degranulation. Correct control of all these processes is necessary for efficient functioning of the neutrophil.
Dysregulation or defects in neutrophil functioning can lead to immune failure or inflammatory diseases. Therefore, it
is of importance to understand the downstream signaling events activated by cytokines and chemoattractants that
regulate neutrophil maturation and function.
The work described in this thesis work has focussed on the intracellular signaling pathways induced by inflammatory
mediators that are involved in maturation and functioning of human neutrophils. An ex-vivo differentiation model
was developed to study granulopoiesis, and the roles of PI3K and MEK were investigated using specific
pharmacological inhibitors. Here, the results of this work are discussed with respect to cell fate decisions.
Two approaches were used to investigate granulocyte functioning. Random arbitrary primer PCR was applied to
identify genes in granulocytes that were regulated by GM-CSF treatment. This technique was found to be effective
for identifying genes regulated in vitro as well as in vivo. Secondly, degenerate PCR technique was used to identify
novel kinases in human granulocytes. In this way, a novel granulocyte specific kinase was cloned whose possible
function(s) are discussed in this section.
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Neutrophil maturation
Granulopoiesis is a complex process by which hematopoietic stem cells (HCS) mature into fully differentiated
functionally competent granulocytes. This process is associated with the control of proliferation and differentiation,
which are regulated by external stimuli including cytokines and growth factors as well as interactions with stromal
cells present in the bone marrow.
Maturation: Communication between transcription factors and cell cycle regulating factors
Specific transcription factors are expressed during granulopoiesis and some of them, such as CCAAT/enhancer
binding protein α (C/EBPα) and PU.1 are key regulators of early gene expression 1. These transcription factors
regulate expression of proteins involved in the maturation process, including the GM-CSF receptor and the G-CSF
receptor, as well as granule proteins such as myeloperoxidase (MPO) and lysozyme 2. Recent studies have
demonstrated a role for additional transcription factors in the control of granulopoiesis. For example, C/EBPε
is expressed predominantly at the late stage of granulocyte differentiation and contributes to induction of
transcription of a number of key genes, including lactoferrin 3-5. Finally, several of more ubiquitously expressed
transcription factors, such as STATs, c-myc and Mad1 are known to play important roles in granulopoiesis as
demonstrated by gene knockout and overexpression studies 1. A schematic representation of the expression of several
transcription factors during granulopoiesis and the phenotype of the respective null mutant mice is illustrated in
Figure 1. The regulation of hematopiesis by transcription factors is complicated by the fact that multiple transcription
factors can work cooperatively. For example, C/EBPα, c-myb and PU.1 cooperate to activate the murine neutrophil
elastase (NE) promoter, and probably cooperate to activate the highly homologous proteinase-3 and azurocidin genes
as well 6; 7. Hematopoietic transcription factors can also influence each other’s expression. Inducible activation of
C/EBP is described to elevate PU.1 mRNA levels, in both 32Dcl3 myeloid cells and the Ba/F3 B cell line 2,
suggesting that C/EBPα acts directly on the PU.1 promoter. In addition, both C/EBPα and PU.1 can directly affect
their own promoters, resulting in enhanced expression 8-10. These findings demonstrate the complexity underlying the
mechanisms by which transcription factors can regulate granulopoiesis.
Apart from transcription factors, evidence has been accumulating concerning the role of cell cycle regulatory
proteins in the myeloid differentiation process. Terminal differentiation appears to correlate with upregulation of the
cell cycle inhibitor p27kip1 (Fig. 1). It has been demonstrated that retinoic acid induced differentiation of U937, HL60
and NB40 cells is associated with upregulation of p27kip1 and down regulation of cyclin E 11. In addition, 32D cells
differentiated towards neutrophils by G-CSF treatment have increased 27kip1 levels 12. Furthermore, the down
regulation of the transcription factor c-myc as referred to earlier, has been associated with differentiation. Many c-
myc target genes are involved in cell cycle progression or protein translation 13, suggesting a counter balance
between differentiation and proliferation. This hypothesis is supported by the fact that murine p27kip1-deficient
myeloid progenitors showed increased proliferation as well as reduced differentiation 12. Furthermore, the
retinoblastoma protein (Rb) is down regulated in granulocyte differentiation, whereas it is upregulated during
erythroid and monocytic differentiation. This suggests that Rb functions as a switch between monocytic and
granulocytic lineages 14; 15.
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Figure 1: Expression of transcription factors and cell cycle regulators during differentiation of human granulocytes and phenotype of respective
knockout mice.
The role of PI3K and MEK in the regulation of transcription factors and cell cycle regulators
In the bone marrow, stromal cells produce cytokines such as SCF, FLT3L, IL-3, GM-CSF and G-CSF, which support
the maturation of hematopoietic stem cells. These cytokines then regulate the expression or activation of
transcription factors necessary for differentiation as described above 1; 16. Binding of cytokines to their receptor
results in the activation of multiple signaling molecules, including PI3K and MEK. In contrast to the established role
of transcription factors in granulopoiesis, surprisingly little is known about the role of signaling molecules.
For the research described in this thesis, an ex-vivo differentiation model has been developed to study the role of
PI3K and MEK in the maturation process of CD34+ HCS towards human neutrophils (Chapter 2). Inhibition of PI3K
was found to abrogate granulocyte maturation in this model. This might suggest that PI3K is critical for the
regulation of hematopoietic transcription factors. Indeed, in B-cells it has been described that PI3K can positively
regulate PU.1 activity via phosphorylation, which is mediated by protein kinase B (PKB) 17. For C/EBPα an
inhibitory effect of PI3K on the phosphorylation of two threonine residues (222 and 226) has been observed, which
is mediated by inhibition of GSK-3 activity 18. It is tempting to speculate that GSK3-induced phosphorylation of
C/EBPα targets it for degradation, as is proposed for c-myc (see further on). Furthermore, an active form of Ras has
been shown to activate C/EBPα, through to phosphorylation of serine 248, which is a protein kinase C (PKC)
consensus site (Behre G JBC, manuscript in press). Since it has been reported that PI3K can activate PKC isoforms
via 3’-phosphoinositide-dependent kinase-1 (PDK1) 19, PI3K may regulate C/EBPα phosphorylation,
dephosphorylation or both during granulocyte maturation.
Proliferation of the HCS was affected by inhibition of both PI3K and MEK. PI3K inhibition resulted in a complete
cell cycle arrest within 24 hours, while inhibition of MEK resulted in a three-fold inhibition of proliferation. Several
cell cycle regulating proteins have been described to be regulated by PI3K and MEK. ERK, which acts downstream
of MEK, has been found to phosphorylate c-myc leading to stability of this protein 20. PI3K has also been
demonstrated to inhibit degradation of c-myc, which is likely to occur through the PI3K-dependent inhibition of
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GSK3. Cyclin D1 levels might also be stabilized by PI3K, since a similar mechanism as for c-myc has been
described for this protein 21. For both MEK and PI3K a role in the regulation transcription of cyclin D1 and p27kip1
has been suggested 22-25. PI3K-induced down regulation of p27kip1 is at least in part regulated via phosphorylation and
inactivation of the Forkhead family of transcription factors 26 27.
These findings (depicted in Figure 2) suggest that PI3K may regulate proliferation and differentiation through
multiple mechanisms. (i) By inhibition of degradation of factors involved in differentiation, such as c-myc, and
possibly cyclin D1 and C/EBPα and/or (ii) by regulation of transcriptional activity by the phosphorylation of
transcription factors, such as Forkheads, PU.1 and possibly C/EBPα. MEK seems to cooperate with PI3K to stabilize
factors predominantly involved in the cell cycle regulation such as cyclin D1 and c-myc, and/or down regulate cell
cycle inhibitors, such as p27kip1. Further work is required to define the precise mechanisms by which PI3K and MEK
regulate granulopoiesis.
Notably, during the early stage of differentiation progenitor cells enlarge to become promyelocytes. In Drosophila
melanogaster, PI3K has been demonstrated to be involved in the control of cell, organ and body size 28. Furthermore,
expression of a constitutively active form of PI3K in mammals resulted in increased hart size, due to an increase in
the size of the individual myocytes, rather than altering the cell numbers 29. It is interesting to speculate that PI3K
activity may be involved in the increase in size of hematopoietic stem cells.
Figure 2:  Schematic representation of the role of PI3K and MEK in regulating transcription factors and cell cycle regulators.
Cell fate decisions: Divide or Differentiate?
Multiple signals are involved in the regulation of differentiation. However, one question remains. What makes a cell
decide to differentiate rather than proliferate? Thus far, two models have been proposed. (i) The “inductive model”
favors the hypothesis that differentiation is controlled by specific cytokine receptors. For example, activation of the
G-CSF receptor specially drives a progenitor cell to the neutrophilic lineage. However, C/EBPα that is important for
the neutrophilic lineage can upregulate G-CSF receptor expression. This suggests that the decisions to differentiate
have to be made earlier. (ii) The “stochastic model” favors the hypothesis that stem cells are already intrinsically
committed to differentiate within the correct microenvironment. However, if a progenitor cell is already
“programmed” for its differentiation fate, why are so many factors differentially regulated during differentiation? It
DifferentiationProliferation
PI3K
ERK
MEK
Rb
p27kip1
c-Myc
PU.1
C/EBPα
PI3K
GSK3 GSK3
MEK
FKHR
Ras
C/EBPε
IL-3 G-CSF
STATs STATs
ERK
E2F
MPO, elastase
Lactoferrin
PKC?
CBF
c-myb
Cyclin D1
CDK4,6
Cyclin E
CDK2
E2F
G1
G2
S
M Mad1
Cyclin B
CDK1
Cyclin A
CDK2
GSK3
PD89059 LY294002 PI3K?PD89059 LY294002
Chapter 7
157
might be considered that early differentiation is a result of stochastic processes, in which the “correctly programmed”
cells then go on to survive, proliferate and differentiate. During late maturation the “inductive model” seems to be
dominant resulting in terminal differentiation. This process is controlled by specific receptors, such as the G-CSF
receptor for the neutrophilic lineage. When proliferation is accelerated by intrinsic defects, or by dysfunction of the
components regulating the inductive process, leuko-proliferative disorders such as leukemia might develop (Fig 3).
This still does not explain what drives a cell to decide to differentiate or proliferate. There are some indications that
immature cells leave the bone marrow and differentiate in situ, where specific cytokines are present to induce the last
step of differentiation. Further studies are required on how signaling molecules mediate the early and/or late
maturation by regulating transcription factors, cell cycle regulating factors, or even adhesion receptors are of
importance to elucidate the mechanisms controlling hematopoiesis.
Figure 3: Cell fate decisions, proliferation, differentiation, or both.
In early maturation proliferation and differentiation can occur concomitantly. During late maturation, differentiation might be
dominant resulting in terminal differentiation correlated with a decreased proliferation. PI3K possible plays a critical role in the
early maturation, since both proliferation and differentiation are inhibited. A role for MEK is observed only the proliferation
process.
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Identification a novel kinase in human granulocytes
Human granulocytes are cells with specific effector functions that ensure efficient killing of invading
microorganisms. Since these cells have such specific functions we speculated that unidentified cell-type specific
signaling molecules involved in these processes might be present in these cells. A degenerate PCR technique was
used to identify novel kinase(s) in human granulocytes. In our search for these granulocyte specific kinases, the
Ca2+/calmodulin-dependent Kinase I-Like Kinase (CKLiK) was identified (Chapter 3). CKLiK belongs to the family
of Ca2+/calmodulin dependent kinases, which include CaMKI, CaMKII, CaMKIV and CaMKK. Although several of
these kinases have a wide tissue distribution, most studies are performed in neuronal cells 30 31. CKLiK was
demonstrated to be predominantly expressed in primary granulocytes, and its activity was induced by stimulation of
G-protein coupled receptors expressed on these cells (Chapter 3). Since CKLiK activity is dependent on Ca2+, a role
for CKLiK downstream of activated GPCRs and their induced Ca2+ signal has been proposed in this thesis.
Role of [Ca2+]i and CKLiK in granulocyte effector functions
Changes in intracellular Ca2+ concentrations ([Ca2+]i) have been associated with multiple functions of human
granulocytes 32. Ca2+ release in neutrophils has been suggested to be regulated in two different ways. Activation of
GPCRs have been shown to result in Ca2+ release from a central store located near the nucleus 33; 34. Alternatively,
cross-linking of integrins results in Ca2+ release from peripheral Ca2+ stores. These peripheral stores can relocate
towards an area near the plasma membrane 35. Chemoattractants, which activate GPCRs, can thus give rise to release
of Ca2+ from the central store, generating a global Ca2+ signal, which is in turn followed by a influx of extracellular
Ca2+ to refill the store 36. Cross-linking of integrins results in release of the locally stored Ca2+ near the plasma
membrane generating a local Ca2+ signal 37. These different modes of Ca2+ signaling may be linked to the induction
of specific granulocyte effector functions in response to inflammatory factors, as is suggested in Figure 4. A model
for the Ca2+ mediated CKLiK activation is depicted in Figure 5.
Figure 4: Hypothetical model of controlling granulocyte function by the release of Ca2+ from central fixed stores and peripheral mobile stores
(a) When a neutrophil first encounters a physiological stimulus, for example PAF on the endothelial cell, cytosolic free Ca2+ is
released from the central Ca2+ store, with accompanying global Ca2+ influx. Integrin upregulation is consequently signaled equally
around the cell surface.  This initial Ca2+ signal would thus lack directionality, because unpolarized nature of the cell and the
central location of the Ca2+ release site. (b) When integrins become engaged on encountering adhesion molecules such as ICAM-
1, cytosolic free Ca2+ is then released from the peripheral stores without influx of extracellular Ca2+, and so a localized Ca2+ signal
is generated. (c) This directional Ca2+ signal leads to cell shape changes in the required direction, in readiness for migration. (d)
During migration, the local stores translocate to the integrin- engaging surface providing a Ca2+ signal at the leading edge of the
cell. (e) The mobile Ca2+ storages will also be strategically placed for liberation of Ca2+ at the required site for NADPH oxidase
activation. This would results in the NADPH oxidase being activated locally at the phagosome by cross-linking stimuli. Global
activation of the respiratory burst and degranulation can also be triggered by, for example, bacterial formlylated peptides. Note
that GPCR activation results in Ca2+ release from the central stores and may be involved in a and f. Cross-linking stimuli, which
induces release from the peripheral mobile stores, may be involved in b, c, and e. (Figure is adapted from Davies et al).
a
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d
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Role of CKLiK in respiratory burst
Inhibition of calmodulin or CKLiK activity resulted in a reduced ROS production in human neutrophils stimulated
with fMLP. It has been described that formation of ROS in human granulocytes requires intracellular Ca2+ 38; 39.
However, the mechanism by which Ca2+ is linked to the induction of the respiratory burst is still unclear. In chapter 4
and 5 it was discussed that CKLiK could effect ROS activity by influencing the activity of exchange factors (GEFs)
for the small GTPases Rac2 or Rap1, or by the phosphorylation of p47phox (see Fig 5). p47phox as well as these small
GTPases are important for the generation of an
active NADPH oxidase complex, necessary for the production of ROS in human granulocytes. Tiam1, a GEF for
Rac, has been shown to be phosphorylated by CaMKII, which results in translocation of Tiam1 to the membrane 40;
41. After neutrophil stimulation with fMLP, p47phox is phosphorylated on multiple serine residues 42. Some of these
serine residues are potential CKLiK phosphorylation sites, as was identified by consensus site comparison. In
addition to this, cross-linking of β2 integrins can also significantly stimulate ROS production in human neutrophils
43, suggesting a role for these integrins in the respiratory burst. Indeed, leukocytes from patients with leukocyte
adhesion deficiency (LAD) who are characterized by deficient or defective β2 integrins, exhibit besides a perturbed
migration an impaired respiratory burst 44. As mentioned above cross-linking of integrins can induce Ca2+ release
from the locally present Ca2+ stores, which in turn can activate downstream signaling events, such as possibly the
activation of CKLiK (Fig. 5).
Role of CKLiK on neutrophil migration
Neutrophil migration over albumin coated surfaces was perturbed when cells were treated with inhibitors for
calmodulin and CKLiK (Chapter 4 and 5). Several phases of neutrophil migration have been suggested to be Ca2+-
dependent. Movement on several substrates is abrogated in Ca2+-buffered conditions, which was associated with
clustering of integrins at the rear of the cell 45. Based on this observation, an endocytotic recycling of integrins in
motile neutrophils, back to the leading edge of the migrating cell has been suggested. Another study demonstrated
that inhibition of CaMKII resulted in a high affinity state of β1 integrins 46, therefore a role for CaMKII on β1-
detachment can be speculated. A similar role for CKLiK might be possible. However, besides an abrogated
migration in the presence of the CKLiK inhibitor, we also observed a reduced number of adhered cells. This would
rather suggest a role for CKLiK in the enhancement of integrin activity. In parallel, increased integrin activity was
observed in T cells that express constitutively active Rap1 47. Therefore, it is tempting to speculate a link between
CKLiK and Rap1. Furthermore, Ca2+ has also been implicated in rear release of the cell during migration. Buffering
of [Ca2+]i results in impaired uropod retraction 48. This force-mediated retraction in neutrophils was found to be
dependent on the phosphorylation of myosin II. Phosphorylation of the myosin light chain can be mediated by the
Ca2+/calmodulin dependent myosin light chain kinase (MLCK) and Rho kinase (ROCK), which acts downstream of
Rho 48; 49. Although these are defined processes, a role for CKLiK in rear release cannot be excluded (Fig. 5).
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Figure 5: Possible mechanisms by which CKLiK regulates granulocyte effector functions.
Activation of GPCRs leads to Ca2+ release from the central store. Ca2+ binding by calmodulin results in a conformational change
leading to binding to and thereby activation of CKLiK. This can lead to the activation of possible downstream targets such as
guanine exchange factors of the Rho family members, intergrins, p47phox, myosin II or CREB. A possible second mechanism in
which CKLiK might be activated is via integrin cross-linking, since this also induce Ca2+ release.
Downstream targets of CKLiK
Since CKLiK can regulate both respiratory burst and migration it might be speculated that CKLiK has a general role
in neutrophil signaling through direct activation of multiple target proteins. The closely related CaMKI has been
demonstrated to be a multifunctional kinase, since it can phosphorylate several target molecules 31. Thus far, CKLiK
has only been shown to phosphorylate the transcription factor CREB (Fig. 5). However, the effect of CKLiK
inhibition on migration and respiratory burst cannot be directly linked with CREB phosphorylation. Possible
additional targets of CKLiK phosphorylation are myosin II and/or p47phox (Fig. 5). Another explanation for a general
effect of CKLiK is that it can target a limited number of molecules, which have a broad function of them selves. Two
potential candidates are the small GTPases (Rac, Rho and Rap1), and the integrins (Fig. 5), since both groups of
molecules can effect many cellular processes as is discussed above 50 51.
PI3K and granulocyte functions
Chemoattractants and chemokines activate many additional signaling pathways, besides increased [Ca2+]i. PI3K is
critically important, since inhibition of this kinase leads to a reduced granulocyte effector functions as already
discussed in the introduction of this thesis. It is interesting to note that we did not observe an effect of PI3K
inhibition on the migration of neutrophils on albumin coated surfaces. Recently it has been described that murine
PI3Kγ-/- mice showed frequently directional changes and failed to orient toward a gradient 52. This discrepancy
might be explained by the fact that our assays are not based on a chemotactic gradient. Additionally, PI3K is
suggested to be necessary to colocalize F-actin and protein kinase B, a downstream target of PI3K, in the leading
edge of the cell 52. In Chapter 4 we observed convergence of a calmodulin sensitive pathway with PKB. Since we
demonstrated a dramatic inhibition of migration using a calmodulin inhibitor, it could be speculated that
phosphorylation on PKB is critical for controlling the migration responses at the leading edge of the cell. It would be
of interest to study the effects of direct inhibition of PKB on migration. The calmodulin sensitive phosphorylation of
PKB is probably not mediated by CKLiK since we did not observe PKB activation in the presence of active CKLiK
(Chapter 3). This suggests that besides CKLiK other CaMKs might play a role in regulating signaling in human
granulocytes. Indeed, we demonstrated by PCR that more family members are present in these cells (Chapter 4).
Therefore, it is important to explore the role of other CaMKs in human granulocytes.
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Concluding remarks
Neutrophil maturation and neutrophil functioning are controlled by multiple signal transduction pathways activated
by several stimuli. The work in this thesis demonstrates the importance of the PI3K and MEK pathways in human
neutrophil differentiation. The use of an ex-vivo differentiation model will allow us to study the role of further
signaling molecules important for maturation, for example GSK-3. Furthermore, since these stem cells can be
transduced with (inducible) active or dominant-negative cDNAs we will be able to study the role of a specific
signaling molecule at different stages of maturation in detail. More insight into the genes that are involved in the
maturation process may also be obtained by the use of RAP-PCR or by microarray analysis. By identifying a
Ca2+/calmodulin-dependent kinase expressed predominantly in human granulocytes, we provide a novel mechanism
for specific Ca2+-induced signaling in these cells. We demonstrate that several important granulocyte effector
functions are dramatically decreased by the inhibition of calmodulin and CKLiK. Besides the role of CKLiK in
respiratory burst and migration, CKLiK might also have an effect on transcription. We demonstrated that CKLiK
could activate the transcription factor CREB and that an active truncated form of CKLiK translocates to the nucleus.
Identification of direct target proteins of CKLiK in future research is imperative to gain insight into the specificity of
Ca2+-mediated CKLiK signaling. Possibly then, CKLiK might be suitable as a therapeutic drug target since it is
specifically expressed in a subset of myeloid cells.
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Naast rode bloedcellen bevat bloed ongeveer 1% witte bloedcellen die belangrijk zijn voor ons immuunsysteem.
Dagelijks worden miljarden van deze cellen aangemaakt in het beenmerg, die na uitrijping in de bloedbaan
terechtkomen. Het grootste deel van de witte bloedcellen worden gevormd door de neutrofiele-granulocyten (oftewel
neutrofielen), die zeer herkenbaar zijn door hun gelobde kern. Deze cellen zorgen ervoor dat lichaamsvreemde
stoffen (zoals bijvoorbeeld bacteriën) direct herkend en opgeruimd worden. Zij zijn dus zeer belangrijk bij een eerste
afweer tegen binnendringende micro-organismen in het lichaam.
Als het lichaam door bacteriën geïnfecteerd is, worden er signalen afgegeven die door neutrofielen opgemerkt
worden. Deze signalering leidt ertoe dat de neutrofielen geactiveerd worden, uit de bloedbaan treden en in de richting
van de infectie migreren. Daar aangekomen, kunnen neutrofielen de bacteriën aanvallen en vernietigen. Zij kunnen
dit o.a. doen door toxische stoffen uit te scheiden. Vervolgens worden de aangetaste bacteriën opgenomen door de
neutrofielen en in zijn geheel afgebroken.
Omdat deze cellen zo reactief zijn, kan het gevaarlijk zijn als een van de bovengenoemde processen ontregeld is.
Bijvoorbeeld, als neutrofielen teveel toxische stoffen uitscheiden, kan naast beschadiging van bacteriën ook het
lichaamseigen weefsel worden aangetast. Verder kan ook door disregulatie een chronische ontsteking ontstaan die
eveneens slecht is voor het omliggende weefsel.
Het is dus van groot belang dat alle processen die betrokken zijn bij de activatie van neutrofielen nauwkeurig
gereguleerd worden. Signalen die op de plaats van ontsteking worden afgegeven, kunnen door neutrofielen
opgemerkt worden omdat zij op hun oppervlak sensoren hebben. (Fig. 1). Deze sensoren worden receptoren
genoemd. Omdat er veel soorten signalen zijn, zijn er ook veel soorten receptoren en ieder signaal heeft een eigen
receptor. Deze signaal-receptor-interactie functioneert als een sleutel-slotprincipe waardoor ieder signaal een unieke
receptor bindt (Fig. 1). Als het signaal molecuul (sleutel) interactie aan kan gaan met de receptor (slot) kan in de cel
weer een specifiek signaal gegeven worden. Juist deze signalen die in de cel veroorzaakt worden (intracellulaire
signalen), zijn bestudeerd en beschreven in dit proefschrift.
De vraagstelling hierbij was, welke signalen een rol spelen bij het functioneren van neutrofielen. Dus bijvoorbeeld,
welke intracellulaire signalen zijn belangrijk voor de verplaatsing van neutrofielen naar de plek van ontsteking? Of,
welke intracellulaire signalen zijn betrokken bij de uitscheiding van de toxische stoffen? Maar ook de intracellulaire
signalen die betrokken zijn bij de rijping (differentiatie) van stamcellen uit het beenmerg naar volwassen neutrofielen
zijn bestudeerd.
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Figuur 1: Schematische weergave van het tot stand komen van intracellulaire signalen in een neutrofiele granulocyt.
Signaal moleculen (bijvoorbeeld vrijgekomen bij een ontsteking) passen in de juiste receptor. Hierdoor vindt er signaaloverdracht
plaats van buiten de cel naar binnen (intra) de cel. Door de binding van een signaalmolecuul aan zijn receptor kunnen vele
intracellulaire signalen geactiveerd worden, zoals is weergegeven met de pijltjes binnen de cel. Activatie van intracellulaire
signalen resulteert uiteindelijk in een respons van de cel, zoals bijvoorbeeld, migratie naar de plaats van ontsteking, maar ook het
tot expressie brengen van bepaalde genen.  De rol van verschillende intracellulaire signalen in het functioneren van neutrofiele
granulocyten is in dit proefschrift bestudeerd.
In hoofdstuk 2 wordt een modelsysteem beschreven voor de differentiatie van stamcel naar neutrofiele granulocyt.
Hiertoe worden stamcellen geïsoleerd uit navelstrengbloed. In dit systeem is de rol van intracellulaire signalering in
het differentiatie proces bestudeerd. Dit is gedaan door gebruik te maken van farmacologische remmers die
specifieke intracellulaire signalen blokkeren. Remming van één van deze specifieke signalen (het
phosphatidylinositol 3 kinase signaal) heeft als gevolg dat stamcellen niet meer kunnen uitrijpen tot volwassen
neutrofielen. Dit geeft dus aan dat dit intracellulaire signaal van belang is voor het normale differentiatieproces.
Omdat neutrofielen een zeer specifieke functie hebben (namelijk aanvallen en elimineren van bacteriën), dachten
we dat er ook specifieke intracellulaire signalen in deze cellen aanwezig konden zijn. In hoofdstuk 3 wordt het
resultaat beschreven van de identificatie van een nieuwe granulocyt specifieke kinase. Het is bekend dat kinases
belangrijke intracellulaire signaleringsmoleculen zijn. Het nieuwe geïdentificeerde en granulocyt specifieke kinase
heeft een sterke overeenkomst met een andere kinase, namelijk het “Ca2+/calmodulin-dependent kinase I” (CaMKI).
We laten zien dat het nieuwe kinase geactiveerd wordt door Ca2+ (calcium) en calmoduline, net zoals het kinase
waarop deze lijkt. We hebben het dan ook CaMKI Like Kinase, CKLiK, genoemd.
Doordat bleek dat CKLiK alleen in neutrofielen voorkomt en gereguleerd wordt door Ca2+ en calmoduline, hebben
we onderzoek gedaan naar de rol van calmoduline in het functioneren van neutrofielen. Hierbij is gebruik gemaakt
van een specifieke farmacologische remmer voor calmoduline. Hoofdstuk 4 beschrijft dat remming van calmoduline
resulteert in een blokkade van neutrofiel migratie en de productie van toxische stoffen.
Vervolgens is de rol van het nieuwe gekarakteriseerde kinase CKLiK in het functioneren van neutrofielen
bestudeerd. Hierbij is gebruik gemaakt van een stof die het CKLiK signaal kan remmen. Uit de resultaten die
beschreven zijn in hoofdstuk 5 blijkt dat CKLiK een belangrijke rol speelt bij de migratie en de zuurstofradicaal
productie.
In hoofdstuk 6 is getracht om op basis van DNA-patronen een geactiveerde neutrofiel te herkennen. Bij
geactiveerde cellen worden bepaalde genen actief aangezet en andere weer actief uitgezet. FLAP is een van die
genen die wordt aangezet. Dat dit daadwerkelijk een gen is dat verhoogde expressie vertoont tijdens activatie is
aangetoond in witte bloedcellen van allergische astmatische patiënten na een allergeen provocatie.
Samenvattend zijn in dit proefschrift bevindingen gedaan die meer inzicht geven in de intracellulaire signalering
van humane neutrofielen. Verder kan gespeculeerd worden over CKLiK als een toekomstig drugtarget.
Receptor A
Signaal molecuul B
Signaal molecuul A
Receptor B
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gehaaste mensen (dan vertrek je toch iets eerder!) hebben mij van tijd tot tijd goed geholpen. Je was een gezellige
pipeteerbuurman, (vooral als je een tijdreeks deed). Kim, als Duitse Groninger ben je toch aardig ingeburgerd in ons
Utrechtse labje. Ik heb al veel lol aan je beleefd, omdat je in de meeste grapjes trapte, die de rest al kon dromen.
Jammer dat ik nu ga, maar we gaan nog wel borrelen en bijkletsen op z’n tijd hè? Miranda, bedankt voor al die keren
dat ik met je mee mocht rijden, en netjes thuis afgezet werd, na een avondje borrelen. Ik vind het leuk dat je kunt
blijven en met jouw inzet kom je er wel. Belinda, samen door de laatste promotie stress, alhoewel ik denk ik iets
meer stress had dan jij. Hoe krijg je dat toch voor elkaar? Madelon, de eerste dag al kwam je me op de hoogte stellen
van het wel en wee op het lab. Maar ook voor goed advies over wat dan ook, kon (kan) ik altijd bij je terecht. Leuk
dat je weer in Utrecht bent (wanneer gaan we nu mozaïeken of is kleine jantje weer een excuus). Lisa, heerlijk dat
Italiaanse temperament van jou. Bedankt voor het mee opzetten van de neutrofiel differentiatie, dat was een hele
klus. Verder de bende van beneden, Jan, Deon, Corneli en Lei, bedankt voor jullie ondersteuning met betrekking tot
microscopen, de FACS, etc. Natuurlijk mag ik ook niet Bart en Erik-jan vergeten de twee meest enthousiaste artsen
onderzoekers. Alhoewel Erik-Jan liever niet genoemd wilde worden (sorry Erik-Jan, nu sta je er toch drie keer in)
Marcela, thanks for hassling over and over again the people in Colombia to send my peptide. It just arrived in time.
I wish you al the best with finishing your phD. Mike, thanks for your “gezelligheid” in the lab and you’re definitely
not a typical American, although, there are some things… just kidding. It was great to have you around. Good luck in
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Dan nog de ex-lab genoten; Niels (altijd even enthousiast, bedankt voor het leuke weekend in Boston. Jacqueline,
samen begonnen met het moleculair werk op lab 1, ’t was gezellig bedankt voor al je tips. We moeten snel weer eens
wat afspreken. Rolf, Thamar, Eric, Annelien (hoe is ie, ben je nu al getrouwd of gaat dat nog gebeuren), Andy,
Carolien, Paula, Nadia, Jaap-Jan, Philip, Humberto, Marja, bedankt voor jullie gezelligheid in het lab.
Dorien, ons hele leven zijn we al hartsvriendinnen. Je weet dat je een belangrijke plaats in mijn leven hebt en
daarom vind ik het fijn dat je naast me staat tijdens mijn promotie. Kus (ook aan René en Rens).
Dankwoord
174
Mam, zonder jou had ik het niet zo ver geschopt. Bedankt voor al je stimulatie en steun mijn hele leven lang. Pap,
de nuchterheid die ik van jou heb kwam soms goed te pas als ik weer eens in een dip zat. Bedankt voor al het
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